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Abstract 
Magnesium (Mg) and its alloys are at the forefront of an emerging series of biomaterials 
know as biodegradable metals. The ability to safely degrade in the body makes them ideal for 
temporary medical applications. Mg alloys have already shown good clinical success in 
orthopaedic and cardiovascular applications, suggesting this field is maturing from research 
consideration into a clinical reality.  
However, there is still considerable work required to fully characterise, understand, and 
control the rate of corrosion in the medical environment (i.e. biocorrosion). If the rate of 
biocorrosion is too high, the implant may fail before the body has finished healing. There are 
also material specific issues, such as the too rapid release of hydrogen gas, a by-product of 
Mg corrosion.  
As such, this thesis aims explore the corrosion of Mg alloys in a medical environment. A 
detailed literature survey considered the methods by which laboratory immersion tests (i.e. in 
vitro) attempt to replicate or mimic the corrosion from live animal or clinical studies (i.e. in 
vivo). A number of recommendations were made for the composition of the immersion 
solution, and the experimental parameters applied during the test (i.e. solution temperature), 
in an effort to improve the standard of in vitro tests and make them more reliable and 
comparable to in vivo biocorrosion.  
Following these recommendations, it was desirable to gather some in vivo biocorrosion data 
for comparison to in vitro data. However, before the samples could be implanted they first 
need to be sterilised. Two potential sterilisation techniques were applied to four Mg alloys, 
and their effect on the biocorrosion rate was measured in vitro. As neither gamma irradiation 
nor ethylene oxide influence the corrosion of the Mg alloys, these were deemed applicable 
techniques for future use.  
Specimens of three Mg alloys were sterilised with gamma irradiation and implanted 
subcutaneously into male and female Sprague-Dawley rats for either one or four weeks. The 
specimens were CT-imaged prior to sacrifice to determine the amount of hydrogen gas in a 
pocket around the sample. The corrosion rate and the size of the hydrogen pockets decreased 
with increasing implantation time. The corrosion rate for two of the alloys was also 
significantly higher in the female rats, as compared to the male rats. The female rats in these 
groups were also associated with a higher incidence of localised corrosion. In general, 
however, the corrosion was quite uniform across the samples surfaces.  
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The results from this in vivo trial were compared to two common simulated body fluids 
(SBFs) in vitro. Hanks’ Balanced Salt Solution (HBSS) was the superior model, attributed to 
the fact that HBSS contains PO42-, which forms an essential part of the corrosion product 
layer in vivo. HBSS was selected as the basis for the second part of the in vitro trial, which 
introduced an amino acid, and protein, in concentrations similar to solutions in the body, into 
the solution to study their effect. It was expected that making the solution more similar to the 
bodily fluids would yield better comparisons to in vivo data. In fact, the opposite occurred. 
Both the amino acids, and the protein, increased the corrosion rate by a factor of ~3, and 
produced significantly more localised corrosion. However, it was also noted that the 
subcutaneous in vivo environment did not contain a body of solution but instead could be 
considered ‘damp’ or ‘wet’, so that the in vivo environment was not equivalent to total 
immersion of the specimen in a body solution. A smaller volume of solution would be 
expected to decrease the rate of corrosion in vivo.   
One of the alloys studied (ZX00) was formed into wire, in order to study Mg alloys in a new 
application: as surgical tacks. However, cold drawing the extruded ZX00 into wire introduced 
iron (Fe) impurity particles into the surface of the specimens. These impurity particles 
increased the corrosion rate, and a variety of techniques were considered in an effort to 
remove them. Mechanically cleaning the wire with SiC grinding paper was found to reduce 
the corrosion rate and produce an even surface finish.  
This wire was then formed into surgical tacks, a device commonly used during laparoscopic 
hernia repair. The prototype absorbable Mg tack was compared against commercially 
available Titanium (ProTacktm), and PLGA (AbsorbaTacktm) tacks. The fixation strength of 
the tacks was tested in situ by fixing strips of mesh to porcine abdominal muscle tissue. The 
Mg tack performed statistically similarly to both commercial tacks.  
Finally, a reflection on the in vitro assessment of Mg biocorrosion was conducted, with a 
focus on practical experience and the associated lessons that could be drawn from the 
experiences. A series of updated recommendations and thoughts are presented, in an effort to 
improve future in vitro immersion testing.  
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Glossary  
Albumin: A family of globular proteins produced by the liver. The most common kind of 
protein in human blood serum. More specifically known as serum Albumin when considered 
in terms of blood.  
Alloy system: The description of what alloying elements, and in what concentrations, are in a 
material. A naming convention is often used to designate the elements and concentrations 
present in a Mg alloy using a letter and corresponding number. For example AE21 is alloyed 
with 2% Al, 1% RE, the remainder is Mg. A legend of the alloying elements and corresponding 
letter designations is presented in the table below. See also HP-Mg.  
Aluminium A Thorium H Lead P Yttrium W 
Bismuth B Strontium J Silver Q Calcium X 
Copper C Zirconium K Chromium R Antimony Y 
Cadmium  D Lithium L Silicon S Zinc Z 
Rare earth E Manganese M Tin T 
Iron F Nickel N Gadolinium V 
Amino Acids: Organic component made of an amine group, a carboxyl group, and an organic 
R side chain which is unique to each different amino acids.  
Balanced Salt Solution (BSS): A solution with physiological pH and concentration of ionic 
salts. Common BSS include Hanks’ (HBSS) and Earle’s (EBSS).  
Bioabsorbable: The ability for a material to be absorbed or dissolved into the body. Also may 
be known as: bioreabsorbable, biodegradable or biocorrodible (in the case of a metal).  
Biocorrosion: The corrosion of a metal in a physiological medium or environment. Can be 
used to describe corrosion either in vitro or in vivo. See also “corrosion”.  
Bovine Serum Albumin (BSA): A serum albumin derived from a bovine species (i.e. cows). 
See also Foetal Bovine Serum and Albumin.  
Blood Plasma: Provides the suspension for blood cells in whole blood. Makes up 55% whole 
blood by volume. Mostly water but also contains proteins, glucose, electrolytes (dissolved 
salts), CO2 and O2. 
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Corrosion: The gradual conversion of a material (usually metals) to a form stable form, via an 
electro-chemical reaction with their environment.  More generally, corrosion can be considered 
comparable to “degradation”.  
Corrosion Morphology: Description of the corroded surface of the specimen. Indicates what 
kind of corrosion has occurred. Generally used in conjunction to a corrosion rate to assess the 
corrosion behaviour of a Mg alloy.  
Corrosion Rate: The numerical description of how quickly a metal corrodes. Often measured 
in units such as mm/y or mg/cm2/day. In general, the amount the sample has corroded is average 
over the exposed surface area to provided understanding of how the sample has corroded on 
average. Also may be known as: degradation rate. Common symbol: P or CR.  
Cell Culture Medium (CCM):  A solution, semi-solid or solid which is designed to support 
cell or microorganism growth. Commonly contains water, a carbohydrate source (e.g. glucose), 
salts and amino acids. Also may be known as: Minimum Essential medium (MEM). Common 
Cell Culture Mediums are Eagle’s Minimum Essential Medium (EMEM) and Dulbeco’s 
Minimum Essential Medium (DMEM).  
EBSS: Earle’s Balanced Salt Solutions, a common type of BSS used as a SBF during in vitro 
immersion tests. See also Balanced Salt Solutions. 
Energy Dispersive X-ray Spectroscopy (EDX): An analytical technique used to analyse the 
chemical or elemental composition of a material.  
Fourier Transform Infrared Spectroscopy (FTIR): A technique used to gain infrared 
spectrum emission or absorption information of a sample in order to identify organic, 
polymeric, and in some cases inorganic components.  
Foetal Bovine Serum (FBS): The blood serum (ie Blood with red blood cells removed) of a 
bovine foetus. Widely used in in vitro biological experiments due to the lack of antibodies and 
high levels of growth factors. BSA is a major component of FBS. See also Bovine Serum 
Albumin and Albumin.  
Foreign Body Reaction: A broad description of the inflammatory or immune response of the 
body to the inclusion of a foreign body into the system (such as a medical implant or device).  
Gibbs-Donnan effect: The uneven distribution of charged particles across a membrane due to 
other particles that may not be able to pass the membrane. For example, negatively charged 
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proteins can’t pass through capillary walls. Therefore, small anions pass the capillary walls 
more readily than small cations (which are attracted to the proteins). 
HBSS: Hanks’ Balanced Salt Solution, a common type of BSS used as a SBF during in vitro 
immersion tests. Different styles or types are employed and may be referred to by a reference 
number. For example, H1387 is a common HBSS used in biocorrosion studies. H6136 is a 
similar solution which also contains a Phenol-red indicator, where 14175 does not contain Mg2+ 
or Ca2+. See also Balanced Salt Solutions.  
HP Mg: Abbreviation for High-Purity Magnesium which is defined here as as-cast material 
having an impurity (predominately Fe) content less than 100 ppm. Heat treatment can cause 
the precipitation of Fe rich particles, and typically increases the corrosion rate, typically by 
more than an order of magnitude. Other common abbreviations (i) Commercially Pure (CP)-
Mg which have a higher impurity content or have been heat treated such that some Fe particles 
have precipitated and thus have higher corrosion rate and (ii) Ultra-High-Purity (XHP)-Mg 
typically have impurity levels less than 5 ppm and thus may be able to undergo heat treatment 
with no adverse particles precipitating.   
In Vitro: Taken from the Latin phrase which translates to “in glass”. Refers to experiments 
conducted in a laboratory, in an experimental apparatus that studies a phenomena outside its 
usual biological context.  
In Vivo: Taken from the Latin phrase which translates to “within the living”. Refers to tests 
that are conducted within a living organism, usually an animal or human. This is opposed to a 
section of the animal (see in situ) or those done in an apparatus that mimics the desired 
environment (see in vitro).   
In Situ: Taken from the Latin phrase which translates to “on site”. Can refer to a range of 
different testing, depending on the context. In this thesis the term is used to denote tests which 
include part of the biological context but has some aspect/s removed from the whole. For 
example, sutures tested on part of an animal (i.e. an organ or section of muscle). Often 
considered an intermediary between laboratory (see in vitro) and live animal (see in vivo) 
studies.  
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Macrophages: A type of white blood cell which are present in all human tissue. Macrophages 
play an important role in the immune response, and will attempt to encapsulate and digest any 
foreign body that does not have proteins which are specific to healthy human cells on its 
surface.  
Minimum Essential Medium (MEM): See Cell Culture medium.   
Open Circuit Potential (OCP): Refers to the potential of the working electrode (i.e. the 
sample) when the specimen is simply placed into a given medium or environment. The anodic 
and cathodic reactions are in steady state; i.e. the speed of the anodic reaction equals the speed 
of the cathodic reaction. Also may be known as the corrosion potential. Common symbol: EOCP 
or ECorr.    
Phosphate Buffered Saline (PBS): A buffer solution commonly used in biological research 
as it is isotonic and non-toxic to most cells. Commonly contains NaCl, KCl and phosphates 
(Na2HPO4 and/or KH2PO4).   
Rare earth elements (RE or REE): A group of elements which have similar properties. 
Comprises the 15 elements in the lanthanide series and two additional elements that share 
similar chemical properties: Scandium (Sc), yttrium (Y), lanthanum (La), cerium (Ce), 
praseodymium (Pr), neodymium (Nd), promethium (Pm), samarium (Sm), europium (Eu), 
gadolinium (Gd), terbium (Tb), dysprosium (Dy), holmium (Ho), erbium (Er), thulium (Tm), 
ytterbium (Yb), and lutetium (Lu).  
Simulated Body Fluid (SBF): A solution which has been created in an attempt to mimic in 
vivo conditions in vitro. Usually a SBF has a similar ion concentration as blood plasma and is 
maintained at a physiological temperature (~37 °C) and pH (~7.35-7.45) to mimic in vivo 
conditions. Common examples of SBFs are PBS, HBSS, EBSS, EMEM and DMEM.  
X-ray Photoelectron Spectroscopy (XPS): A surface sensitive spectroscopy technique that is 
used to quantify the chemical composition of the surface of a material.  
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Chapter 1: Introduction 
This chapter introduces the topic of metallic biomaterials and biodegradable metals, and 
focusses on magnesium (Mg) alloys and Mg biocorrosion. The objectives and significance of 
the thesis is outlined, and a research planned is presented. The contents of the chapters are 
outlined.  
Several of the subsequent chapters are developed from published works. A preamble such as 
this is provided before each chapter to signpost how the chapters relate to one another, and 
how they build into the wider thesis.  
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  Sean Johnston1, 2 
1 The University of Queensland, Materials Engineering Division, School of Mechanical & 
Mining Engineering, Brisbane, Qld 4072, Australia 
2 The University of Queensland, Centre for Advanced Materials Processing and 
Manufacturing (AMPAM), Brisbane, Qld 4072, Australia 
 
1.1. Metallic Biomaterials   
During surgery clinicians often rely on a range of medical implants or devices to support 
damaged tissue as it heals. These implants and devices take many shapes and forms, 
including orthopaedic screws, sutures, surgical staples, hernia meshes and cardiovascular 
stents. These implants can be made from a range of materials. Many load bearing applications 
employ metals, because metals have a combination of high fracture toughness and high 
mechanical strength [1, 2]. In particular, corrosion resistant metals such as titanium, stainless 
steel, and nitinol (an alloy of titanium and nickel) have been favoured as in addition to 
strength and toughness, they have good biocompatibility and only corrode marginally in the 
biological environment [2, 3]. This high corrosion resistance gives confidence that the 
implant will provide consistent structural stability to the damaged tissue. 
However, this high degree of stability has an obvious consequence. While some implants are 
required for the rest of the patient’s life (e.g. a joint replacement), many are only required 
until the body has sufficiently healed the damaged tissue (e.g. a suture or bone screw). 
Corrosion resistant metals are ideal for permanent implants, but may pose potential problems 
when used in temporary applications. Every surgery comes with inherent risks and costs, so 
removing the implant once healing has finished is never simple and is not ideal in most cases. 
However, leaving the implant in place also has risks. The high corrosion resistance of these 
metals is essential to their biocompatibility, as many of the elements used in these alloys, 
such as titanium, chromium and cobalt, are toxic in even small quantities [2]. However, no 
metal is completely immune to corrosion and the release of some quantity of toxic particles 
or ions can occur through wear and small amounts of corrosion [4-7]. The risk of such a 
release logically increases with increasing implantation time. Additionally, all implants evoke 
some amount of immune response or foreign body reaction [8, 9]. Again, the risks associated 
with such a reaction logically increase with time.  
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As well as these generic issues, there can also be problems specific to certain applications. 
For example, the high elastic modulus of these materials can also be an issue for orthopaedic 
implants as it can create a strength imbalance between the implant and the surrounding bone, 
leading to stress shielding effects which can cause osteopenia [10]. 
For many cases the risks outlined above are considered minor and manageable. Nevertheless, 
there is an impetus to consider alternative materials which may not be susceptible to similar 
issues. This has lead researchers to consider a new class of metallic biomaterials are 
degradable, as well as functional.  
1.2. Biodegradable Metals & Biocorrosion  
Alloys made from magnesium (Mg), iron (Fe) and zinc (Zn) are being considered for 
temporary medical applications as a new class of biomaterials known as biodegradable metals 
[11]. These metals produce non-toxic ions which have known processing pathways in the 
human body [11], allowing them to safely corrode in the body once implanted, so that the 
implant slowly loses strength as the body heals. This eliminates the need for a secondary 
surgery to remove the implant, and also limits the risk of negative foreign body reaction by 
reducing the amount of time the implant is present in the body [8, 9, 12, 13].  
Of these three metals, Mg alloys have received the largest share of the research attention [1, 
11]. Mg alloys are exceptionally lightweight, with a density of 1.74 g/cm3, giving them a 
higher specific strength than stainless steels and titanium alloys. Mg is also the second most 
abundant element in the human cellular systems, and is involved in many metabolic pathways 
[14]. Mg has a stabilising effect on DNA, while also being a vital cofactor in almost all 
enzyme systems involved in DNA processing [14]. Excess Mg is efficiently processed 
through the renal system [15-17]. Mg alloys have also been found to be not just 
biocompatible, but also bioactive, as they encourage bone growth surrounding the implant 
when used in orthopaedic applications [18]. Additionally, Mg alloys have a stiffness much 
closer to that of cortical bone which is believed to reduce stress shielding effects [1, 10]. This 
combination of inherent biocompatibility and good mechanical properties have led to strong 
consideration for Mg alloys as biomedical implant materials, and produced a number of 
commercially available (and clinically successful) products [19-22].  
However, the use of Mg as a biomaterial is not without its challenges, most of which are 
linked to the implants corrosion rate. The corrosion of Mg in an aqueous environment is 
presented in equation (1).  
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This is the equation which governs how the samples degrade in a medical environment (i.e. 
biocorrosion). The corroding Mg produces hydrogen gas. If the Mg implant corrodes slowly, 
this gas can dissipate harmlessly. However, if the corrosion is too fast, the gas can form 
pockets or bubbles and harm the biocompatibility of the implant [23-25]. Additionally, a high 
corrosion rate likely decreases the structural integrity of the implant, causing it to fail before 
the damaged tissue has fully healed.  
Mg(ୱ) + 2HଶO(୪) → Mg(OH)ଶ(ୱ) + Hଶ(୥)  (1) 
As such, it is imperative that the corrosion rates of Mg medical devices are low, controlled, 
and predictable. To achieve this, a full and deep understanding is needed of the factors that 
influence Mg biocorrosion, as well as the biocorrosion environment itself.  
1.3. Objectives & Significance  
Mg biocorrosion is commonly studied via two separate but intimately linked methodologies: 
laboratory (in vitro) immersion tests and live animal (in vivo) trials. Both methods have their 
advantages and limitations, and the results often inform future testing in both areas.  
In vitro tests are versatile, cheap, and usually quick to set up. However, the biological 
environment within the body is complex, and thus mimicking it in a laboratory setting has 
proven challenging. The lack of a standardised testing methodology has led to a distrust of in 
vitro results, with many tests needing to be repeated due to inconsistent methods and 
procedures [26]. It is for this reason that in vitro procedures are often benchmarked against 
results from in vivo trials.  
However, these in vivo tests are expensive, and also carry a high ethical burden. Additionally, 
there are a number of complicating factors that are not well understood about the in vivo 
biocorrosion environment, which can limit the usefulness of the data.  
This thesis aims to develop a more comprehensive understanding of the factors that influence 
biocorrosion in both environments (in vitro and in vivo), in order to improve both the 
effectiveness and consistency of biocorrosion testing. Additionally, a significant amount of 
time and resources is saved by reducing the number of tests that need to be repeated. By 
enhancing our ability to measure or assess different aspects of biocorrosion we can better 
predict how implants perform in service, and ideally improve their performance.   
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Additionally, this thesis also explores areas of potential growth for Mg alloys as medical 
devices. Currently much of the focus has been on a cardiovascular stents [13] and 
orthopaedic implants[1].  
While Mg alloys have been proven clinically successful in both of these areas [19-22, 27], we 
believe there are other temporary medical implants which could be improved with Mg 
components. In this thesis the focus has been predominately on wire based applications, with 
a case study made of Mg wire used as a surgical tack.   
1.4. Research Plan & Thesis Structure  
Figure 1 presents a schematic representation of the research plan underpinning this thesis. 
Circular shapes are areas of research or topics significant to this emerging discipline, 
rectangular shapes are chapters within this thesis. 
 
 
 
Figure 1: Schematic representation of the research plan. 
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The thesis examines the areas outlined in Figure 1 as follows:  
Chapter 1: Introduction  
Chapter 1 (i.e. this chapter) provides an introduction to the key topics discussed in this thesis 
including metallic biomaterials, biodegradable metals (focussing on magnesium), and 
biocorrosion.   
Chapter 2: Literature Review  
Chapter 2 provides a review of the relevant literature, based on the publication: “Building 
towards a standardised approach to biocorrosion studies: a review of factors influencing Mg 
corrosion in vitro pertinent to in vivo corrosion”.  
Chapter 3: Influence of Sterilisation on Biocorrosion  
This chapter is based on the publication: “The influence of two common sterilization 
techniques on the corrosion of Mg and its alloys for biomedical applications”. Following on 
from the discussion of in vitro biocorrosion testing presented in chapters 2, this chapter uses 
an in vitro immersion test to determine which sterilisation techniques are safe for Mg alloys. 
Sterilisation is an essential part of the processing for all medical implants. This research 
determined the sterilisation technique used on the Mg specimen prior to the animal testing 
reported in chapter 5.     
Chapter 4: In Vitro vs In Vivo 
This chapter is based on the publication: “Optimisation of Simulated Body Fluids as In Vitro 
Models of In Vivo Mg Biocorrosion”. In vivo data is gathered and compared to a series of in 
vitro solutions and environments, in an effort to better understand both corrosion 
environments. This study also considers important aspects of the in vivo condition, such as 
the composition of bodily fluids and if the sex of the animal has an influence on the 
biocorrosion environment.  
Chapter 5: Forming of Wire & the Influence of Surface Condition of Corrosion  
This chapter is based on the publication: “Influence of surface condition on the corrosion of 
ultra-high-purity Mg alloy wire”. Temporary wire based medical devices are identified as a 
relatively unexplored niche suitable for Mg alloys. A method for forming Mg wire is 
developed, and a series of surface conditions are explored to determine their influence on 
biocorrosion in vitro.  
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Chapter 6: Prototype Mg Surgical Tack  
This chapter is based on the publication: “Absorbable Mg Surgical Tack: Proof of Concept & 
In Situ fixation strength”. This is the first reported consideration for the use of Mg wires as 
surgical tacks. The novel Mg tack prototypes are compared against commercially available 
titanium and polymer tacks in an in situ lap-shear test using porcine abdominal muscle tissue.  
Chapter 7: Practical Considerations for In Vitro Biocorrosion Immersion Testing  
This chapter is based on the publication: “Investigating Mg Biocorrosion In Vitro:  
 Lessons Learnt & Recommendations”. This research builds on the literature review 
recommendations of Chapter 2, as well as the practical experience from Chapters 3-5, and 
presents the more practical lessons, and associated recommendations, for in vitro 
biocorrosion testing.   
Chapter 8: Summary, Recommendations, & Future Work  
The final chapter presents the key findings of the thesis, and considers how they might 
influence or direct future research in this area.  
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Chapter 2: Literature Review 
 
This chapter provides the foundational literature review of the thesis and critically analyses 
current methods of biocorrosion assessment. Each element of the simulated body fluids 
(SBFs) used in in vitro immersion tests are systematically analysed to determined how 
important they are to the overall corrosion behaviour, and at which concentration they need to 
be included for the tests to be valid. Similarly, critical parameters of the in vitro 
methodology, such as solution temperature and flow rate, are analysed and recommendations 
provided.  
This chapter forms the basis for much of the in vitro corrosion testing carried out in 
subsequent chapters, and is combined with the in vivo results in Chapter 4 to attempt to better 
characterise the Mg biocorrosion mechanism/s both in vitro and in vivo.  
The authors listed contributed to this chapter as follows:  
Contributor Concept for the 
review  
Wrote 
Paper 
Edited 
Paper  
Sean Johnston 75% 100% 40% 
Matthew Dargusch 5% - 30% 
Andrej Atrens  20% - 30% 
 
  
- 12 - 
 
Building towards a standardised approach to biocorrosion studies: 
a review of factors influencing Mg corrosion in vitro pertinent to  
in vivo corrosion 
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Abstract  
The factors that influence magnesium (Mg) corrosion in vitro are systematically evaluated 
from a review of the relevant literature. We analysed the influence of the following factors on 
Mg biocorrosion in vitro: (i) inorganic ions, including both anions and cations, (ii) organic 
components such as proteins, amino acids and vitamins, and (iii) experimental parameters 
such as temperature, pH, buffer system and flow rate. Considerations and recommendations 
towards a standardised approach to in vitro biocorrosion testing are given. Several potential 
SBFs are recommended. Implementing a standardised approach to experimental parameters 
has the potential to significantly reduce variability between in vitro biocorrosion tests, and to 
help build towards a methodology that accurately and consistently mimics in vivo corrosion. 
However, there are also knowledge gaps with regard to how best to characterise the in vivo 
environment and corrosion mechanism. The assumption that blood plasma is the correct 
bodily fluid upon which to base in vitro methodologies is examined, and factors that 
influence that corrosion mechanism in vivo, such as specimen encapsulation, bear 
consideration for further studies.     
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1. Introduction 
1.1. Medical Magnesium & Biocorrosion  
Alloys of Magnesium (Mg), Zinc (Zn) and Iron (Fe) are being developed as a new class of 
metallic biomaterials known collectively as biodegradable metals [1]. These are different to 
traditional metallic biomaterials, which are dominated by corrosion resistant metals such as 
titanium, cobalt-chromium alloys and stainless steel [2]. The key application for 
biodegradable metals is for temporary medical implants and devices [3-7]. Biodegradable 
metals corrode and disappear after implantation. This eliminates the need for a subsequent, 
second surgery to remove the implant or device, as well as lowering the risk of infection and 
foreign body reaction [8-12]. Mg based implants have experienced good clinical successes in 
recent years [13-17]. 
In addition to be using effectively in temporary implants, Mg alloys have potential to be 
developed into multifunction medical materials [1]. Mg encourages osteogenesis [18], which 
has clear potential for orthopaedic applications [2]. Furthermore, the corrosion products of 
the Mg implant may be beneficial in certain applications [1]. For example, Mg corrosion 
releases H2 gas, as shown by the overall corrosion reaction in equation (1). This hydrogen 
may be significant, as rats who inhaled H2 after brain injury had a lower level of brain tissue 
infarction [19]. Chen 2017 [20] proposed a mesh made from a Mg alloy for cranial repair, as 
the Mg enhances bone regrowth, and the H2 that diffuses into the brain tissue may reduce the 
extent of tissue damage.  
𝑀𝑔 + 2𝐻ଶ𝑂 → 𝑀𝑔(𝑂𝐻)ଶ + 𝐻ଶ  (1) 
Nevertheless, despite the potential benefits of Mg alloys in medical applications, the key 
factor that must be addressed, is the apparent, relatively-high corrosion rates of Mg alloys 
[21, 22]. The tendency to corrode in the body allows Mg alloys to be used in temporary 
medical implants or devices. However, these corrosion rates must be controlled. Too rapid 
corrosion of the implant can cause issues stemming from (i) rapid ion release, (ii) excessive 
H2 gas production forming gas pockets, (iii) local pH increases, and (iv) premature loss of 
structural integrity of the implant. The creation of hydrogen gas pockets has been of 
particular concern for biodegradable Mg implants [23, 24], and the size of the gas pockets is 
linked to the samples corrosion rate [25].  Ideally, the corrosion rate of the implant would 
match the rate at which the body tissue heals, as depicted in Figure 1 [26]. 
- 14 - 
 
 
Figure 1: Diagram describing ideal degradation behaviour (and associated change in mechanical integrity) of 
a degradable orthopaedic implant [26]. 
In an effort to achieve this goal, a considerable body of research has been conducted to 
understand and control Mg corrosion in medical environments, which is also referred to as 
biocorrosion. The majority of this research into Mg biocorrosion has been conducted via in 
vitro immersion tests [27-39].  
1.2. Variability of In Vitro Testing & the Need for Standardisation  
In vivo and clinical data are undeniably vital to the study and success of Mg biomaterials. 
However, the high financial and ethical burdens associated with in vivo testing should, and 
does, limit their use. Consequently, in vitro testing continues to be the most frequently used 
method to study Mg biocorrosion.  
In vitro testing can be utilised to reduce the ethical burden on in vivo studies by pre-screening 
a large batch of potential alloys to determine the best candidates, significantly reducing the 
number of animal sacrifices necessary for an in vivo assessment [40]. In vitro testing can also 
be used to assess factors that may be impossible, or impractical, to measure in vivo or in situ. 
As an example, the authors’ pervious work considered the influence of pH on the 
biocorrosion of several Mg alloys [36]. This study would not been possible in vivo as 
changing an animal’s blood pH would have been difficult, dangerous and unlikely to pass 
ethical scrutiny.  
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It has long been the goal of biocorrosion research to construct an in vitro methodology that 
accurately compares to in vivo behaviour [41]. In order for a laboratory or in vitro corrosion 
test to be able to predict in service corrosion (in this case in vivo corrosion), the in vitro 
corrosion testing must adhere to the following principle: the in vitro corrosion test must 
produce the same corrosion mechanism as that operating in service. This typically means 
considering the essential causative factors for the in-service corrosion, and reproducing these 
factors in the in vitro environment. This can be an iterative process. Success is evident when 
the in vitro corrosion tests and the in service corrosion (in vivo) have the same corrosion 
rates, the same corrosion manifestation, and the same corrosion products.  
However, the early testing failed to accurately predict in vivo corrosion rates or the corrosion 
mechanism. Initial testing used immersion conditions in simple NaCl solutions, but these 
were found to be inappropriate [42]. Subsequently, a wide range of solutions and 
methodologies have been explored [36, 43-46] each with advantages and limitations, 
although some studies still continue to use NaCl solutions [47]. Table 1 provides a 
comparison of the constituent elements of several commonly used in vitro immersion solution 
[24, 48-50].  
Table 1: Comparison of common immersion solutions used in in vitro biocorrosion studies compared to blood 
plasma. Please see the glossary for an explanation of the acronyms used.     
 Component  Blood 
Plasma 
[48, 49] 
HBSS (H1387) 
[24] 
HBSS (14175) 
[50] 
EBSS 
[48] 
MEM 
[48] 
Inorganic 
Ions 
(mM) 
Cl- 100.0-103.0 145.0 143.3 125.0 125.0 
HCO3- 22.0-30.0 4.2 4.2 26.0 26.0 
H2PO4- 0.0-0.08 0.4 0.4 - - 
HPO4-2 0.0-1.0 0.3 0.3 1.0 0.9 
SO42- 0.5 0.8 - 0.4 0.4 
Mg2+ 1.0-1.5 0.8 - 0.4 0.4 
Ca2+ 2.5 1.26 - 1.8 1.8 
Na+ 140.0-142.0 142.0 142.8 144.0 143.0 
K+ 5.0 5.8 5.8 5.4 5.4 
Organic 
Components 
(g/L) 
Protein (e.g. 
albumin) 
35-80 - - - - 
Amino Acids 0.25-0.40 - - - 0.95 
Vitamins Variable (in 
range of  
µg-mg) 
- - - 0.008 
Glucose 0.9-1.1 1.0 1.0 1.0 1.0 
This variety in experimental solutions and conditions makes comparison between studies 
challenging, which has necessitated a number of studies to be repeated.  
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The complex and interacting factors which influence biocorrosion in vitro has split opinions 
within the field, leading to some distrust of in vitro biocorrosion testing [41], which is a 
significant impediment to progress in the field of biocorrosion and biodegradable metals. A 
movement towards standardization has been discussed [41] but with such a complex system, 
lack of complete knowledge, and such varied methodologies, progress towards this end has 
been challenging.   
As the ultimate goal of in vitro testing is to accurately predict and mimic the in vivo corrosion 
behaviour [41], it would seem logical to just compare several in vitro conditions to the in vivo 
results and determine which is most accurate or representative. However, due to the complex 
nature of the biocorrosion environment, and the large variations and inconsistencies in the in 
vitro conditions, this direct approach has not been as widely accepted as could be hoped. To 
illustrate this, a case study is made of two studies, which have directly compared in vitro 
biocorrosion to in vivo and effectively came to opposite conclusions. These studies are 
outlined briefly in Table 2 [24, 50].     
Table 2: Two studies which have directly compared in vitro corrosion to in vivo corrosion. 
 Marco et al. [50] Zainal Abidin et al. [24] 
SBF PBS, HBSS (14175) & DMEM HBSS (H1387) 
Animal Model Sprague-Dawley rat (male), Femur Mister rat (male), 
Subcutaneous 
Solution Volume 
Control 
30 mL/cm2 for PBS & HBSS, 50 
mL/cm2 for DMEM 
0.7 L/sample 
pH Control & 
buffer 
No control for PBS & HBSS. 5% CO2 
atmosphere for DMEM 
Active CO2 
Alloys Pure-Mg, Mg10Gd & Mg2Ag HP-Mg, WZ21 & AZ91 
Number of 
Samples 
n=6 in vitro 
n=2 in vivo (2 samples per 1 rat) 
Minimum of n=4 
for various time points 
Summary of 
results 
A large amount of variation was found in 
the corrosion rates of the alloys tested 
when comparing in vitro and in vivo 
results. DMEM was considered the best 
solution used as it produced a similar 
corrosion layer to the in vivo model. 
CO2 buffered HBSS (H1387) produced 
similar corrosion rates in vitro when 
compared to in vivo for HP-Mg and 
WZ21. The AZ91 samples had much 
lower corrosion rates in vivo, attributed to 
these samples being encapsulated in 
fibrinous tissue. 
The studies presented in Table 2 provide valuable insight into the comparison between in 
vitro and in vivo biocorrosion conditions. However, their impact is limited by inconsistent 
experimental conditions. Marco et al. [50] compared several Mg alloys in several in vitro 
solutions to samples in Sprague-Dawley rats. This study found a large amount of variation 
between these conditions, but ultimately concluded that DMEM was most suitable as it more 
closely reproduced the in vivo corrosion layer. However, there are several concerns with the 
in vitro methodology employed.  
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No pH control was employed for the simpler SBFs (PBS and HBSS), while a 5% CO2 
atmosphere was used for DMEM. Additionally, the HBSS used did not contain Ca2+ or Mg2+. 
This omission is sigificant as HBSS usually contain these ions [36, 37, 51, 52], and it is likely 
the reason that there was poor agreement between the corrosion layers of the HBSS samples 
comapred to in vivo in this study.  
In contrast, Zainal Abidin et al. [24] found CO2 buffered HBSS (containing Ca2+ and Mg2+) 
to be a good model for intramuscalr in vivo corrosion in Mister rats. It was further proposed 
that the reason for this good agreement was that the SBF used had a similar ionic content to 
blood, and a reliable buffer system which was similar to that used in the human respiratory 
system. However, this was the only in vitro environment tested, and this result provides 
limited scope to the question of the the existance of a more optimum in vitro system or 
solution. It is impossible to determine from these results if this is the best SBF or if additional 
components, such as protiens, might have further improved the comparision.   
These results indicated that there is currently still lacking a “gold standard” methodology 
which provides optimum comparision to in vivo results. However, in vitro evaluations 
continue to be an important component in biocorrosion testing for the foreseeable future. As 
such, it is important that in vitro tests are structured to be as accurate, repeatable, and 
consistent as possible. This need is reflected in the ASTM standard currently in development 
which seeks to provide guidance for the in vitro assessment of biodegradable/absorable 
metals  [53]. A deep and full understanding of how each aspect of the in vitro environment 
influences the biocorrosion of Mg alloys is an essential part of improving in vitro testing, and 
building towards a standardised biocorrosion methodology.  
In order to achieve this aim, and to help inform the development of standard testing practice 
in this area, a systematic analysis is herein conducted on each element or parameter of the in 
vitro biocorrosion system individually, in order to create a clearer picture of which aspects 
are most vital to a standardised approach. Current key knowledge gaps or areas of interest are 
also identified.  
This review focuses on the influence of (i) inorganic ions, (ii) organic components, and (iii) 
experimental parameters such as temperature, pH and solution flow rate. On this foundation, 
recommendations are made (i) on the immersion solution and (ii) experimental parameters 
that should be considered in a standardised biocorrosion methodology.   
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2. Magnesium Corrosion Assessment  
Corrosion of Mg in a medical environmental (aka biocorrosion) converts metallic Mg into the 
stable Mg2+ ion. This occurs in the presence of water, which is simultaneously reduced to 
form hydrogen gas (H2). Hydroxide ions (OH-) are also formed. These readily react with 
Mg2+ ions to form the corrosion product magnesium hydroxide (MgOH)2, because of the low 
solubility of (MgOH)2. The overall reaction is given in equation (1).  
Corrosion of Mg alloys is typically faster than the corrosion of high-purity Mg in simple 
chloride solutions, because the second phase in the Mg alloy causes micro-galvanic 
acceleration of the corrosion of the alpha-Mg matrix [22, 54-56]. When secondary phases 
precipitate into the primary Mg matrix a micro-galvanic reaction occurs, causing the less 
noble of the two phases to corrode preferentially. The phase that experiences accelerated 
corrosion is almost always the Mg matrix as Mg is anodic to most metals. This micro-
galvanic corrosion acceleration typically occurs preferentially next to the second phase, and 
is often wrongly characterised as pitting corrosion. In less aggressive solutions, like sulphate 
solutions, the corrosion products on the matrix phase can overcome this micro-galvanic 
acceleration, and the corrosion rate can begin to decrease despite the presence of second 
phase particles, as for example Mg-Y alloys in the work of Liu et al. [57]. 
The corrosion of Mg is commonly characterised via a corrosion rate. This corrosion rate 
measures the average amount of Mg that has been corroded over a period of time. Typical 
units are mm/y or mg/cm2/day. Both of these units are equally valid, and require a simple 
conversation factor to compare. For consistency, the corrosion rates discussed herein use 
mm/y.  
Corrosion rates are measured via a number of different techniques, the most common being 
(i) mass loss, (ii) hydrogen evolution and (iii) Tafel extrapolation of cathodic polarisation 
curves. A detailed description of each technique can be found in any one of several good 
reviews [54, 55, 58]. Each technique has strengths and limitations. Consideration should 
always be given to using a number of techniques in tandem, in order to mitigate any potential 
issues or inaccuracies that may occur when only employing a single technique. Corrosion 
rates are useful for a direct comparison between samples or alloys, however they may not 
provide a complete picture of the corrosion when considered on their own. Consideration of 
the corrosion morphology is also recommended, as this provides information on the type of 
corrosion that has occurred [42, 59].  
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Many studies also conduct an analysis of the corrosion products and the layers these products 
form on the sample’s surface (aka surface films) [60]. More stable corrosion products or 
oxide/hydroxide films forming on the surface of the sample reduce the sample’s active 
contact area with the solution, thereby providing some protection from corrosion. This is of 
particular importance in more complex solutions, such as those used when measuring 
biocorrosion. Typical Mg corrosion products, such as Mg(OH)2, are not expected to form a 
stable corrosion-product film under physiological pH levels, and thus only provide partial 
protection. However, in more complex solutions, such as those employed in biocorrosion 
testing, more varied corrosion products can form [21]. These additional corrosion products 
can form surface films, which provide more substantial protection, and slow the corrosion 
rate of the sample [21, 54].   
2.1. Nomenclature  
To ensure this review provides useful commentary to the widest possible audience, a glossary 
of terms is presented at the end of this paper. This glossary defines, explains or otherwise 
clarifies terms, acronyms, and/or abbreviations that are common in this field of study.   
Additionally, it is noted that due to the variable nature of measuring and reporting 
biocorrosion data, many studies have resisted direct comparison of the biocorrosion rates 
reported. As such, a series of terms are proposed herein to indicate a percentage range of 
influence. These are outlined as follows: 
 Minimal: effectively no change in the corrosion rate 
 Slight: ~0-25% change in the corrosion rate  
 Moderate: ~25-100% change in the corrosion rate 
 Substantial: > ~100% change in the corrosion rate 
These terms allow the reader to appreciate the magnitude of the influence measured, while 
avoiding conversations or comparisons which might have appeared disingenuous, and 
maintaining the integrity of the original study and data set.   
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3. Inorganic Ions  
3.1. Anions 
Human body fluids contain anions such as chlorides (Cl-), carbonates (HCO3-), phosphates 
(H2PO4- & HPO42-), and sulphates (SO42-) [61]. The influence of anions, in particularly 
chlorides, on the corrosion of metals has been well studied [62-64], and such anions have 
gathered significant interest in the field of Mg biocorrosion.  
3.1.1. Chloride Ions (Cl-) 
Chloride ions are known to increase corrosion rates of Mg alloys by destabilising partly-
protective films in simpler solutions such as 3.5% NaCl [54, 65], and this is commonly 
expected to be the case in more complex solution such as SBFs. The presence of Cl- 
destabilises the partially protective Mg(OH)2 corrosion layer to form MgCl2, which is water 
soluble and therefore does not protect the underlying Mg [66].  This reaction is presented in 
equation (2). Increased concentration of Cl- was found to increase the probability for localised 
corrosion of AZ91 in a range of modified SBFs [59]. Cl- were also postulated to have 
destabilised the corrosion product layer, inducing the dissolution of the mildly protective 
Mg(OH)2 layer and transforming it into a soluble MgCl2 layer in CP-Mg samples [67].   
𝑀𝑔(𝑂𝐻)ଶ + 2𝐶𝑙ି → 𝑀𝑔𝐶𝑙ଶ + 2𝑂𝐻ି  (2) 
These results suggest that the influence of Cl- may be similar to that in simpler solutions. 
However, further investigation into the effects of this ion have been pursued as the 
complexity of SBFs, specifically the wide array of ions present, can require a nuanced 
approach. Taltavull et al. [51] studied the influence of Cl- on the biocorrosion of HP-Mg, 
AZ91 and ZE41.  Five immersion solutions were tested, and are presented in Table 3 with a 
comparison to blood plasma [51]. To maintain pH within physiological levels, they used the 
same buffer system as that by Zainal Abidin et al. [24] between CO2 gas and the dissolved 
NaHCO3. This system is covered in detail in the following section on carbonates, as well as 
in Section 5.2. An increased incidence of localised corrosion was associated with an increase 
in Cl- for all three alloys. However, the higher incidence of localised corrosion was not 
always correlated with an increased corrosion rate.  
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Table 3: Solutions used in Taltavull et al. [51] to study the influence of Cl- on HP-Mg, ZE41 and AZ91 with 
blood plasma given as a reference. When referring to this study, solutions are referred to sequentially from 
solution 1 ([Cl-] = 0) to solution 5 ([Cl-] = 1). 
Figure 2 presents a comparison between the HP-Mg and ZE41 samples [51], with the AZ91 
samples behaving similarly to the ZE41. There was a substantial increase in the corrosion rate 
between solutions 1 and 2 for AZ91 and ZE41, and a slight increase for HP-Mg. This 
indicated that the presence of Cl- caused an increase in corrosion rate, due to the disruption of 
the partially protective corrosion product layer by the aggressive Cl- ions. This lead to an 
increase in micro-galvanic interaction between the second phase and the Mg matrix for AZ91 
and ZE41, as more surface area was exposed to the corrosive medium, and the disruption of 
the corrosion product layer lessened the passivating influence of alloying elements such as Al 
in AZ91. The effect of disrupting the partially protective surface film was small for HP Mg 
because HP Mg is single phase and therefore will not experience micro-galvanic effects. 
Solution 3 was a HBSS, and the additional ions in this solution substantially reduced the 
corrosion rate of the samples compared with that in solution 2, despite the moderate increase 
in Cl- content. The cause of this decreased corrosion rate was attributed to the changed 
surface film which was in turn caused by the increased phosphate ion concentration, (in 
combination with Ca2+, Mg2+, and HCO3-). These ions all alter or add to the corrosion product 
layer, which has an influence on the corrosion rate of the sample. For a more detailed 
understanding of the effects of these ions, please consult the section of this review dedicated 
to the ions individually. 
In the solutions 4 and 5 (where NaCl was added to the HBSS) there was again a clear 
distinction between the HP-Mg, and the other alloys. The higher sensitive to Cl- continued for 
the AZ91 and ZE41, again attributed to the micro-galvanic effects between the secondary 
phases and Mg matrix. The higher Cl- content, and the associated increased localised 
corrosion, was associated with a substantially higher corrosion rate for ZE41 and AZ91, 
whereas there was minimal influence on the corrosion rate of the HP-Mg samples, which had 
no second phase.  
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This confirms that the influence of Cl- is dependent on the alloy being tested, however 
typically an increase in chloride concentration will cause an increase in corrosion rate.  
 
Figure 2: Comparison of (a) HP-Mg and (b) ZE41 in a range of solutions with variable Cl- content [51]. 
These results support that increasing the Cl- content tends to increase the biocorrosion rate of 
Mg alloys by disrupting the partially protective corrosion product layer, and should be 
maintained within a physiologically relevant range. Additionally, the ability of the Cl- content 
to promote localised corrosion is more pronounced in alloys with a greater amount of 
secondary phase. The micro-galvanic corrosion, which is common to such alloys, leaves them 
susceptible to this type of localised corrosion attack because the electrochemical potential 
between the two phases provides an additional driving energy for the corrosion of the Mg 
matrix.  
As such, it is recommended that multiple alloys be used when investigating an aspect of 
biocorrosion, as a single alloy may not tell the entire story.    
3.1.2. Carbonate Ions (HCO3-) 
Another well-studied anion common to most SBFs and biological solutions is HCO3-. This is 
important predominately because of the role it plays in the respiratory buffer system [68]. 
This system is presented in equation (3).  
HଶO + COଶ ↔ HଶCOଷ ↔ Hା + HCOଷି (3) 
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Studying the influence of HCO3- on biocorrosion is challenging, as it requires an effort to 
decouple the influence the ion has on the Mg samples directly from the buffering potential it 
provides to the solution. For a detailed discussed of the influence of solution pH and various 
buffering systems on the biocorrosion of Mg please consult section 5.2. In summary, it has 
been found that low solution pH promotes the dissolution of Mg, and high solution pH 
decreases the corrosion rate by stabilising the corrosion layer [36]. Mg corrosion in an 
unbuffered solution leads to an increase in solution pH. In a simple NaCl solution the pH 
increases to ~10.3 after several hours due to the low solubility of Mg(OH)2; the physical 
chemistry by which the pH is controlled by the low solubility of Mg(OH)2 is fully described 
by Atrens et al. [55].  
Xin et al. [59] considered the influence of a range of ions, including HCO3-, on the corrosion 
of AZ91. The presence of HCO3- appeared to initially stimulate corrosion, before aiding 
passivation due to the precipitation of MgCO3 and CaCO3, which slightly lowered the 
corrosion rate and completely supressed any incidence of localised corrosion. This result was 
support by the results of Ma et al. [67] who conducted a primarily electrochemical study of 
the biocorrosion of CP-Mg and also concluded that the presence of HCO3- initially increased 
the corrosion rate but eventually promoted the deposition of a protective corrosion layer 
which reduced the corrosion rate. However, these results [59, 67] only provide a binary 
comparison between solutions with and without HCO3-. As previously discussed, HCO3- are 
an essential component to the buffer system shown in Equation (3). It is likely that without 
this buffer, the pH of the solutions without HCO3- would have risen quickly due to the 
corrosion of Mg. These samples would have been more quickly passivated than the samples 
in buffered solutions containing HCO3-. In this way, what may appear as a relative increase in 
corrosion rate could have resulted from a retardation of the corrosion rates due to increasing 
solution pH.  
In a further study, Xin et al. [69] studied a range of  HCO3- concentrations over a 24 hour 
immersion. A substantially higher concentration of HCO3- decreased the corrosion rate 
substantially in the first few hours; however this effect diminished to a slight or minimal 
influence by the end of the 24 hour test. Additionally, this large initial increase may have 
been a result of the higher levels of Tris-HCl buffer, which were included in the solutions 
with less HCO3- to better buffer the solution. This was a surprising experimental decision, as 
the same authors have found that the Tris-HCl buffer substantially increased the corrosion 
rate of Mg alloys in SBF [70].  
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In a similar study, but without the Tris-HCl influence, Agha et al. [71] considered the 
biocorrosion of HP-Mg in a range of solutions with varying buffering salt concentrations. 
Increasing concentrations of HCO3- (4.4, 22 and 44 mM) yielded minimal change in the 
corrosion rate. This result was supported by the study of Kirkland et al. [72] where a minimal 
to slight difference was found between HBSS and EBSS when an active CO2 buffer was used, 
as presented in Figure 3. A comparison between the HBSS and EBSS in Table 1 indicates the 
primary difference between the balance salt solutions is the higher level of HCO3- in EBSS. 
This result suggests this higher concentration does not significantly influence the corrosion 
rate, provided the pH is adequately controlled (as is discussed further in Section 5.2). 
 
Figure 3: The mass loss corrosion rate of CP-Mg in different SBFs and buffers, at 37 °C for 1 week. 40 g/L of 
BSA was added to include proteins in the MEM + BSA solution. Note: these corrosion rates were calculated  
from the % mass loss presented in Kirkland et [72]. KMB- Kirkland Biocorrosion Medium, a modified SBF. 
These results suggest that HCO3- influences the corrosion through the formation of corrosion 
products such as MgCO3 and by buffering the solution. However, there is little difference in 
the corrosion rate in SBFs with HCO3- in the range from 4.4, to 44 mM, once there is a 
protective surface film.  
It should also be noted that increasing HCO3- concentration has an influence on the stability 
of the SBF, and this should be accounted for accordingly. Blood plasma is an inherently 
unstable solution, which precipitates carbonate based compounds. As previously stated, Table 
1 indicates the primary difference between HBSS and EBSS is the higher concentration of 
HCO3- in EBSS.  While this does make EBSS more physiologically similar to blood plasma, 
it comes at the cost of stability, and it is noted that careful preparation, pH control and a 5% 
CO2 atmosphere is required to prevent excess precipitation of CaCO3 [49, 73].  
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In contrast, the lower HCO3- levels in HBSS allows it to be used in normal atmospheric 
conditions [49]. Adequate buffering and pH controls are nevertheless strongly recommended 
and can be achieved by active CO2 control (i.e. bubbling CO2 directly into the solution) as 
discussed in section 5.2.  
3.1.3. Phosphate Ions (H2PO4- & HPO42-) 
Phosphates are known corrosion inhibitors, and are widely used in protective coatings [74], 
so that it would be expected that the phosphates in blood plasma would tend to inhibit the 
corrosion of Mg. The phosphate ions H2PO4- and HPO42- are often considered together and 
discussed simultaneously. In this review, when referring to both species, the term 
“phosphates” is used.  
Xin et al. [59] found that HPO42- moderately decreased the corrosion rate of AZ91, and 
delayed the onset of localised corrosion. This result was supported by Ma et al. [67] who 
found that a combination of both phosphate ions slightly retarded the corrosion of CP-Mg and 
promoted the formation of a magnesium phosphate (Mg-P) precipitation layer on the surface 
of the samples.  
These results help to explain the substantial decrease in corrosion rates shown in Figure 2 
between solutions 2 and 3 [51]. Phosphates are a notable addition to the system in solution 3 
(a HBSS), as are sulphates and a number of cations. EDX and XPS analysis of corrosion 
products in this and other HBSS suggests that phosphates have an influence on the corrosion 
product layer (usually in combination with Mg2+ and/or Ca2+) [75]. This is significant as the 
(Mg, Ca)-P corrosion layers have been identified in in vivo studies [50]. Yamamoto et al. [76] 
considered the solubility limits of phosphate ions in EBSS to determine that Ca-P 
precipitation should be preferential in this solution at higher pH or when other nucleation 
opportunities present. These findings were supported by EDX analysis, which found Ca and 
P incorporated into the corrosion product layer.  
These results show that phosphates are an integral component to the biocorrosion system both 
in vitro and in vivo. Their incorporation into the corrosion product layers to form (Mg, Ca)-P 
influences the corrosion mechanism of the Mg alloys and as such, their inclusion in SBFs is 
essential for an accurate biocorrosion assessment.   
3.1.4. Sulphate Ions (SO42-)  
Xin et al. [59] and Ma et al. [67] found that SO42- had minimal effect in promoting the 
dissolution of Mg. Moreover, these effects appear to be much less than those of other anions. 
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Agha et al. [71] found the addition of MgSO4 did not influence the corrosion rate of HP-Mg 
samples, although it was claimed that the addition of MgSO4 did have a homogenizing 
influence on the corrosion product layer [71]. These results indicate that, while sulphates are 
an important component in most SBFs and should continue to be included, their influence is 
minimal when compared to other anions present in blood plasma.   
3.2. Cations  
In addition to anions, human bodily fluids also contain a range of cations including 
magnesium (Mg2+), calcium (Ca2+), sodium (Na+) and potassium (K+) [61]. The solubility of 
Mg2+ and Ca2+ is limited, and it is easy for these to be precipitated from solution. In fact, 
drinking water is typically deliberately supersaturated in these ions to provide protection for 
the iron pipes used in the reticulation of drinking water [74]. Thus, it would be expected that 
these ions would likely become part of the corrosion products and would tend to be mildly 
protective. In contrast, most salts of K+ and Na+ are highly soluble, and these two ions would 
be expected to have little direct involvement in the corrosion of Mg.  
However, unlike anions, the influence of these cations on the biocorrosion of Mg alloys is 
less well studied. Typically in order to study the influence of an ion on biocorrosion, an ionic 
salt is added or substituted into the SBF. This results in a change in the concentration of both 
the anion and the cation. As an example, in the study of Xin et al. [59] each increase in anion 
content was accompanied by an increase in either K+ or Na+. As anions and cations are 
intrinsically linked, it becomes important to have a full understanding of both types of ions in 
order to decouple the influence that each may be having.  
3.2.1. Magnesium Ions (Mg2+) 
The concentration of Mg2+ in solution would be expected to influence the precipitation and 
stability of Mg containing precipitates, due to the common ion effect. Following from this, a 
decrease in corrosion would be anticipated.  
Ning et al. [77] considered the influence of four cations (Mg2+, Ca2+, Na+, K+) on the 
corrosion of AZ31B. The influence of the cations in decreasing the corrosion of this alloy 
was ranked as follows (from most retardation to least): 
Mg2+ > Ca2+ > Na+ > K+ 
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However, this result was again a binary comparison of presence and absence. Agha et al. [71] 
found that the addition of MgSO4 had a minimal influence on the biocorrosion of HP-Mg in a 
HBSS. As SO42- has been found to slightly increase the dissolution of Mg previously [59, 67] 
it is reasonable to assume that Mg2+ was slightly retarding the corrosion in this case, 
countering the effect of the addition of SO42-. These results suggest that, when a solution is 
devoid of Mg2+, the addition of these ions has a moderate to substantial influence on 
decreasing the corrosion rates. However, if a solution already contains a level of Mg2+, which 
approximates that of blood plasma, then further Mg2+ addition to the solution has minimal 
effect on the corrosion. It is also worth noting that even if Mg2+ ions are not present initially, 
they are always introduced into the system through the corrosion of Mg until the solubility 
limit of Mg(OH)2 is reached, typically in a matter of hours.  
3.2.2. Calcium Ions (Ca2+) 
As previously discussed, the incorporation of (Mg, Ca)-P compounds into the corrosion layer 
has been found to slow the corrosion rate of Mg alloys [67, 75]. These compounds are also 
essential to forming a more physiologically accurate corrosion layer [50]. Additionally, as 
with MgCO3, the precipitation of CaCO3 will also inhibit the dissolution and slow the 
corrosion rate [59]. These results might suggest that addition (or removal) of Ca2+ from the in 
vitro system would strongly influence the corrosion rate of Mg alloys.  
This hypothesis is support by the work of Ning et al. [77] wherein the presence of Ca2+ was 
found to be secondary only to Mg2+ when decreasing the corrosion rate of AZ31B samples. 
This result was also support by Agha et al. [71] wherein the addition of CaCl2 was associated 
with a moderate decrease in the corrosion rate, as presented in Figure 4. This result might be 
initially somewhat surprising considering the literature strongly suggests that Cl- promote the 
corrosion of Mg alloys, as discussed in section 3.1. This result suggests that Ca2+ has a 
greater influence retarding the corrosion of Mg alloys than twice the concentration of Cl- 
when the base solution does not originally contain Ca2+. This further highlights the important 
role that cations play in the corrosion mechanism, and the necessity to include them during 
analysis.  
Ca2+ also forms an important component of a physiologically relevant corrosion product 
layer. Marco & Myrissa et al. [50] compared the biocorrosion of several Mg alloys in a 
variety of in vitro solutions against in vivo conditions.  
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The corrosion layer formed in the HBSS (14175) used in this study was found not to match 
the corrosion layer of layer of samples in vivo, largely due to a lack of Ca containing species. 
This result is surprising as these species have been identified in previous biocorrosion studies 
which have used HBSS (H1387) [75]. The HBSS (14175) used in this study is compared to 
another HBSS (H1387) commonly used in biocorrosion studies in (both are presented in 
Table 1). The obvious difference between these solutions is the absence of Mg2+ and Ca2+ in 
the HBSS (14175) used in this study [50].  
 
Figure 4: Pure Mg tested in HBSS with a variety of addition elements [71]. 
These results suggest that, similar to phosphates, Ca2+, are essential in forming a 
physiologically accurate corrosion product layer, and therefore may influence the corrosion 
mechanisms both in vitro and in vivo.  
3.2.3. Sodium (Na+) & Potassium (K+) Ions  
Ning et al. [77] found that both Na+ and K+ have minimal influence on the corrosion of Mg, 
with K+ slightly less significant than Na+. The elemental mapping of the corrosion layer in 
Marco & Myrissa et al. [50] revealed trace amounts of Na+ and K+ in the corrosion product 
layer following in vitro with a slightly higher levels of incorporation presenting after in vivo 
corrosion.  The incorporation into the corrosion product layer in vivo suggests these ions may 
play a role in the surface chemistry in vivo, but to a much lesser role than other elements such 
as O, Mg, Ca and P.  Their inclusion in in vitro immersion solutions should not be 
overlooked, but appears to be less sensitive than other elements studied.  
- 29 - 
 
4. Organic Components  
In addition to inorganic ions, bodily fluids also contain a number of organic components such 
as proteins, amino acids, vitamins, macrophages and red blood cells. The addition of these 
components to the in vitro system increases the complexity of solutions that attempt to 
replicate the in vivo corrosion environment. While organic components are undoubtedly an 
essential component of many bodily fluids, their exact effect on the biocorrosion of Mg 
alloys is a matter of some debate. Organic components have been applied inconsistently 
between studies, hindering accurate comparison of corrosion data. These components are 
largely discussed in relation to blood and blood plasma, as many simulated body fluids are 
utilised specifically because they have a similar ionic content to that of human blood plasma 
[24]. Plasma constitutes the majority of human blood by volume, with the remainder coming 
primarily from red blood cells [78]. 
4.1. Proteins 
Proteins, in particular albumin, are an essential competent of human plasma [79] and are the 
majority component of plasma aside from water, as shown in Table 1. A number of studies 
have considered the influence protein have on the biocorrosion of Mg alloys. These studies 
have often focused on albumin as these are the most abundant protein species in blood 
plasma [80, 81].  In general, proteins are incorporated into an in vitro system by the mixing of 
foetal bovine serum (FBS) or bovine serum albumin (BSA) into a SBF [82, 83].   
Liu et al. [83] conducted an electrochemical study of AZ91 and found the addition of BSA 
decreased the open circuit potential (OCP) of the sample, but the addition of 1 g/L protein 
had minimal effect on the corrosion rate. A further study by Liu et al. [81] on Mg-1.5Ca in 
NaCl solutions containing albumin found that the presence of proteins increased the charge 
transfer resistance of the corrosion layer on the surface of the Mg sample, and substantially 
decreased the corrosion rate as measured by hydrogen evolution. Yamamoto et al. [76] also 
found that the addition of protein moderately retarded the corrosion of pure Mg. Zhang et al. 
[84] found the addition of 10% protein to a SBF slightly decreased the corrosion rate of a 
Mg-Nd-Zn-Zr alloy, while the addition of 1% HUVEC (human umbilical vein endothelial 
cells) slightly increased it. SEM analysis indicated C and N peaks, and appeared to indicate 
incorporation of proteins into the corrosion product layer [84]. The proposed mechanism was 
that the divalent Mg ions interacted with the proteins to form a covering layering, and thereby 
decreased the corrosion rate [83]. 
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However, this mechanism has not been supported by further studies. Törne et al. [85] 
investigated the corrosion of CP-Mg in a variety of SBFs and buffering systems, as well as 
citrated whole blood and blood plasma. The corrosion rate in CO2-buffered SBF was 
substantially lower than in either blood or in blood plasma (by a factor of 10). This suggests 
that the inclusions of proteins increased the corrosion rate, rather than decreased it. 
Additionally, in a previous study by the same authors, biological components were found to 
be incorporated in the corrosion products of Zn samples [86]. However, this finding was not 
replicated during the follow up similar study on Mg, and neither EDX nor FTIR found 
evidence of organic materials incorporated into the corrosion layer on the Mg samples [85].    
Further studies have concluded that the addition of proteins to SBFs increased as opposed to 
decrease the corrosion rates. Gray-Munro & Strong [87] explored the Mg(OH)2-solution 
interface and found that the presence of proteins (i) encouraged the dissolution of the partially 
protective Mg(OH)2 corrosion layer and (ii) inhibited the deposition of Ca-P on the sample 
surface. Both of these surface layers tend to slow the biocorrosion of Mg alloys, and their 
removal or absence would be assumed to increase the corrosion rate of Mg samples. This 
analysis has support by the findings of Walker et al. [48] where a substantial increase in 
corrosion rate was measured when proteins were incorporated into the SBF for all six Mg 
alloys tested, as presented in Table 4. However, this increase in corrosion rate did not 
correspond to a better match between in vitro and in vivo corrosion rates. In fact, the 
comparison was actually substantially worse in the solution which contained proteins 
compared to the simpler SBF used (EBSS). A substantial increase in corrosion was also 
observed in a study by Kirkland et al. [72] when 40 g/L of BSA was added to MEM, as 
presented in Figure 3.The increase corrosion rate indicates that proteins do influence the 
biocorrosion of Mg alloys. However, the poor agreement to the in vivo results presented in 
the same study suggest the in vivo corrosion environment may not be fully characterised by 
blood plasma, and additionally factors may play a role which is not captured in vitro. 
Table 4: Corrosion rates (mm/y) measured from mass loss after 7 days. EBSS contains similar ionic content to 
blood. MEM is similar but also includes amino acids and vitamins. MEM + Protein includes 40 g/L protein. The 
In Vivo model was subcutaneous implantation into Male Lewis rats [48].  
Alloy EBSS MEM MEM + Protein In Vivo 
HP-Mg 0.57 0.73 2.19 0.39 
AZ31 0.79 1.29 1.94 0.34 
Mg-0.8Ca 0.57 0.94 2.81 0.31 
Mg-1Zn 0.51 0.96 1.72 0.38 
Mg-1Mn 0.76 0.86 2.77 0.30 
Mg-1.34Ca-3Zn 1.62 4.72 3.29 0.79 
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A potential explanation of the disparity between these studies may come from the 
concentration of proteins tested. Table 5 presents the composition of the solutions used by 
Yamamoto [76]. In this study, it was claimed that E-MEM+FBS contained approximately 
half the wt% proteins compared to blood plasma [76]. However, this does not appear to be 
the case, as the protein concentrations presented in Table 5 suggest that E-MEM+FBS 
contained less than 10% of the proteins present in blood Plasma. In the initial study by Liu et 
al. [83] proteins were added to a maximum of 1g/L, again a small fractions of the levels 
present in blood plasma. In stark comparison, Walker et al. [48] and Kirkland et al. [72] 
incorporated 40 g/L of proteins, achieving close to physiological levels, and much higher 
corrosion rates than in vivo. Additionally, the pH was controlled in this study, although there 
is concern over the volume of solution used. Walker et al. [48] immersed samples in 30 mL 
of solution, approximately half of which was changed daily to mimic normal kidney function. 
This method is discussed in more detail in Section 5.3, and may be worthy of critical 
analysis. Kirkland et al. [72] used a ratio of 20 mL of solution per 1 cm2 of sample surface 
area, which is below the desired level, also discussed in Section 5.3 and in another work by 
the same group [58].   
Table 5: Composition of solutions used in Yamamato et al. [76] compared to blood plasma. 
 
Regardless, the results of Walker et al. [48], presented in Table 4, suggest the inclusion of 
proteins (as well as amino acids and vitamins, covered in Section 4.2) do substantially 
increase the corrosion rate of Mg alloys, but this change does not translate to better 
predictions of in vivo corrosion. This result creates quite a conundrum.  
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The ultimate goal of in vitro testing is to accurately and consistently mimic in vivo corrosion 
as closely as possible. As stated previously, the best way to achieve this is to recreate the in 
vivo corrosion mechanisms in vitro. From the data presented above it is clear that proteins (as 
well as other organic components) do interact or influence the Mg corrosion mechanisms. 
However, their inclusion in the in vitro environment produces less comparable corrosion rates 
compared to in vivo. It is clear that this topic requires significant further study to begin 
answering these questions.  
Finally, it is worth noting that the findings of Walker et al.[48], as well as those of Gu et al. 
[82], suggest that the influence of proteins on biocorrosion rates may be alloy dependent. The 
results of Walker et al. [48], presented in Table 4, show the corrosion rate increasing for all 
the alloys when comparing MEM and MEM + protein, except for Mg-1.34Ca-3Zn which 
presented in slower corrosion rate when proteins were included, although these corrosion 
rates were still greater than those in EBSS. This disparity between alloys was also seen in Gu 
et al. [82] where the corrosion of Mg-Ca, AZ31 and AZ91 was studied via electrochemical 
techniques such as OCP and polarization resistance in HBSS, DMEM and DMEM+10% 
FBS. Mg-Ca corroded moderately faster in the presence of proteins, whereas AZ91 corroded 
moderately more slowly following the addition of FBS. AZ31 samples corroded moderately 
faster in the presence of proteins but only for the first 3 days of the test, whereafter the trend 
reversed and the solution containing protein corroded moderately more slowly. However, it 
should be noted that these tests were conducted after 7 days and while the initial pH was 
correct (~7.4), there is no indication if pH control or a buffer system was employed which 
suggests that when these measurements were taken the pH was likely far from 
physiologically accurate. The influence of solution pH on corrosion and corrosion rates is 
detailed in Section 5.2, however it can be simply stated that there exists a negative correlation 
between solution pH and corrosion rate (i.e. at high pH the corrosion rate decreases). This 
lack of pH control limits the efficacy of the data collected.  
However, the results of Walker et al. [48] and Gu et al. [82] do suggest that Mg alloys may 
react different to the presence of proteins in SBF. This was also supported by the work of 
Johnston et al. [88] where the effect of proteins was tested on CP-Mg and Mg-Y samples in 
DMEM and DMEM +10% FBS. Samples were tested in two conditions: (i) polished, and (ii) 
unpolished (i.e. with an oxide layer on the samples surface). The addition of FBS appeared to 
have a minimal effect on both CP-Mg samples (polished and unpolished).  
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However, FBS was found to substantially slow the corrosion of unpolished Mg-Y samples, 
while substantially increasing that of the polished Mg-Y. This suggests that the influence of 
proteins may not only be variable with regards to alloy composition, but may also be 
dependent on surface condition or the presence (or composition) of an oxide film. However, 
as with the study of Gu et al. [82], there was inadequate pH control in the study of Johnson et 
al. [88] which lead to rapid rise in solution pH. As previously stated, this has a significant, 
negative influence on the accuracy of the results. Nonetheless, these results suggest that the 
interaction between Mg alloys and proteins may be more complex than previously thought.  
In summary, it is noted that while small amount of proteins may cause the corrosion rate to 
decrease, when they are included to a level comparable to that of blood plasma the corrosion 
rate will likely increase substantially. However, this substantially increase has not been 
associated with an improved comparison to in vivo results. As previously stated, these results 
create something of a conundrum. The goal of in vitro biocorrosion testing is to accurately 
mimic the in vivo corrosion mechanism and therefore the corrosion rate. Proteins clearly 
influence the corrosion mechanism of Mg alloys, and as they are present in vivo, warrant 
consideration. However, their inclusion produces a poorer correlation between in vitro and in 
vivo results, when compared to SBFs such as HBSS and EBSS, which do not contain organic 
components.  
It is also apparent from the data presented that the in vivo corrosion environment and 
associated corrosion mechanism has not been fully characterised. A better understanding of 
how the samples corrode in vivo will improve our ability to mimic this in vitro. In the interim, 
it is left to the experiments discretion whether to include or exclude proteins from the in vitro 
solution. However, if they are to be included it is strongly recommended they be present at 
levels comparable to blood plasma. Additionally, it is recommended that a reference alloy 
(preferably HP-Mg) and at least one other alloy be studied.  
It also worth noting that further studies should consider the chemistry of the organic 
components in the SBF, and the stability of such elements in these solutions. 
4.2. Amino Acids, Vitamins & Other Nutrients  
Blood is used to transport nutrients such as amino acids, lipids, sugars, and various vitamins, 
around the body [89]. Amino acids in particular have gathered interest in biocorrosion studies 
[76], likely because of their presence in certain SBFs such as MEM as shown in Table 1. 
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However, it is worth noting that these additional components, such as amino acids, are at 
much lower concentrations in blood compared to proteins [79, 89].  
Kirkland et al. [72] found a slight increase in the corrosion rate between EBSS and MEM for 
CP-Mg (presented in Figure 3), where the effective difference between the SBFs is the 
inclusion of amino acids and vitamins in MEM (as shown in Table 1). Yamamoto & 
Hiromoto [76] found a substantial increase in corrosion rate between EBSS and E-MEM, 
which also indicated that the presence of amino acids accelerated the corrosion of CP-Mg. 
These results are supported by Walker et al. [48] who measured a slight to substantial 
increase (depending on the alloy) in corrosion rate between samples immersed in EBSS and 
MEM, as shown in Table 4. As these amino acids and vitamins were added simultaneously, it 
is difficult to decouple the effect they may have individually on the Mg alloys tested. 
However, MEM had a higher corrosion rate when compared to EBSS for all 6 alloys tested, 
across almost all of the time points [48]. This result suggests that amino acids and/or vitamins 
do indeed accelerate the biocorrosion of Mg alloys in vitro. However, this increased 
corrosion rate did not correspond to a better comparison to in vivo data. As can be seen from 
Table 4, EBSS was more comparable to the presented in vivo corrosion rates than either 
MEM or MEM with protein for all of the alloys tested [48]. As such, it is difficult to reach a 
conclusion on the addition of these elements. Nevertheless, they are undoubtedly important 
components in blood plasma, and therefore warrant consideration. This result also suggests 
that our characterisation of the in vivo corrosion environment could be improved, and the 
factors that influence corrosion in vivo could be better understood.  
Another nutrient that is commonly included in most SBFs, as shown in Table 1, is glucose. 
Zeng et al. [90] and Cui et al. [91] studied the influence of glucose on the biocorrosion of CP-
Mg and Mg-1.35Ca respectively in 0.9% NaCl. The formation of gluconic acid was found to 
moderately increase the corrosion rate of both materials in NaCl solutions. However, Zeng et 
al. [90] also showed a slight decrease in corrosion rate with increasing glucose content in 
HBSS, which was attributed to the increase Ca-P deposition on the samples surface which, as 
discussed in sections 3.1 and 3.2, retards the samples corrosion. It should be noted that both 
of these studies lacked adequate control of the solution pH, which is shown in Section 5.2 to 
have a strong influence on Mg biocorrosion. However, this lack of pH control was of much 
greater concern in a follow up study by the same group studying a more complex interaction.  
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Wang et al. [92] studied the influence of amino acids, glucose and a combination of the two 
components in 0.9% NaCl on CP-Mg samples. Individually, glucose and amino acids were 
found to have a similar influence, slightly decreasing the corrosion rate of CP-Mg. This result 
is in contrast to the works previously mentioned which found both constituents increased the 
corrosion rate. However, perhaps the most interesting result from this study was the 
combined influence of glucose and amino acids [92]. Each of these constituents individually 
was found to slightly decrease corrosion by itself, but when combined in the solution they 
were found to substantially increase the corrosion rate. This increase was attributed to a 
bonding reaction between the glucose and amino acids which tends to retard the precipitation 
of the partially protective Mg(OH)2 species. However, it is unclear whether this reaction 
would take place, or have any effect, in more physiologically accurate conditions as this 
bonding reaction required alkaline conditions. As stated previously, Section 5.2 of this report 
will detail how vital solution pH and buffering is to accurate biocorrosion studies and this 
study serves as a further reminder of how important this parameter is.  
To the authors’ knowledge, at time of writing the influence of other nutrients such as lipids 
on the biocorrosion of Mg alloys has not been discussed or assessed.  
Amino acids and/or vitamins appear to increase the rate of biocorrosion for Mg alloys. 
However, it is unclear at this time if this increased corrosion rate in vitro corresponds to a 
better correlation to in vivo results and in fact current results indicate the opposite. In light of 
this it is difficult to recommend either their inclusion or exclusion to a standard in vitro 
biocorrosion model. However, if they are to be included it is recommended they be included 
at a physiologically relevant level. As glucose is already a consistent part of most SBFs, the 
inclusion of glucose is recommended, again at the physiological relevant level (as is currently 
the case with most SBFs).  
4.3. Macrophages   
Foreign body reactions are a common complication associated with implanted biomaterials 
and medical devices [93]. The tendency for these reactions to occur is in fact an argument in 
favour of the use of degradable implant materials, such as Mg, as opposed to permanent 
implants, which will be in the body longer and therefore run a greater risk of incurring a 
negative reaction [93, 94]. However, temporary implants can nevertheless illicit a negative 
immune or inflammatory response from the patient’s system. As such, understanding how 
these reactions alter the biocorrosion of Mg implants is an important point of study. 
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Macrophages are a type of white blood cell that are commonly associated with these reactions 
[93, 94]. Macrophages are found in all tissues [95], and are known to secrete reactive oxygen 
species (ROS) which have been found to increase the corrosion of other metallic biomaterials 
such as Ti [96].   
Zhang et al. [97] studied the influence of macrophages on the biocorrosion of Mg–2.1Nd–
0.2Zn–0.5Zr (abbreviated as JDBM). Macrophages were found to substantially increase the 
corrosion rate of this alloy, owning to the deposition of ROS onto the samples surface. The 
influence on the biocorrosion was found to be proportional to the density of the macrophages 
on the surface of the sample and the incubation time of the cells.  
Mg implants must be able to provide consistent and reliable support to the patient in their 
intended application regardless of host response. As such, understanding the influence of 
foreign body reaction, implant site infection and other negative host reactions on the 
biocorrosion of Mg implants is a vital step in safeguarding their success. However, as these 
organic components are present in an inconsistent manner in vivo, they are not recommended 
for use in generic biocorrosion studies. Instead, it is suggested that they be specifically added 
to the standardised in vitro conditions when their specific influence is being assessed.   
4.4. Red Blood Cells  
As previously mentioned, after blood plasma, red blood cells are the most abundant 
component of human blood, making up almost 50% of the bodily fluid [78]. Despite this 
abundance in the human system, their inclusion into biocorrosion studies has been rare. 
However, the works that have included red blood cells have found consistent results. Törne et 
al. [85] found minimal difference in the corrosion current densities, and corresponding 
corrosion rates, of CP-Mg samples immersed in blood plasma (1.0 ± 0.02 mm/y) and whole 
blood (1.10 ± 0.12 mm/y). As the primary difference between blood plasma and whole blood 
is the inclusion of red blood cells in the latter, this suggests that these cells had a minimal 
influence on Mg biocorrosion. This result is supoorted by the work of Geis-Gerstorfer et al. 
[98] who compared the corrosion of a range of Mg alloys in both whole blood and PBS. In 
this study, red blood cells were found to have minimal adhension on the surface of the Mg 
alloys.  
The current results in the literature suggest that red blood cells have a negligible influence on 
Mg biocorrosion, and thus there is little evidence to justify their inclusion in SBFs used in in 
vitro immersion testing.  
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4.5. Consideration for Other Bodily Fluids  
While blood, and more specifically blood plasma, has been the baseline for many studies 
developing physiologically accurate biocorrosion environments, consideration should also be 
given to the intended application of the implant. It is advisable for studies, which consider 
Mg alloys for applications where the primary bodily fluid in contact with the implant would 
not be blood, to adjust the composition of their immersion solution accordingly.  
The work of Lock et al. [99] provides a good example of this during their investigation of an 
Mg-Y alloy stent for use in the urine tract. In this study, artificial urine (AU) was used as an 
immersion solution. It was also noted in this study that human urine is much more variable in 
ionic composition between patients than blood or blood plasma [99]. Another applications 
that could be considered is that of a Mg biliary stent, which has recently been investigated in 
vivo [100]. If future in vitro tests prove necessary for this application, a simulated bile 
solution would seem appropriate for in vitro biocorrosion testing.  
For further discussion of this topic please see Chapter 4 (Section 4.3).  
5. Experimental Parameters   
The variation between in vitro studies is not limited to the immersion medium. There is 
considerable variation in how experimental parameters are set and controlled, which can have 
a substantial influence on Mg biocorrosion. More consistent management of key 
experimental parameters will reduce variability between in vitro biocorrosion tests, and is an 
essential component of a standardised biocorrosion methodology.  
5.1. Temperature  
The first corrosion testing was conducted at room temperature [42] in simple chloride 
solutions and was found to not give a good indication of in vivo corrosion. One aspect was 
that the simple nature of these solutions was not appropriate as already discussed. Another 
aspect was that the temperature was below the human body temperature of 37 °C [101]. This 
is significant as an increased in temperature is associated with increased chemical activity, 
due to the increase in kinetic energy that is afforded from the increased temperature. This 
increased activity would be expected to be correlated with a higher corrosion rate, and 
experimental results have found that is indeed the case with biocorrosion testing. Kirkland 
claimed that a change of 17 °C would increase the corrosion rate moderately to substantially, 
depending on the alloy being investigated [102].  
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This claim was supported in a following publication [103] that indicates a substantial increase 
in the corrosion rate of CP-Mg, Mg-0.8Ca and Mg-1Zn as the immersion temperature was 
increased from 20 C to 37 C in buffered HBSS. As such, biocorrosion testing at the 
physiological accurate temperature of ~37 °C is seen to be both reasonable and necessary.   
5.2. pH & Buffer Systems  
Another consideration for Mg biocorrosion testing is solution pH and the consequent 
requirement for a buffer system. As shown in equation (1), Mg corrodes to produce Mg(OH)2 
and in NaCl solutions the pH typically rises to ~10.3 typically within hours of immersion due 
to the low solubility of Mg(OH)2 [55]. While unbuffered SBFs can reach this high pH value 
[104], they also have a tendency to plateau at a somewhat lower pH depending on 
experimental conditions [90, 105]. Regardless, this plateau is always much higher than the 
physiological pH of ~7.35-7.45 and therefore will strongly influence the corrosion and 
corrosion rates.  
Increased solution pH has been found to cause a moderate to substantial decrease in the 
biocorrosion of Mg alloys [36, 106]. The solubility of the corrosion layer decreases with 
increasing pH, and at elevated pH values Mg(OH)2 is able to provide increasing 
protectiveness to the samples surface, lowering the rate of biocorrosion. Therefore, it is 
essential that solutions be maintained at a physiological pH level of ~7.35-7.45 [107, 108].   
To maintain the pH at the appropriate value, a buffer system is usually employed. A number 
of buffer systems have been used including CO2-HCO3- (often called the bicarbonate buffer), 
HEPES and Tris-HCl [72]. The bicarbonate buffer is easily used because NaHCO3 is an 
integral part of SBFs such as HBSS, so the addition of CO2 into the system is all that is 
required to complete the buffer. This buffer is the same as that in the human respiratory and 
has been found to be effective in a range of SBFs [51, 109]. HEPES has been found to be 
effective at controlling the pH of solutions, however it also substantially increases the 
corrosion rate of Mg alloys as presented in Figure 3, as well as alters the composition of the 
corrosion layer [72, 85]. The Tris-HCl buffer has also been found to substantial increase the 
biocorrosion rate of CP-Mg, particularly in the first 24 h of immersion [70, 110]. 
Consequently, the bicarbonate buffer is strongly recommended, as it is both the most 
effective and most physiologically comparable buffer system.   
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However, the bicarbonate buffer system requires active CO2 input in order to be effective 
[109].  When utilising balanced salt solutions as cell cultures, pH is commonly regulated via 
a 5% CO2 atmosphere. Several studies have attempted to utilise this method in biocorrosion 
testing, but it has proven ineffective. Witecka et al. [49] considered the corrosion of ZM21 in 
two different conditions (as cast and ECAPed) in three SBFs (HBSS, EBSS and E-
MEM+10%) while controlling the pH with a 5% CO2 atmosphere. The pH of the solutions 
throughout the first 24 hours of the tests is presented in Figure 5. It was noted that the pH of 
the HBSS and EBSS quickly rose above physiological pH in this test, while the E-
MEM+10%FBS was maintain at approximately the ideal pH. From this result it is clear that 
passive pH control (e.g. a 5% CO2 atmosphere) is not sufficient for HBSS or EBSS. This 
result was used as a rationale for using E-MEM+10%FBS instead of HBSS or EBSS in future 
studies. However active control, where CO2 is fed as needed into the solution directly, has 
shown to be effective in balanced salt solutions such as HBSS and EBSS [24, 36, 37, 51, 
109]. A specific partial pressure of CO2 has been discussed [75], however a simpler method 
utilising a pH controller to regulate the CO2 release has also proven effective [36, 111].  
 
Figure 5: pH of solutions (HBSS, EBSS and E-MEM+10%FBS) over the first 24 hours of testing in a 5% CO2 
atmosphere [49]. 
The conclusions drawn from Witecka et al. [49] are a good example of how seemingly small 
changes in the experimental procedure can significantly impact the results and conclusions 
generated. The assertion that E-MEM+10% FBS is the most suitable solution for future 
studies was the conclusion drawn from the data gathered. However, it is impossible to 
determine if E-MEM+10% is actually a better solution than HBSS or EBSS, or if it was 
simply a factor of more favourable pH control. If the pH of the other SBFs was controlled 
more actively, and maintained within the physiological range, a very different conclusion 
may have been drawn.  
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In summary, utilising active pH control with a CO2-bicarbonate buffer system (where CO2 is 
bubbled directly into the solution) is recommended to maintain the solution pH within a 
physiological range of 7.35-7.45 and is essential to accurate biocorrosion assessment in vitro.   
5.3. Ratio of Solution Volume to Sample Area  
Equation (1) indicates that the corrosion of Mg alloys is associated with an increase in 
Mg(OH)2, which is partially dissociated into Mg2+ and OH-.  As discussed in sections 3.2 and 
5.2 respectively, Mg2+ and OH- are expected to influence the corrosion of Mg alloys during in 
vitro biocorrosion testing. A basic principle of corrosion testing is to use a sufficiently large 
volume of solution so that the composition of the solution does not change significantly 
during the corrosion test, or to change the solution periodically as the solution becomes 
contaminated. 
In light of this, a number of techniques have been considered in order to minimise the impact 
the samples’ corrosion has on the immersion solution. The most conventional of which is 
ensuring a sufficiently large ratio of solution volume to sample surface area. The influence of 
this ratio was considered by Kirkland et al. [58], as well as Yang and Zhang [104] on the 
biocorrosion of Mg. Both studies found that at low levels, this ratio was very impactful on the 
corrosion of the samples, and this influence tapers out at large ratios, as depicted in Figure 6. 
By ensuring a sufficiently large solution volume, when compared to the size of the sample, 
pressure is taken off the buffer system, as the corrosion of the sample will have a smaller net 
influence on the pH of the solution.  
 
Figure 6: Influence of the ratio of solution volume to sample surface area on the corrosion of pure Mg in Hanks' 
solution [58]. 
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A different approach to determine the desired volume of solution has been to scale the 
experimental solution volume to an amount of body plasma, and then daily replace an 
equivalent amount of solution as could reasonably be processed by the kidneys [48, 76]. In 
these studies the amount of blood plasma in a body is taken to be within 2.75-3.0 L [112, 
113], and the amount of urine excreted to be 1.4-1.5 L [113, 114]. Therefore samples are 
submerged in either 2.75-3.0 mL, and 1.4-1.5 mL is removed and replaced with fresh solution 
each day [48, 76]. However, this method fails to scale the size of the sample, and therein the 
amount of corrosion occurring. As shown in Figure 5, when such a small volume of solution 
is used, the system can quickly become overwhelmed.   
Replenishing part of the solution each day to avoid build-up of (i) Mg2+, (ii) deletion of other 
important ions, and (iii) increase of solution pH, is another potential approach. This technique 
may prove particularly effective for long term tested (> 7 days), or for samples with high 
corrosion rates. However, this approach involves the necessity to disturb the corrosion 
experiment daily. Moreover, relying solely on this technique for pH control when using a 
small body of fluid is not recommended, as solution pH can change quite rapidly, as shown in 
Figure 5 where only 110 mL of solution was used [49]. Therefore it is recommended that a 
reasonable ratio of solution volume to sample area (equal to or greater than 1 cm2 : 50 mL) is 
employed, with solution replacement used in tandem for long term studies. We have typically 
used ~500 mL of solution per specimen. 
5.4. Solution Flow Rate 
The majority of in vitro testing is conducted in static immersion conditions. However, several 
studies have considered the influence solution flow rate on the corrosion rate and morphology 
of Mg samples. The solution flow rate can affect corrosion behaviour in a number of ways 
such as (i) enhancing mass transfer on the samples surface, (ii) stirring the solution and 
preventing build-up of ions or localised pH increases in stagnant solution, (iii) flow induced 
shear stress on the surface of the sample or (iv) solution flow removing the corrosion 
products from the samples surface, exposing the surface to the corrosive medium.  
Soya et al. [115] found the corrosion of AZ31 plates increased by 13% when the flow rate 
was doubled from 85 mm/s to 170 mm/s. The effects of flow in this test appeared gradual, 
and as the test was only conducted over a 24 hour period, it is possible the difference would 
have increased or decreased over time.  
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The authors have previously considered the influence the hydrogen capture apparatus may 
have on the corrosion of samples, in terms of stagnating solution flow and causing localised 
changes in the immersion solution [36]. This study compared specimens suspended under 
hydrogen capture burettes to specimens in mild flow conditions. The mild flow conditions 
were created with a pump and drain which cycled solution between two containers at a rate of 
~85 mL/s. These may appear like high flow conditions, but it is worth noting that the 
relatively large pump and drain diameter (~10 mm) resulted in mild flow conditions spread 
across six samples. These samples in the mild flow conditions had a slightly higher corrosion 
rate on average than those in stagnant conditions beneath the hydrogen capture burettes.  
However, the slightly higher corrosion rate was associated with a lower incidence of localised 
corrosion. The change in corrosion morphology was attributed to the mild flow conditions 
removing some of the corrosion product from the samples surface. Build-up of corrosion 
product on the surface of samples is known to retard corrosion, but may also create 
conditions necessary for localised corrosion (such as crevice corrosion) to occur. Thus it is 
possible that the increased flow rate removed corrosion products from the samples surface, 
exposing the Mg beneath and thus simultaneously increasing the corrosion rate and inhibiting 
the environment necessary for certain types of localised corrosion.  
Maybe the most detailed analysis of solution flow on Mg corrosion was conducted by Wang 
et al. [60]. In this study Mg-5Zn-0.3Ca plates were studied under a number of flow 
conditions, and AZ31 stents in stagnant conditions were compared to those under solution 
flow. One of the novelties of this study was to calculate the flow induced shear stress (FISS) 
created on the sample from the solution flow. These flow rates and associated shear stresses, 
as well as the average corrosion rate of the Mg-5Zn-0.3Ca plate samples, are presented in 
Table 6 [60]. It is worth noting that the spread of data was relatively large for all the samples 
bar those in stagnant conditions.  
Table 6: Flow rate, associated FISS & approximate average corrosion rate for Mg-5Zn-0.3Ca plates and AZ31 
stents in DMEM. Pipe Diameters 3.2mm and 6.3mm respectively [60].  
Sample  Flow Rate (mm/s) FISS (Pa) Corrosion rate (mm/y) 
Mg-5Zn-0.3Ca 
Plates 
0.0 0.00 ~1.2 
10.4 0.07 ~1.6 
20.8 0.15 ~1.9 
41.6 0.31 ~2.2 
83.2 0.62 ~2.4 
AZ31 
Stent  
0.0 0.00 ~0.4 
57.7 0.05 ~1.2 
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All three studies were in agreement that increasing flow rate, and thereby shear stress, is 
associated with an increased corrosion rate. However, in addition to an increase in general 
corrosion, Wang et al. [60] also discovered a higher incidence of localised corrosion at high 
flow rates. This result is in conflict with the authors’ previous work, however it is believed 
this disparity in an artefact of flow conditions [36]. The samples in Wang et al. [60] were 
studied as stent materials and as such were placed directly in the pipe, in order to better 
mimic services conditions. The solution flow in the authors’ previous study [36] was spread 
across the 6 samples in a large body of solution (~3L). This indirect solution flow would 
likely be associated with a much lower shear stress.  
This comparison highlights an importance consideration for solution flow in in vitro tests: 
expected application. The expected services conditions of the implant is strongly dependant 
on the implant site and intended application of the device. These factors determine what level 
of solution flow the implant is subjected to in vivo. As an example, a cardiovascular stent 
must be substantially more resilient to solution flow conditions when compared to an 
orthopaedic implant.  
For generic biocorrosion assessment, where an intended application is not yet determined, a 
low flow rate is recommended, in order to maintain homogeneity within the solution in terms 
of pH and composition of the elements discussed in sections 3 and 4. Examples of apparatus, 
which make use of slight solution flow can be found in the literature [36, 111]. For a large 
body of solution, a flow rate of <100 mm/s is recommended from literature values and the 
authors experience with this style of testing. This flow rate should also be coupled with a 
large pipe diameter (>8 mm) to minimise the shear stress induced on the samples. Samples 
should also not be placed in close proximity the pump inlet or pipe outlet, again in order to 
minimise the FISS influence on the samples corrosion. For an apparatus where a smaller 
body of solution is used, a lower flow rate (<50 mm/s) is recommended.  
If the intended application has a high expected flow rate (i.e. a cardiovascular stent) the 
expected service shear stress should be estimated and the test adjusted to best mimic this. 
Wang et al. [60] tabulated a range of mean wall shear stresses associated with various 
cardiovascular sites and these are presented in Table 7 [60]. Values such as these should be 
combined with a shear stress (𝜏) calculation such as Doriot’s Equation [116], presented in 
equation (4), to better approximate in vivo service conditions. Equation 4 factors in variables 
such as solution shear viscosity (𝜂), solution laminar flow rate (Q), and pipe diameter (D). 
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These shear stress values are of greater concern than the solution flow rate because they 
better capture the complex fluid dynamics of the system that is being approximated. 
Regrettably, there are no useful literature values that detail the expected flow rate or shear 
stress for orthopaedic implants. It is expected that the flow and associated shear stress around 
these implants would be low, however, further consideration and research into this area is 
needed before a definitive recommendation can be made. 
  𝜏 =
32 𝜂 𝑄
𝜋𝐷ଷ
 (4) 
 
Table 7: Mean wall shear stress in various cardiovascular environments [60]. 
Cardiovascular Site Shear Stress (Pa) 
Coronary Artery 0.68 ± 0.03 
Femoral Artery 0.36 ± 0.16 
Supraceliac Aorta 0.35 ± 0.08 
Infraenal Aorta 0.13 ± 0.06 
Finally, it should be noted that while most tests, which approximate body fluid flow, have a 
consistent flow rate, body systems tend to pulsate. This is especially true of the 
cardiovascular system, where the patient’s heart rate will frequently change the rate of 
solution flow across the device.  Saad et al. [117] have developed an apparatus which is 
claimed to mimic the dynamic environment surrounding an orthopaedic implant. This system 
is yet to be verified with in vivo results, but still is a promising step towards models and 
apparatus, which can correctly characterise the influence of physiologically accurate fluid 
flow on biocorrosion. Presumably a similar apparatus, also employing a peristaltic pump 
system, could be developed to mimic the cardiovascular system as well.  
6. Consideration for Selecting an Appropriate In Vivo Model  
This review, and indeed most biocorrosion studies, are predicated on matching in vitro 
corrosion and corrosion rates to the service condition. This service condition is usually 
approximated with an in vivo animal model. However, there are factors that should be 
considered when selecting an appropriate in vivo model, and before attempting such a 
comparison. If there is an intended application or final product already in mind, this decision 
is narrowed considerably. The two most commonly considered applications for Mg medical 
devices are in orthopaedics and cardiovascular surgery [1, 16, 17].  
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The selection of appropriate animal models which reflect or match the part of the targeted 
part of the human system most effectively is a topic which gathers much discussion and 
research in biomedical materials [118, 119].  
For orthopaedic applications small animal studies are generally conducted in rodents such as 
rats or rabbits [18, 27, 120, 121]. For larger animal studies sheep [122] and pigs [123] have 
been used previously, with dogs and goats also established in the field [119]. In 
cardiovascular applications rats are also used as a small animal model [124-126], with pigs 
generally favoured once large animal trials are required [127].  
However, for many biocorrosion studies the end product is not yet determined, or perhaps 
there are multiple end products being considered. This creates a problem because it would be 
expected that the different environments within the body would change the corrosion 
behaviour of the samples. For example, the likelihood flow shear stress related corrosion, as 
discussed in Section 5.4, would be expected to be quite different for a sample implanted in an 
artery compared to an intramedullary nail implanted into bone.  
Willbold et al. [128] explored the influence of implant site on the corrosion of RS66 samples 
in New Zealand white rabbits. Samples were implanted (i) into the medial femur (bone), (ii) 
under the skin of the back (subcutaneous) and (iii) into the lumbar musculature 
(intramuscular). The corrosion rates for various time points are presented in Table 8 [128]. 
After 1 week, the corrosion rates of the subcutaneous and intramuscular samples were quite 
similar (5.70 and 5.34 mm y-1, respectively), and both substantially higher than the samples 
implanted into bone (1.65 mm y-1). However, there were moderate-substantial changes in 
these corrosion rates for most of the time points measured, culminating in the final time point 
of 8 weeks where this trend was reversed with bone having the highest corrosion rate (5.45 
mm y-1), and subcutaneous and intramuscular were again quite similar (3.46 and 3.04 mm y-1, 
respectably).  
Table 8: Comparison of the corrosion rate of RS66 samples, as measured from volume loss, after implantation 
into various tissues of female New Zealand white rabbits [128]. 
 1 Week 2 Weeks 3 Weeks  4 Weeks  8 Weeks  
Bone (mm y-1) 1.65 2.65 2.45 3.82 5.45 
Subcutaneous (mm y-1) 5.70 6.58 6.30 5.29 3.46 
Intramuscular (mm y-1) 5.34 3.89 5.67 4.18 3.04 
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These results suggest the corrosion rate may not be intrinsically linked to the implant site, and 
indeed this was the conclusion of Sanchez et al. [32]. During a comparative review of in vitro 
and in vivo corrosion rates, it was concluded that “when comparing the corrosion rates for 
one specific material, the rates are not very different, or at least the differences cannot be 
attributed to the implant location” [32].  
Verifying this is challenging, as there are similar challenges present when comparing in vivo 
data as with in vitro in terms of variable experimental methodologies. Factors such as (i) the 
animal model, (ii) alloy and process history, (iii) sample geometry and (iv) time points the 
corrosion was evaluated, can all influence the corrosion rate measured and inhibit direct 
comparisons. However, there are some few studies, which have enough similarities to justify 
a direct comparison. Two such studies are in Table 9 [126, 129]. These studies considered 
CP-Mg wire in both an orthopaedics and cardiovascular location, and while the time points of 
analysis were not identical, they were comparable. This data indicates that the difference in 
corrosion rate between these two different applications may not be as great as was initially 
thought. This is a single point of comparison and likely does not complete the picture but it 
does suggest that further direct comparisons and studies are warranted.  
Table 9: The corrosion of CP-Mg measured in vivo, comparing the corrosion rate of an orthopaedic and 
cardiovascular model. 
Intended 
Application 
Animal 
Model 
Implant 
Site  
Sample 
Description  
Time 
Points  
Corrosion 
Rate 
(mm y-1) 
Reference 
Orthopaedics Male Wister 
rats  
Left 
Femora  
0.4mm 99.9% 
Mg wire  
42 days  ~0.6 [129] 
Cardiovascular  Male 
Sprague-
Dawley rats  
Abdomin
al Aorta  
0.25mm 99.9% 
Mg wire 
5-30 
days  
~0.3-0.6 [126] 
A potential explanation for the unexpected similarity between the orthopaedic and 
cardiovascular corrosion rates in this case may be tissue encapsulation. In the study of Zainal 
Abidin et al. [24] the Mg samples were all completely encapsulated in fibrous tissue 
following 1 or 2 months of intramuscular implantation in a guinea pig model. This 
encapsulation was suggested as the reason the corrosion rate of the fast corroding AZ91 
samples was substantially decreased (by a factor of 10) in vivo. Fibrous encapsulation was 
also present during the subcutaneous implantation of fine WE43B wires in adult female mice 
[130], and was also suggested as the reason for the slower in vivo corrosion rates. This type 
of soft tissue reaction is also present in the exposed parts of orthopaedic implants. 
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 Erdmann et al. [131] compared orthopaedic screws made from Mg-0.8Ca and 316L stainless 
steel implanted into the tibiae of New Zealand white rabbits. Both implants were tolerated 
well, and had similar inflammatory reactions. There was also some degree of tissue 
encapsulation on the head of the screws, which was in contact with the cranial tibial muscle.  
A similar result was observed by Willbold et al. [122] following implantation of AZ31 
screws into the hip bone of mature female sheep. Myrissa et al. [132] implanted Mg pins 
transcortically into the femoral bone of male Sprague-Dawley rats. No tissue reaction was 
recorded for the Pure Mg or Mg-2Ag pins. However, fibrous and bone tissue encapsulation 
was reported in some of the Mg-10Gd pins, which corroded substantially faster than the other 
alloys. It should be noted that while an excessive amount of fibrous encapsulation may 
indicate a negative host response, the formation of some amount of fibrous tissue may be 
considered normal. Well integrated, biocompatible implants can still induce a fibrous tissue 
reaction [133].  
Additionally, a similar phenomenon has also been reported for stents where a layer of 
endothelium coated the struts of an Mg stent implanted into the abdominal aorta of New 
Zealand white rabbits [134]. Tissue encapsulation appears to be an expected result of contact 
with blood [98, 135].  
As suggested by Zainal Abidin et al. [24], this encapsulation may be slowing the corrosion 
rate in vivo, helping to explain why in vitro corrosion rates often overestimate those seen in 
vivo [32]. This would also help to explain the good agreement between the different 
applications presented in Table 9. Unfortunately to date there is limited data detailing how 
encapsulation influences the corrosion environment or the composition of the bodily fluids in 
vivo. Without adequate characterisation of the in vivo environment it is impossible to properly 
mimic in vitro. Therefore, even though a degree of inhomogeneity is likely in vivo, it is still 
important for in vitro solutions to remain homogenous to ensure they are repeatable. This 
topic is explored further in Chapter 4. 
A question that is raised by this hypothesis is the nature of SBFs and what bodily fluid should 
be the basis for in vitro biocorrosion tests. Currently blood plasma has been used as it was 
assumed most applications would have the implant in contact with this fluid. However, as 
discussed in 4.5, if the expected service condition encounters a different bodily fluid it is 
recommended that this fluid be used as the basis for the SBFs during corrosion assessment.  
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To the author’s knowledge, the nature of the extracellular fluid within the encapsulated 
tissues has not been considered by any biocorrosion studies. There is limited data available 
on this fluid, however it is known that the protein content has been measured as only 50-60% 
of that of blood plasma [136]. This may help to explain the poor agreement found by Walker 
et al. [48] when proteins, amino acids and vitamins were added to their SBF. 
A full exploration of the nature of the tissue encapsulation and how it effects the corrosion 
mechanism and associated corrosion rates would undoubtedly improve our ability to mimic in 
vivo corrosion in vitro.   
Ultimately, an in vivo model should match the expected in service condition as closely as 
practicable. However, it may well be the case that there is not yet a planned service condition, 
or the alloy/s are being investigated for multiple applications. In this case, the current state of 
the literature appears to support simpler in vivo models such as subcutaneous or 
intramuscular implantation. More complex in vivo models (such as implantation into the 
bones or vascular system) require greater expertise and therefore have a higher cost. 
Additionally, the ethical burden for this kind of surgery is likely to be higher. As both ISO 
and ASTM standards both recommended either subcutaneous or intramuscular implantation 
for short-term assessment of biomaterials [137-139], and the data gathered from these simpler 
tests appear as valid as more complex surgeries by and large, it seems this is a reasonable 
place to begin testing. However, if the intent is to investigate a specific application then an in 
vivo location which will better mimic that application is recommended (i.e. within an artery 
for cardiovascular applications or within bone for orthopaedic). This topic is discussed 
further in Chapter 4. 
7. Concluding Discussion & Recommendations  
7.1. Immersion Solution  
The variability between immersion solutions has been a point of contention when discussing 
biocorrosion testing for a number of years. At this point in time, the authors do not believe 
that the selection of a single “appropriate” solution is possible. However, when each 
component is analysed carefully and systematically, it is possible to clarify which 
components are necessary, and at what concentrations. Blood plasma is the most common 
bodily fluid and thus is an appropriate baseline for in vitro biocorrosion testing. However, as 
discussed in section 4.5, if an application would involve contact with another fluid primarily, 
consideration should be given to incorporating the characteristics of this fluid into the testing.  
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The inclusion and concentrations of components (i.e. inorganic ions and organic elements) 
can have a varied influence on the biocorrosion of Mg alloys. Certain components can have a 
large influence on corrosion rate and mechanism, while others have a comparatively small 
effect. As such, the importance of including each component (and at what concentration) has 
been summarised in Table 10. 
Table 10: Recommended components and concentration SBFs should contain in future in vitro biocorrosion 
studies.  
Component  Recommended 
Concentration 
Rationale References 
Cl- Required  
(100-150 mM)  
Cl- change the corrosion morphology of the specimen by 
facilitating micro-galvanic corrosion (and therein 
localised corrosion), as well as influencing the solubility 
of the corrosion product layer. However, their influence 
is lessened in complex solutions. Therefore, the use of 
SBFs which have slightly higher Cl- content (between 
20-50 mg greater than that of blood plasma) are still 
believed to be applicable.  
[51, 59, 67] 
HCO3- Required  
(4-30 mM)  
HCO3- play an important role in the corrosion product 
layer and are essential in maintaining a physiologically 
accurate buffer system and pH level. However, their 
inclusion to physiological levels can prove challenging 
in vitro as the solution may easily become 
supersaturated and thus excess precipitation may occur. 
As the corrosion rate and pH levels are both maintained 
in solutions with lower levels of HCO3-, it is 
recommended that they be included in the solution but it 
is not mandatory to they are present in concentrations 
similar to blood.  
[51, 59, 71] 
H2PO4-  
& HPO42- 
Required  
(0.5-1.0 mM) 
Phosphates are key components in a physiologically 
accurate corrosion product layer as they allow the 
precipitations (Mg, Ca)-P species.  
[24, 50, 59] 
SO42- Recommended 
(0.4-0.8 mM) 
SO42- were found to have a minimal effect on Mg 
corrosion compared to the other anions.    
[59, 67, 71] 
Mg2+ Recommended  
(0.5-1.5 mM) 
Mg2+ play an important role in the precipitation of most 
species in the corrosion layer (as would be expected). 
Their inclusion is recommended. However, unlike most 
other ions analysed they will be incorporated into the 
SBF naturally during the corrosion process. As such, 
any ill effects from their exclusion will likely be 
corrected quickly as the sample/s corrode.  
[71, 77] 
Ca2+ Required 
 (1.25-2.5 mM) 
Ca2+ are integral to a physiologically accurate corrosion 
product layer. Their inclusion (or exclusion) has a 
significant effect on the corrosion mechanism.  
[50, 77] 
Na+ Recommended  
(140-150 mM) 
Found to have minimal influence on biocorrosion. [77] 
K+ Recommended  
(5-6 mM) 
Found to have minimal influence on biocorrosion. [77] 
Proteins May be included at 
experimenter’s 
discretion  
(35-80 g/L)  
The inconsistencies within the approaches and results in 
this area make a recommendation challenging. Some 
studies report a decrease in corrosion rate when proteins 
are included (although it should be noted they were 
present at levels much lower than in the body). In 
contrast, several studies indicate that, when included to 
[48, 76, 81-
83, 85, 87] 
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a physiologically relevant level, proteins substantially 
increase the corrosion rate. However, this increase does 
not correspond to a better comparison to in vivo results 
and in fact weakens such a comparison. This result 
creates a conundrum. It is clear that proteins do 
influence or interact with Mg corrosion and are therefore 
worthy of study. However, the ultimate goal of in vitro 
tests is accurate prediction of in vivo corrosion and the 
addition of proteins to the in vitro system appears to 
harm this goal.  
As such, it is difficult to categorically recommend either 
their addition or exclusion from in vitro biocorrosion 
studies and it is left to the experimenter’s discretion. If 
they are included they should be present in 
physiologically relevant quantities.  
Amino Acids, 
Vitamins & 
Other 
Nutrients 
May be included at 
experimenter’s 
discretion  
(quantity will vary 
depending on 
nutrient)  
The inclusion of amino acids and vitamins appears to 
increase the corrosion rate; however this was also found 
to create a less accurate correlation to in vivo results than 
an SBF without these elements. As such, it is difficult to 
determine if they should be included in future.  
Therefore, it is left to the experimenter’s determination 
whether to include these elements. However, if they are 
included, they should be present in physiologically 
relevant quantities.  
As glucose is common to many solutions, and at similar 
concentrations, its inclusion is recommended in the 
physiologically accurate range. 
[48, 76] 
Macrophages Only to be included 
in specialised studies 
Found to increase the corrosion rate by depositing 
reactive oxygen species onto the samples surface. 
However, as macrophages are associated with an 
immune response their inclusions is not recommended 
in a general biocorrosion testing protocol. Instead, they 
should be added when trying to determine specifically 
how the alloy/s perform when a negative immune 
reaction occurs.  
[97] 
Red Blood 
Cells 
Not necessary to 
include  
While red blood cells make up almost 50% of blood by 
volume, current literature suggests they do not influence 
Mg biocorrosion. As such it is not necessary to include 
them in biocorrosion testing.  
[85, 98] 
7.2. Experimental Parameters  
Unlike the immersion solution, where there is still work to be done to select an ideal or “gold 
standard” solution, the selection of appropriate experimental parameters for in vitro 
biocorrosion testing is a more straight-forward task. The recommended experimental 
parameters for use in future studies are summarised in Table 11, with a rationale given for 
each and a reference to the relevant literature. If these parameters are followed, it is strongly 
believed that the variability between in vitro biocorrosion tests will be greatly reduced. 
Examples of experimental apparatus, which incorporate many of the parameters outlined in 
Table 11 can be found in the literature [36, 111], and are a good starting point when 
considering future in vitro biocorrosion testing.  
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Table 11:  Recommended experimental parameters for future in vitro biocorrosion studies. 
Parameter Recommendation  Rationale References 
Temperatur
e 
~37°C Physiological temperature is essential for accurate 
characterisation of biocorrosion. 
[103] 
pH ~7.35-7.45 Physiological pH level, essential for accurate 
characterisation of biocorrosion. 
[36, 106] 
Buffer CO2-Bicarbonate A buffer system is essential to maintain a stable pH level 
throughout testing. The bicarbonate buffer system has 
been shown to be more accurate than zwitterion-based 
buffers. Active control of pH (where CO2 gas is bubbled 
directly into the solution) is preferred over passive 
application (i.e. a 5% CO2 atmosphere) as active control 
is more effective at maintain pH levels.  
[49, 51, 72, 
75] 
Sample 
area to 
solution 
volume 
ratio 
~50 mL/cm2 
(minimum) 
To minimise the influence of ions release during the 
immersion test (e.g. Mg2+ and OH-), a high ratio of 
solution volume to active sample surface area is 
recommended. This will also ease pressure on the buffer 
as any change in pH will be smaller in a larger body of 
solution. 
Additionally, replenishing solution at a rate similar to that 
at which the kidneys process blood in vivo can be 
employed. This method is particularly suggested for long 
term studies to avoid saturation of Mg2+ ions.  
[58, 76] 
Flow rate Application 
dependant.  
 
For generic studies: 
A large body of 
solution (>5 L) with 
a low flow rate 
(<100 mm/s) and a 
large pipe diameter 
(>8 mm) 
 
 
In general a slight or mild flow rate is recommended to 
maintain solution homogeneity. For large apparatus with 
sufficient solution volume (>5 L) a flow rate of less than 
100 mm/s is recommended with a large pipe diameter (>8 
mm) to minimise the shear stress influence on the 
biocorrosion. This style may also be applicable for low 
flow rate applications (e.g. orthopaedic).  
 
For higher flow rate applications (e.g. cardiovascular 
stents) the expected service shear stress should be 
estimated and conditions recreated to best mimic this. 
Factors that will influence this in vitro (as well as in vivo) 
include: solution viscosity, flow rate, and pipe geometry.   
[36, 60, 116, 
140] 
 
Additionally, consideration should be given to a minimum number of samples tested. A 
minimum of 3 samples per condition is recommended to account for variability within the 
alloy or preparation. It is also recommended to characterise not only the corrosion rate but 
also the corrosion products and morphology. It is recommended that HP-Mg samples be 
included as a reference. However, including additionally alloys is also recommended, as there 
is evidence that different alloys may vary considerably during biocorrosion testing [50].  
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7.3. Final Thoughts & Recommendations  
The recommendations presented herein are not intended to be prescriptive, and likely will not 
result in a perfect in vitro environment, which mimics in vivo conditions. Instead, this review 
is meant to be a guide for future studies so we can begin to build a standardised approach to 
biocorrosion testing.  
Currently progress has been slow as there is much variability between in vitro methodologies, 
which makes comparison between studies increasingly difficult. A standard approach will 
allow researchers and readers to see exactly what the effect of a certain element or parameter 
is on the in vitro corrosion, free from the concern that the method in question did not consider 
a certain factor (i.e. didn’t control pH). These comparisons are the basis for iterative 
improvements, and once a standard approach to in vitro biocorrosion testing is established, 
we can begin in earnest the iterative approach to improving it. A selection of studies which 
are predominately consistent with the recommendations in Tables 10 and 11 are presented in 
Appendix A.  
Additionally, as the ultimate goal of in vitro testing is to better approximate or mimic the in-
service corrosion, it would behove us to improve our understanding of the corrosion 
environment in vivo. A full and deep understanding of the in vivo corrosion environment is 
essential to accurate characterisation of biocorrosion, and should include an understanding of 
the influence of factors such as (i) proteins, (ii) amino acids, (iii) vitamins, and (iv) tissue 
encapsulation. Once we have a full and accurate understanding of the in vivo corrosion 
environment we can begin to better mimic it in vitro. In the interim, our progress will 
continue to be slow and studies will continue to suspect or require repetition until a standard 
approach to in vitro biocorrosion can be established. Following this point, this standard can 
be iteratively improved to better match in vivo corrosion once factors influencing the 
corrosion mechanisms become better understood.  
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Chapter 3: Influence of Sterilisation on Biocorrosion 
 
As identified in the literature review (Chapter 2), in vitro biocorrosion data is often validated 
against in vivo results. This is indeed the intention within this thesis (Chapter 4). However, 
prior to any in vivo study, the samples must first be sterilised. To ensure this does not impact 
the validity of the tests, two applicable sterilisation techniques were tested on a range of Mg 
alloys in order to determine their effect on biocorrosion. If either technique were to change 
the in vitro corrosion behaviour of the Mg alloys it would be disqualified for further use.   
The in vitro biocorrosion methodology utilised herein is in keeping with the 
recommendations presented in Chapter 2.   
Please note that whilst the title of the paper has been left unchanged to avoid confusion, the 
rest of the paper has been changed to British English (i.e. “sterilise” vs “sterilize”) to 
maintain consistency throughout the chapters of this thesis.  
The authors listed contributed to this chapter as follows:  
Contributor Designed 
Experiment 
Provided 
Materials 
Conducted 
Experiment 
Wrote 
Paper 
Edited  
Paper 
Sean Johnston 75% 30% 85% 100% 50% 
Zhiming Shi 5% 20% 5% - - 
Cherilyn Hoe - - 10% - - 
Peter Uggowizter - 10% - - 5% 
Martina Cihova - 10% - - 10% 
Jorg Loffler - 10% - - 5% 
Matthew Dargusch 10% 10% - - 15% 
Andrej Atrens 10% 10% - - 15% 
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Abstract  
This paper studied the influence of two common sterilisation techniques, ethylene oxide (EO) 
and gamma irradiation (GI), on the corrosion rate of four Mg-based materials in CO2–
bicarbonate buffered Hanks’ solution. The four materials were: high-purity (HP)-Mg, ZE41, 
ultra-high purity (XHP)-Mg and XHP-ZX00. The corrosion rate was measured via mass loss 
(Pm) and hydrogen evolution (PH).  Two-way Analysis of Variance (ANOVA) was conducted 
to assess the effect of the sterilisation techniques on the corrosion rates across the four 
materials. The ANOVA analysed the variables of (i) material and (ii) sterilisation condition 
(EO, GI and an unsterilised control group), and (iii) the interaction between these two 
independent variables. Neither sterilisation technique (EO and GI) significantly influenced 
the corrosion rate as measured by Pm (p < 0.84) or PH (p < 0.08). This result was consistent 
across the four materials tested, as there was no interaction between the test variables of 
material and sterilisation condition for Pm (p < 0.49) or PH (p < 0.27).  As neither EO nor GI 
influenced the corrosion rates, either of these techniques warrants consideration for use on 
Mg-based medical implants and devices. 
1. Introduction 
Sterilisation is an essential step in the processing of any medical implant. Eliminating all 
biological pathogens, including bacteria, spores, viruses, and fungi from the implant surface 
is a key factor in reducing the risk of infection [1, 2]. Failure to correctly sterilise a surgical 
implant can lead to an implant site infection, hindering proper healing. There is also the 
potential for increased fiscal burden, or risk for financial loss, to the institution responsible 
[2, 3].  
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However, certain sterilisation techniques can diminish the properties of the implant materials 
[4, 5]. Therefore, identifying the correct sterilisation technique for an implant material is a 
critical step in the development process. This is especially challenging for new implant 
materials, such as magnesium (Mg) that may not be well studied. The potential for Mg alloys 
to be used in absorbable medical implants and devices has gathered considerable interest in 
recent years [6-9]. The clinical success reported for several commercially available products 
[10, 11] provides strong support for bioabsorbable Mg devices moving from an academic 
consideration to a clinical reality. The ability for Mg to corrode in the body without harming 
the patient allows Mg implants to be used as temporary implants. However, one of the key 
barriers to the widespread use of Mg in many clinical applications is their high corrosion 
rates [12]. The overall corrosion reaction for Mg is presented in equation (1) [12].  The 
corrosion rate must be controlled within a range suitable to an intended application, as 
corrosion governs (i) the mechanical integrity of the implant, and (ii) the biocompatibility of 
the implant. Therefore, it is critical to the success of the implant, and to the safety of the 
patient, to cultivate a full and deep understanding of the factors that influence the corrosion of 
Mg-based biomaterials.  
Mg(ୱ) + 2HଶO(୪) → Mg(OH)ଶ(ୱ) + Hଶ(୥)  (1) 
Liu et al. [13] considered the influence of a range of sterilisation techniques (steam 
autoclaving, ethylene oxide, glutaraldehyde, dry heat and gamma irradiation) on the surface 
characteristics and biocompatibility of MgCa and pure Mg. The sterilisation techniques did 
influence the material properties; however, these effects were somewhat inconsistent. For 
example, the surface morphology of MgCa appeared to be more sensitive than that of the 
pure Mg samples, as the high temperature environment of the steam autoclave and dry heat 
sterilisation accelerated corrosion on the surface of the MgCa samples, while having a 
smaller effect on pure Mg. The study concluded by endorsing gamma irradiation, as it 
appeared to minimise the effects on the samples surface chemistry and their biocompatibility 
[13]. Seitz et al [14] considered the influence of four common sterilisation techniques (steam 
autoclaving, dry heat, gamma irradiation and ethylene oxide) on the mechanical properties of 
two magnesium alloys (LAE442 and MgCa0.8), as well as pure Mg. There were some effects 
although these were again somewhat inconsistent.  For example, dry heat sterilisation 
increased the ultimate strain of LAE442, while decreasing the same property in MgCa0.8. 
Ethylene oxide was found to have the least influence on the mechanical properties of the 
three materials studied.  
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To the authors’ knowledge there has only been one study which has considered the influence 
of sterilisation on Mg biocorrosion [15]. Feyerabend et al. [15] considered the effects of a 
series of sterilisation and disinfection techniques (70% ethanol, Glutaraldehyde, steam 
autoclaving, dry heat, UV irradiation, gamma irradiation and electron-beam irradiation) on 
the mechanical and corrosion properties of Mg6Ag alloy. Gamma irradiation and ethanol 
were the only techniques which did not influence the grain size of the Mg6Ag samples. 
Ethanol, gamma irradiation and electron-beam irradiation all decreased the corrosion rate, 
while dry heat substantially increased the corrosion rate. However, this study was limited to a 
single alloy. The results of Liu et al [13] and Seitz et al [14] suggest that sterilisation 
techniques may effect different Mg-based materials differently.  
This study aims to aid the development of safe sterilisation protocols for future Mg-based 
medical implants by determining the influence of common, applicable sterilisation techniques 
on the corrosion of Mg and a range of Mg alloys.  
1.1. Sterilisation Techniques  
The present authors considered twenty-five in vivo studies that involved Mg-based implants 
to determine which sterilisation techniques were commonly employed on Mg and its alloys. 
Of these twenty five studies, three studies [16-18] used ethylene oxide (EO), nine studies [9, 
19-26] used gamma irradiation (GI), four studies [27-30] used ultrasonic cleaning with 
ethanol, and nine studies [31-39] provided no information on the sterilisation technique used.  
For the purposes of infection control, medical items and equipment are separated into discrete 
categories which outline the level of disinfection or sterilisation required [40]. Mg implants 
are considered critical items in a medical context as they will be in contact with aseptic areas 
of the body once implanted and as such, require full sterilisation [40]. Ultrasonic cleaning 
with ethanol was therefore discounted for the use on Mg-based implants as alcohols, such as 
ethanol, are categorised as disinfectants and not sterilising agents, primarily due to their lack 
of sporicidal action [40].  
EO is a colourless, flammable gas. Its alkylating reactivity makes it a powerful sterilisation 
agent [2] reacting with cellular constituents such as DNA, amino acids, and enzymes, leading 
to their denaturation and preventing normal cellular metabolism and reproduction [41]. 
Implants are able to be sterilised through breathable packaging [41]. EO has emerged as a 
cost-effective and reliable alternative for materials which are heat and/or moisture sensitive 
[41-43].  
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However, such a strong alkalizing agent has clear, inherent risks. Occupational exposure to 
EO has been linked to increased risk of various cancers [40]. EO is also known to form toxic 
residues, which require complex and lengthy aeration procedures to be removed from the 
sample surface [41]. Strict protocols must be followed in order for this technique to be used 
safely [40, 41] and thus it mandates a special and therewith costly infrastructure.  
GI utilises a form of ionizing radiation emitted by a radioisotope, commonly Cobalt-60, to 
sterilise medical implants and devices [44]. The short wavelength, high-intensity radiation 
reacts with DNA preventing the proliferation of microbial species [44]. GI is characterised by 
its deep penetration and low dose rates, with minimal temperature rise of the irradiated body 
[45]. The latter makes this technique favorable for materials that are sensitive to heat or 
moisture, and the former is advantageous as the deep penetration allows the sterilisation of pre-
packaged products. GI once made up only a small fraction of the sterilisation market. However 
this market share has grown considerably in recent years owing to the simplicity of this 
technique, its reliability and its cost effectiveness [45].  
Both EO and GI were deemed suitable sterilisation techniques for this study, as they are both 
appropriate for use on heat sensitive materials. This is in contrast to other techniques such as 
steam autoclaving or dry heat sterilisation, as these techniques are unlikely to be suitable for 
Mg alloys. The high temperature vapour used in steam autoclaving may lead to corrosive 
attack on a Mg implant [13], and the high temperatures of dry heat sterilisation may have an 
undesirable effect on the Mg microstructure [15]. Additionally, both EO and GI sterilisation 
can be performed through packaging, which is advantageous for single use items such as Mg 
implants. This decision was supported by consultation from members of the Federation of 
Sterilising Research and Advisory Councils of Australia (FSRACA).  
1.2. Magnesium-Based Materials  
Four Mg-based materials were selected for this study: high-purity (HP)-Mg, ZE41, ultra-
high-purity (XHP)-Mg and XHP-ZX00. These materials present a good cross section of Mg 
alloys and alloy systems which have previously been considered in biocorrosion studies. HP-
Mg and XHP-Mg allow analysis free from alloying influences [46-48]. The Mg-Zn-Ca alloy 
system has received significant interest for biomedical applications [18, 49-51]. ZE41 was 
included for two reasons: (i) zinc and rare earth elements (RE) are common alloying elements 
in Mg bio-alloys [31, 52] and (ii) ZE41 has a substantially higher corrosion rate than the 
other materials tested [47], providing a broader profile of corrosion rates.  
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2. Methodology & Materials  
2.1. Material & Microstructure 
Table 1 presents the chemical composition of the four materials, analysed by inductively 
coupled plasma atomic emission spectroscopy (Spectrometer Services Pty Ltd, Australia). 
The HP-Mg and ZE41 samples were tested in the as-cast condition. Samples were cut from 
cast ingots into specimens of approximately 5 x 10 x 10 mm in size. Each sample was 
machine-ground using 1200-grit SiC grinding paper, cleaned with ethanol and stored in a 
desiccator until being packaged for storage or sterilisation. The XHP-Mg was produced via 
distillation [54], and then extruded at 300 °C (extrusion speed and ratio 0.2 mm s-1 and 1:69 
respectively) to form ~6 mm diameter rods. The extruded XHP-Mg samples were cut to 
~15 mm lengths. A batch of the XHP-Mg was alloyed with small amounts of calcium and 
zinc to form the XHP-ZX00 alloy, which was extruded at 345 °C (extrusion speed and ratio 
0.2 mm s-1 and 1:70 respectively) to form ~3 mm diameter rods. The extruded XHP-ZX00 
bar was cold drawn into wire, facilitated by periodic annealing at 340 °C for 5 min every 2nd 
or 3rd pass. Each pass resulted in a reduction ratio of ~0.95, with ~30 passes required to reach 
a diameter of ~0.6 mm. The XHP-ZX00 wire samples were cut to lengths of ~50 mm. Both 
extruded and wire samples were manually ground to 1200 grit with SiC grinding paper, 
cleaned with ethanol and stored in a desiccator until being packaged for storage or 
sterilisation. 
Table 1: Chemical composition of materials used in this study (by wt.%). 
Element HP-Mg ZE41 XHP-
Mg 
XHP-
ZX00 
Mg Balance Balance Balance Balance 
Al 0.017 0.010 <0.002 <0.002 
Zn 0.003 4.59 0.002 0.43 
Cu 0.005 0.001 <0.001 <0.001 
Fe 0.001 0.004 <0.001 0.002 
Ca 0.018 0.021 0.004 0.42 
Mn 0.008 0.001 <0.001 0.001 
La <0.005 0.51 <0.005 <0.005 
Ce <0.005 1.0 <0.005 <0.005 
Pr <0.005 0.13 <0.005 <0.005 
Optical microscope images of a typical sample of each material are present in Figure 1. 
Samples were polished and then etched with a standard picric-acetic acid mixture and imaged 
with a Canon EOS 5D MARKII camera and Reichert-Jung POLYVAR (MET) optical 
microscope.  
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Please make note of the scale bar in the lower right corner of each image, as the samples had 
a large range of grain size and thus it was impossible to provide a consistent magnification 
that adequately imaged all samples. Treatment with gamma irradiation or ethylene oxide gas 
was found not to influence the microstructure of the materials tested.   
 
Figure 1: Optical microscope images of typical of (a) as cast HP-Mg, (b) as cast ZE41, (c) extruded XHP-Mg 
and (d) XHP-ZX00 wire (recrystalised following heat treatment). Scale bars are 1000, 250, 500, and 50 μm 
respectively samples.  
The HP-Mg samples presented large grains (~4000-5000 μm) compared to the other materials 
in this study. This is not surprising for unalloyed, as-cast samples. As this material was 
unalloyed no secondary phases are present. The ZE41 samples had grains of relatively 
consistent size (~250μm). The higher alloy content in this as cast sample is associated with 
secondary metallic phases, which are likely to be Mg7Zn3(RE) and Mg12RE [55, 56].  The 
XHP-Mg samples presented mixed sized grains that ranged between 50-500 μm. These were 
much finer than the other unalloyed material (HP-Mg) likely due to the extrusion processing. 
Again, as this was an unalloyed material no secondary phases were present. By far the finest 
grains were present in the XHP-ZX00 samples (~5-10 μm). This material was produced 
similarly to the XHP-ZX10 discussed in Hofstetter et al.[50].  
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In summary, the low amount of alloying facilitates the cathodic Mg2Ca particles to be present 
in preference to other intermetallic, which are anodic to the pure Mg matrix and thus will 
increase the corrosion rate. The presence of these Mg2Ca particles during heat treatment (i.e. 
hot extrusion) will help to  “pin”  the grains in accordance to the Zener limit [57] producing a 
fine grain structure. 
2.2. Sterilisation  
Nine samples of each material were ground, dried in the desiccator, and sealed in airtight 
sample bags under normal atmospheric conditions. Three samples of each material were 
stored in a cool, dry environment away from direct light as non-sterilised controls, three were 
sterilised with an EO treatment and three were sterilised with GI.  
 Ethylene Oxide (EO): The sample bags were opened to allow gas to enter the bag 
and sterilise the samples. Samples were sterilised with a routine production cycle 
(dwell time of 180 min, temperature range of 51-61 °C, relative humidity ≥ 30 % and 
EO gas weight of 30 kg), which was verified to be within the validated release 
parameters. The validation was done in accordance to ISO standard 11135:2014(E). 
The samples were sterilised by Medline Assembly Australia, Pty Ltd. Following 
sterilisation the sample bags were sealed under normal atmospheric conditions. 
 Gamma Irradiation (GI): Samples received a dose of 26.8 kGy from a Cobalt-60 
source in accordance to ISO 11137-1:2006. The samples were sterilised by Steritech, 
Pty Ltd, Australia. 
2.3. Immersion Testing 
The corrosion behaviour of the samples was evaluated using an in vitro immersion test. The 
test was conducted over a seven day period in CO2–bicarbonate buffered Hanks’ Balance Salt 
Solution (HBSS). Table 2 provides the chemical composition of the HBSS used in this study. 
HBSS was selected as it has been shown to give a good model of in vivo corrosion rates for 
slowly corroding samples [46]. As Mg corrodes in medical environments (i.e. in Hanks’ 
solution or in vivo) more complex corrosion products form on the surface of the sample, often 
incorporating calcium or phosphate ions [46]. As such it is important to ensure that each 
sample has a sufficiently high ratio of solution volume to sample surface area to ensure the 
concentration of these ions does not change significantly during the test. Such a ratio will 
provide a more than sufficient supply of ions to mimic the in vivo environment for the given 
time period, as well as reducing the burden placed on the buffer system.  
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We have taken this ratio to be 50mL:cm2 as this has been found to be effective in similar 
studies conducted over this time period (7 days) [58].   Each sample was placed in an 
individual beaker with ~600 mL of solution, enough to ensure this ratio was achieved for 
even the largest samples. 
Table 2: Immersion solution was made from Sigma H6136 Hanks’ solution, with NaHCO3 added to buffer the 
solution pH. Chemical compounds combined to form the solution are provided (mmol L-1).  
CaCl2 
(anhydrous) 
MgSO4 
(anhydrous) 
KCl KHPO4 
(anhydrous) 
NaCl NaH2PO4 
(anhydrous) 
D-
glucose 
Phenol 
Red-Na 
NaHCO3 
1.26 0.81 5.37 0.44 136.89 0.22 5.55 0.03 4.20 
The solution was monitored multiples times daily, with measurements made of temperature, 
pH and solution level. Following measurements, adjustments were made as necessary. The 
immersion solution was maintained at ~37 °C by a water bath. Solution pH was adjusted with 
the addition of CO2 gas such that the average solution pH was ~7.45 across the immersion 
period. The majority of samples experienced a consistent pH range of ~7.45 ± 0.2. The HP-
Mg samples did have a more varied pH range (± ~0.4), however this variation was consistent 
within the sterilisation groups of this alloy, and did not impact the analysis between these 
groups. Pure water was added each day to compensate for water evaporation.  
The samples were suspended with fishing line beneath inverted burettes, in a standard 
hydrogen capture apparatus [59, 60]. Measurements of hydrogen evolution volume were 
recorded multiple times daily. Following the immersion test, the corrosion products on the 
sample surfaces were removed using chromic acid [61], and the samples were dried with hot 
air and stored in a desiccator. Measurements of samples weight and dimension were recorded 
both pre- and post-immersion.   
2.4. Corrosion Evaluation 
Corrosion rates are a method of evaluating the average amount of corrosion that has occurred 
over a period of time. Corrosion rates measured from mass loss (Pm) and total hydrogen 
evolution (PH) are commonly used in Mg corrosion studies [12] and were calculated for each 
sample using equations (2) and (3) respectively.  
𝑃୫ = 2.1
Δ𝑚
𝐴𝑡
  (2) 
𝑃ୌ = 2.088
𝑉ୌ
𝐴𝑡
 (3) 
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Equation (3) is derived from equations (1) and (2) using stoichiometry to determine the 
amount of Mg (Δ𝑚) that is required to produce that volume of hydrogen gas (𝑉ୌ) under 
laboratory conditions (1 atm, 25 °C). Equation (2) assumes ideal gas behaviour, which is 
reasonable for hydrogen gas in these conditions [62]. Corrosion rates are often measured in 
units of either mm y-1 or mg cm-2 day-1. The units of mm y-1 were selected to ease comparison 
between other data sets that have considered these materials [47, 48, 53]. In order for 
equations (2) and (3) to output corrosion rates in mm y-1, the change in mass (Δ𝑚) is 
measured in mg, total hydrogen evolution (𝑉ୌ) is measured in mL, the surface area (𝐴) is in 
cm2, and the immersion time (𝑡) is measured in days.  
Equations (2) and (3) also assume the density of all materials to be ~1.74g/cm3. There was 
some slight variations in the density of the materials used, however this was small and had a 
minimal influence on the magnitude of the corrosion rates. Additionally, the primary aim of 
this study was to determine if there was a difference in the corrosion rates of samples of the 
same material, sterilised with different techniques. As such, any influence of density was 
negated as there was effectively no difference in density for samples of the same materials.  
2.5. Statistical Analysis 
Two-way analysis of variance (ANOVA) with replication was used to reveal statistically 
significant differences between the corrosion rates measured. Two-way ANOVA was used as 
there were two independent variables: material (n=4) and the sterilisation condition (n=3). 
The null hypothesis assumes the data sets are the same and that any variation occurred by 
chance, indicating that the independent variable (either material or sterilisation condition) did 
not influence the corrosion rate. The probability value, p, represents the chance that the null 
hypothesis is true, and any variation between the data sets was random. Statistical 
significance was defined as a probability of p ≤ 0.05; that is there was less than a 5% 
probability that the null hypothesis was true.  
The interaction between these independent variables (material and sterilisation condition) was 
also investigated. Interaction refers to the influence the independent variables may have on 
each other. The interaction null hypothesis was there was no interaction between the two 
independent variables. If this was supported (p >0.05), there was a high probability that there 
was no interaction between the independent variables, and thus the influence of sterilisation 
condition should be consistent across the four materials. An ANOVA was conducted on both 
corrosion rates (Pm and PH). 
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3. Results 
Table 3 presents the results from the immersion test. The mass loss and hydrogen evolution 
data have been converted into corrosion rates using equations (2) and (3), which normalise 
the corrosion data in terms of surface area. The average solution pH of all the samples was 
within ± 0.1 of the pH range of human blood [63].  
Table 3: Immersion test data for Mg samples immersed in CO2-Bicarbonabte buffered HBSS at 37 °C for 7 
days. Corrosion rates measured from mass loss (Pm) and hydrogen evolution (PH) are presented with a ratio 
comparing the two. The average solution pH over the immersion period is also presented. 
Material Sample Sterilisation 
Condition 
Pm [mm y-1] PH  [mm y-1] Ratio  
PH : Pm 
Average 
Solution pH 
HP-Mg 1 Control 0.34 0.04 0.11 7.43 
2 Control 0.31 0.08 0.27 7.44 
3 Control 0.28 0.11 0.38 7.43 
4 EO 0.31 0.12 0.37 7.45 
5 EO 0.33 0.07 0.22 7.43 
6 EO 0.37 0.04 0.10 7.42 
7 GI 0.38 0.00 0.00 7.43 
8 GI 0.31 0.22 0.71 7.41 
9 GI 0.33 0.11 0.33 7.43 
ZE41 1 Control 1.41 0.43 0.30 7.42 
2 Control 1.61 0.42 0.26 7.43 
3 Control 1.12 0.34 0.30 7.48 
4 EO 1.46 0.45 0.31 7.49 
5 EO 1.80 0.68 0.38 7.50 
6 EO 1.29 1.32 1.03* 7.50 
7 GI 1.30 0.19 0.14 7.52 
8 GI 1.10 0.19 0.17 7.54 
9 GI 1.45 0.61 0.42 7.53 
XHP-Mg 1 Control 0.38 0.03 0.07 7.36 
2 Control 0.48 0.03 0.06 7.36 
3 Control 0.41 0.03 0.07 7.35 
4 EO 0.38 0.02 0.07 7.40 
5 EO 0.48 0.02 0.04 7.41 
6 EO 0.34 0.04 0.11 7.41 
7 GI 0.38 0.04 0.11 7.41 
8 GI 0.57 0.09 0.16 7.41 
9 GI 0.38 0.02 0.07 7.37 
XHP-ZX00 1 Control 0.61 0.38 0.63 7.36 
2 Control 0.54 0.03 0.06 7.35 
3 Control 0.55 0.03 0.06 7.36 
4 EO 0.47 0.81 1.73* 7.44 
5 EO 0.56 0.22 0.39 7.35 
6 EO 0.48 0.07 0.14 7.36 
7 GI 0.48 0.12 0.25 7.49 
8 GI 0.60 0.09 0.15 7.39 
9 GI 0.60 0.08 0.13 7.37 
*Denotes a sample with a ratio very close to or greater than 1.00, suggesting there may have been  
  an issue with the hydrogen evolution data 
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Table 4 presents the results of the two-way ANOVAs conducted on the corrosion rates 
calculated from mass loss and hydrogen evolution. 
Table 4: Two Way ANOVA analysis (with replication) for corrosion rates calculated from Mass loss (Pm), 
Hydrogen evolution (PH). 
Corrosion 
Rate 
Source of Variation Degrees of 
Freedom 
p value 
Pm Material 3 << 0.01 
Sterilisation Condition 2 0.84 
Interaction  
(Material x 
Sterilisation) 
6 0.49 
PH  
 
Material 3 << 0.01 
Sterilisation Condition 2 0.08 
Interaction  
(Material x 
Sterilisation) 
6 0.27 
3.1. Mass Loss  
Figure 2 presents the average Pm evaluated for each material and sterilisation condition. The 
corrosion rates indicate some slight variations between the different sterilisation groups. 
However, there was no consistent pattern from this data. EO sterilisation appeared to slightly 
decrease Pm for the XHP-ZX00 and XHP-Mg samples and conversely appeared to slightly 
increase Pm for the HP-Mg and ZE41 samples. Similarly, the sterilisation with GI irradiation 
appeared to have little or no influence on Pm for the XHP-ZX00 samples, while slightly 
increasing Pm for the XHP-Mg and HP-Mg samples, and slightly decreasing those of the 
ZE41 samples.  
Table 4 indicates that there was a significant difference between Pm for the four Mg materials 
tested (ANOVA, p << 0.01). This result was not surprising, as ZE41 was selected as it has 
previously shown relatively high corrosion rates compared to the other Mg-based materials 
tested [47], and this was consistent with the data presented in Figure 2.   
There were no significant differences between the corrosion rates of the different sterilisation 
groups (ANOVA, p = 0.84). This result indicated that Pm did not differ significantly between 
the sterilised groups, and thus that neither technique influenced the corrosion rate of the Mg-
based materials. Additionally, there was no significant interaction between the test variables 
of material and sterilisation condition (ANOVA, p = 0.49), indicating that this result was 
consistent across all four materials. 
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Figure 2: Average corrosion rates evaluated from mass loss (Pm) of five Mg-based materials immersed in 
buffered HBSS for seven days at 37 °C and an average pH of ~7.45. Two sterilisation techniques were tested: 
ethylene oxide (EO), gamma irradiation (GI) and compared to a non-sterilised control. Standard error bars 
were calculated for each average corrosion rate. 
3.2. Hydrogen Evolution  
Table 3 presents the corrosion rates evaluated from mass loss (Pm) and hydrogen evolution 
(𝑃ୌ) for each sample. Pm showed good consistency for each material group, with relatively 
small variation between samples. In contrast, PH showed (i) a considerable amount of 
variability for HP-Mg and XHP-ZX00, and (ii) 𝑃ୌ was typically considerably smaller than Pm 
for all four materials. These results were consistent with previous observations in simulated 
body fluids such as HBSS [12, 47, 64]. Two of the samples registered ratios (𝑃ୌ to Pm) 
greater than 1.0, which suggested that hydrogen was evolved at a faster rate than would be 
expected from the amount of mass loss. This result was physically impossible, and it was 
considered more probable that there was a fault or leak in the burettes used to collect the 
hydrogen for these samples.  
Figure 3 presents the hydrogen evolution volume of the samples, normalised to surface area, 
against immersion time. An average evolution value was calculated for each sterilisation 
condition, with standard errors calculated for each average measurement. As with the mass 
loss data, there was some variation in the hydrogen evolution curves between the sterilisation 
groups.  
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However, these trends were again inconsistent between materials. EO appeared to increase 
the evolution on the Mg alloys (ZE41 and XHP-ZX00), while having no or limited effect on 
the pure Mg samples (XHP-Mg and HP-Mg). Conversely, GI appeared to increase the 
evolution of the pure Mg (HP-Mg and XHP-Mg), whole decreasing the evolution of XHP-
ZX00 and having little to no influence on the ZE41.  
 
Figure 3: Comparison of the average cumulative hydrogen evolution volume, normalised for surface area, for 
(a) HP-Mg, (b) ZE41, (c) XHP-Mg and (d) XHP-ZX00 samples immersed in CO2-bicarbonate buffer HBSS for 7 
days at 37 °C. Standard error bars are presented for each average evolution measurement.  
The materials presented in Figure 3 had relatively consistent hydrogen evolution behaviour 
between the sterilisation types, as deduced from the shape of the evolution curve in each 
graph. The HP-Mg samples had predominately steady, and a somewhat linear, evolution rate 
throughout the test, without an apparent incubation period or plateau region.  
The ZE41 samples presented hydrogen evolution curves consistent of a Mg alloy with a high 
corrosion rate [46]. An initial incubation period occurred with a low, relatively linear 
evolution rate. Following this incubation period, the hydrogen evolution rate increased to a 
more rapid evolution rate between 50 and 72 hours.  
The XHP-Mg samples exhibited a plateau-type behaviour (around the 96 hour mark) that was 
consistent with other slowly corroding samples [46, 53] where a peak was reached and then 
the hydrogen evolution volume decreased before plateauing or slowly rising again. 
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These decreases were too consistent to be attributed to changes in atmospheric conditions, 
and indicated that some hydrogen was being absorbed or lost. This issue has been previously 
experienced by the authors [53]. These decreases are most prevalent in samples with low 
corrosion rates as the absolute volume of hydrogen evolved is low, which enhances the effect 
of small changes. Currently there is no proven mechanism to explain the lost hydrogen. It is 
believed that the hydrogen may be absorbed by the sample or the solution[65]. Changes in 
gas solubility due to pressure or temperature may also be influencing the stability of the 
result, however this is unlikely to have caused such a consistent drop as in Figure 3c, but may 
be contributing to or exacerbating the issue.  
The XHP-ZX00 samples exhibited the greatest variation in evolution curve between the 
sterilisation groups. The control and GI groups plateaued, with the GI group decreasing to 
almost zero. Conversely the EO group appeared to increase almost linearly, with slight 
evidence of an incubation period around 96 hours. However, the absolute value for these 
samples was small, due to the small size of the samples and the corresponding error ranges 
was relatively large. Hydrogen evolution measurements are known to be somewhat 
problematic for slowly corroding samples [12], and these issues are further acerbated in small 
samples, such as the wire used in this study [53]. 
To better assess the validity of any trends in the hydrogen evolution data, a two-way ANOVA 
was conducted on the corrosion rates evaluated from this data. The results of this analysis are 
presented in Table 4.  
As with Pm, there was a significant difference measured in PH for the four materials 
(ANOVA, p = 0.01). This result was expected, and was consistent with observations from the 
authors’ previous work [47], as ZE41 corroded much faster than the other materials tested. As 
with the mass loss there was no significant difference between the corrosion rates of the 
sterilised groups (ANOVA, p = 0.08), however this result was much lower than for Pm. There 
was also no significant interaction between the test variables of material and sterilised 
condition (ANOVA, p = 0.27) again indicating this result was consistent across the four 
materials tested.  
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4. Discussion 
4.1. Difference in Corrosion Rate between Materials  
The materials selected in this study represent a range of alloying elements, purity levels and 
corrosion characteristics. The results from Table 4 suggest that the material had a significant 
influence on both Pm (p << 0.01) and PH (p << 0.01). This result was expected as the ZE41 
samples were included as they tend to have a high corrosion rate, and thus will broaden the 
profile of corrosion rates in this study [47]. This high corrosion rate was attributed to 
secondary phases present in the samples microstructure which are cathodic compared to the 
pure Mg matrix and thus promote the corrosion of the bulk material [66].  
The corrosion behaviour of the XHP-ZX00 was not adversely influenced by secondary 
phases as the composition and processing of this alloy were designed to produce only the 
Mg2Ca phase. This phase was targeted as it was anodic to the Mg matrix, in contrast to the 
other intermetallic phases that can form in the Mg-Zn-Ca series which are cathodic to the Mg 
matrix and thereby tend to increase the corrosion rate [50]. The very fine grains of this alloy 
were intended to enhance its mechanic properties, but may also help to mitigate localised 
corrosion attack. Grain boundaries are areas of high free energy, and tend to have higher 
concentrations of secondary phases or precipitates. As such, they are susceptible to corrosion 
attack. Therefore, it would be expected that finer grains would increase the corrosion rate of a 
sample. However, if the grain size is sufficiently fine it homogenises the corrosive attack and 
thus can reduce the corrosion rate [67]. Additionally, these samples were mechanically 
cleaned, as this was found to be the most effective surface treatment to reduce the corrosion 
rate for this wires of this alloy in the authors’ previous work [53].    
It was initially surprising that the HP-Mg samples corroded slightly slower on average than 
the XHP-Mg samples. The corrosion behaviour of Mg alloys is strongly influenced by 
impurity elements such as Fe, Ni, Cu and Co. These impurities have poor solubility in Mg 
which can cause them to precipitate particles which are cathodic to the Mg matrix, thus 
inducing micro-galvanic effects and accelerating the samples corrosion [68, 69]. These 
precipitates occur readily when the concentrations of the impurity element is above a 
tolerance limit. Therefore, it was assumed that an increase in purity would be associated with 
an increase in corrosion resistance [48]. However, the purity of a sample is most influential 
when the sample has undergone thermal processing, as heat treatment can reduce an alloys 
tolerance for a given impurity substantially [48, 70].   
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This was significant, as the XHP-Mg samples have undergone heat treatment during 
extrusion, while the as-cast HP-Mg samples have not. It is likely that the corrosion rate of the 
HP-Mg samples would have increased if they had undergone a similar thermal processing as 
the XHP-Mg samples. The large grain size disparity between the materials may also be 
expected to influence the corrosion, however for pure Mg it is unclear what this effect was 
expected to be [71, 72]. The inconsistent grain size in the XHP-Mg samples could also be 
indicative of incomplete recrystallisation, which could influence the texture of the samples 
and therefore their corrosion performance. This comparison serves as a clear indicator that to 
avoid errors or misleading conclusions, a full understanding of a samples thermal or 
processing history is necessary for accurate comparative analysis.  
The use of material as an independent variable in the ANOVA was required to determine if 
the materials were all influenced by the sterilisation techniques in a consistent manner. As the 
interaction hypothesis was found to hold true for both ANOVAs, as shown in Table 4, it can 
be concluded that there was no influence or interaction between the two independent 
variables (material and sterilisation condition). Therefore, the effect (or lack thereof) of each 
sterilisation technique was consistent across all the materials tested.  
4.2. Influence of Sterilisation Technique  
The corrosion of the four Mg-based materials was measured via mass loss and hydrogen 
evolution. This data is presented in Table 3, and Figs. 2 and 3. This data indicated no 
influence between both sterilised groups (GI or EO) and the control group on the corrosion 
behaviour. This was supported by the two-way ANOVAs, presented in Table 4, which did 
not find sterilisation via EO and GI to have a significant influence on either measured 
corrosion rate (Pm or PH).  
Furthermore, no significant interaction was found between the independent variables of 
material and sterilisation condition for either corrosion rate (Pm and PH). This indicated that 
the lack of influence was consistent across the four materials tested. However, it is 
noteworthy that the p values for the hydrogen evolution corrosion rates were smaller than for 
the mass loss measurements. While these p values were still above the level of significance (≤ 
0.05), this result was closer to the significance level than that measured from mass loss. 
Despite this, there was still strong evidence to support the use of either sterilisation technique 
on Mg alloys, as neither method was found to significantly influence the corrosion behaviour 
of the materials tested. Therefore, it is the authors’ recommendation that either of these two 
techniques is worthy of consideration for use on future Mg-based biomedical implants.  
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4.3. Corrosion Rates Measured from Hydrogen Evolution  
The measure of hydrogen evolution has been a staple of Mg corrosion studies for many years 
[12, 64]. This type of test is inexpensive as it does not require sophisticated equipment and 
can be set up quickly, thus allowing data to be gathered at a relatively swift pace. The time-
dependent information gathered also provides insights which are not possible with end-point 
analysis methods, such as mass loss, which only give information of the average amount of 
corrosion that has occurred during the test period. However, there are many known issues 
surrounding the hydrogen evolution method [12, 58]. Figure 4 presents a comparison from 
the authors’ previous work [47] of a range of studies which considered Mg biocorrosion in 
HBSS (37 °C, pH ~7.4) utilizing both Pm and PH. The data in this figure was consistent with 
the present study, in that PH was predominately lower than Pm. These inaccuracies are more 
pronounced in slower corroding Mg alloys [12, 47] and are further exacerbated in 
biocorrosion testing as Mg-based materials tend to corrode more slowly in complex, more 
physiologically accurate solutions when compared to traditional NaCl solutions [31, 73].  
 
Figure 4: Comparison between corrosion rates evaluated from total hydrogen evolution (PH) and mass loss (Pm) 
from a number of studies which considered biocorrosion in a similar environment. Figure is reprinted with 
permission from [47]. The solid line is a 1:2 ratio (PH : Pm), the dash line is a 1:1 ratio. 
 
The inconsistencies found with several of the hydrogen evolution data points in this study 
support the use of multiple corrosion evaluation techniques when studying Mg biocorrosion. 
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Despite the known issues with corrosion measurement techniques such as hydrogen 
evolution, many studies still rely on them solely to characterise corrosion behaviour. The 
results obtained in this, and previous studies, clearly show the potential dangers such reliance 
on a single technique can pose to the veracity of a study.   
It was for these reason that the authors’ employed a number of checks to ensure the data was 
reliable, including (i) measuring the hydrogen data in tandem with corrosion rates from mass 
loss and (ii) employing a statistical analysis to verify any trends or results observed. The 
hydrogen evolution curves presented in Figure 3 indicated that the hydrogen evolution 
behaviour of each sample group was relatively consistent between the samples treated with 
different sterilisation techniques, as each of the curves had similar shapes within the material 
groups. The main difference appeared to be the magnitude of hydrogen that was evolved, 
which was analysed by comparing the corrosion rates (PH) of each sample. The two-way 
ANOVA, presented in Table 4, indicated that PH was not significantly influence by the 
sterilisation technique. This result was in good agreement with ANOVA performed on the 
mass loss data. The consistency of the results between the two corrosion rate measurements 
and ANOVAs suggests that the limitations of the hydrogen evolution method have been 
mitigated in this instance, and supports the reliability of the results presented.   
5. Conclusions  
1. Sterilisation with ethylene oxide and gamma irradiation is supported for use on Mg-based 
implants or devices as neither technique was found to influence the corrosion rate of a 
range of Mg-based materials.  
2. Measurement of corrosion with several techniques in tandem (in this instance mass loss 
and hydrogen evolution) was useful in mitigating the limitations of each technique 
individually. For this reason, the authors strongly urge that future studies do not rely on a 
single corrosion evaluation technique, as this may lead to inaccurate results or false 
conclusions. In this study, both corrosion rate measurements, as well as the corresponding 
ANOVA statistical analysis, were in good agreement. This consistency supports the 
reliability of the data and conclusions drawn from it.    
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Chapter 4: In Vitro vs In Vivo 
 
As discussed in Chapter 2, the in vitro assessment of Mg biocorrosion is often validated 
against in vivo results. This is because the expected service condition of any Mg implants is 
much closer to an in vivo study, even a small animal study, than an in vitro apparatus. As 
such, we sought to validate our understanding of the in vitro biocorrosion mechanism by 
comparing it to in vivo data. Moreover, we seek to understand the in vivo biocorrosion by 
controlled in vitro experiments in which we can control each variable. 
Several Mg alloys were implanted subcutaneously into Sprague-Dawley rats, and left for 
either 1 or 4 weeks. The corrosion of these samples was compared to two common in vitro 
solutions: Hanks’ balanced salt solution, and Earle’s balanced salt solution. The solution 
which proved best to mimic in vivo biocorrosion was then used in a second set of in vitro 
trials wherein organic materials (an amino acid and protein) were added to make this SBF 
more similar to the bodily fluids found in vivo.  
Prior to implantation, the samples had to be sterilised. The results from Chapter 3 identified 
that this process was not expected to affect the corrosion results. However, ZE41 was deemed 
unsuitable for in vivo study due to its high corrosion rate. WE43 was substituted, as this alloy 
is commonly studied in medical applications.  
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Abstract  
Corrosion of ZX00, WE43, and HP Mg implanted subcutaneously into Sprague-Dawley rats 
is compared to corrosion in simulated body fluids. Hanks’ solution was a better model for in 
vivo corrosion than Earle’s. Amino acid and protein increased the corrosion rate of all Mg 
alloys by ~3x. Mg specimens implanted subcutaneously were not immersed in a solution, but 
this environment can be described as ‘damp’, and is not analogues to total immersion in 
interstitial fluid. This reduced body of solution is expected to inhibit corrosion and counteract 
the increase in corrosion promoted by the presence of protein and amino acids. 
Key words: 
Magnesium, Corrosion, Biocorrosion, In vitro, In Vivo  
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1. Introduction 
1.1 Magnesium biomaterials 
Magnesium (Mg) alloys are emerging as next generation absorbable biomaterials. Their 
ability to safely corrode in the body makes them ideal candidates for temporary medical 
applications [1, 2]. Mg implants are bioactive in that their presence enhances osteoblast 
production and promotes bone regrowth around the implant [3], which has obvious 
advantages and applications in orthopaedics [4]. The clinical success of Mg orthopaedic [5, 
6] and cardiovascular [7-9] implants suggests there is a substantive future for Mg alloys as 
medical materials.  
The primary impediment to more widespread use of Mg alloys as medical implants is their 
relatively poor corrosion performance. Mg alloys corrode readily in aqueous environments 
[10, 11], and indeed this property makes them suitable for temporary implant applications. 
However, the corrosion must be slow, controlled, and predictable, so that the implant has 
been fully resorbed only after the body has healed sufficiently. Consequently, a considerable 
body of research has studied Mg corrosion in medical environments (i.e. biocorrosion) [1, 11-
14].   
Biocorrosion research can be split into two broad categories:  laboratory studies (i.e. in vitro), 
and live animal trials (i.e. in vivo). Each of these plays an important role. In vitro studies offer 
cheap, ethical, first steps in studying a new proposed medical material, alloy, or process. 
However, even extensive in vitro investigations leave a gap that needs to be filled before 
human clinical trials can begin. This gap is bridged via in vivo animal studies. In vivo trials 
are vital in helping to screen novel techniques and materials prior to clinical testing, in order 
to ensure these new technologies are effective and, more importantly, safe for human 
patients.  
In vivo studies also play a key role in informing and refining the methods used during in vitro 
testing, as has been the case with biodegradable metals such as Mg alloys. Furthermore, 
much of the research conducted in understanding biocorrosion is done via in vitro immersion 
tests [12], and the methodology used during these immersion tests is informed by the results 
of in vivo biocorrosion studies [12, 15]. In fact, the accuracy with which in vitro studies 
predict or match in vivo biocorrosion is often used as the metric of the success of these 
laboratory studies [16, 17]. In an effort to better mimic the in vivo biocorrosion environment, 
a range of simulated body fluids (SBFs) have been employed in vitro. A selection of these is 
presented in Table 1, with two body fluids provided for comparison.  
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However, the ability to accurately mimic in vivo biocorrosion with in vitro immersion tests 
has had limited success. This was discussed in detail in a recent review which identified the 
important components of the SBF, as well as aspects where our understanding could be 
improved [12]. Several of the key aspects identified form the focus of the current study. 
Beforehand however, it is necessary to provide a more detailed characterisation of the in vivo 
biocorrosion environment that is being studied.    
Table 1: Composition of the solutions used and discussed in this study, with blood plasma and interstitial fluid 
given as a comparison. Balanced Salt Solutions (Hanks-HBSS, Earle’s-EBSS), and Minimum Essential Medium 
(MEM).  
 Component  Blood 
plasma 
[16, 18] 
Interstitial 
fluid 
[19, 20] 
HBSS  
(H1387) 
 
EBSS 
(E7510) 
 
MEM 
(M9288) 
 
MEM 
(M0268) 
 
Inorganic 
ions 
(mM) 
Cl- 100-103 115 145 125 145 125 
HCO3- 22-30 26 4.2 26 4.2 26 
H2PO4- 0.0-0.08 - 0.44 1.02 0.44 1.02 
HPO4-2 0.0-1.0 0.6-1.7 0.34 - 0.34 - 
SO42- 0.5 0.7 0.81 0.81 0.81 0.81 
Mg2+ 1.0-1.5 0.5-0.7 0.81 0.81 0.81 0.81 
Ca2+ 2.5 1.2-1.5 1.26 1.80 1.26  1.36 
Na+ 140-142 136-146 142 144 142 143 
K+ 5.0 4.0 5.81 5.37 5.81 5.37 
Organic 
components 
(g/L) 
Protein (e.g. 
albumin) 
35-80 20 - - - - 
Amino Acids 0.25-0.40 0.25-0.40* - - 0.87# 0.87 
Vitamins Variable (in 
range of  
µg-mg) 
Variable 
(in range 
of  
µg-mg)* 
- - 0.008 0.008 
Glucose 0.9-1.1 1.0 1.0 1.0 1.0 1.0 
*assumed to be the same or similar to that of blood plasma.  
#L-Glutamine (0.292 g/L) is added.  
1.1. Extracellular fluids  
Body fluids can be split into two broad categories: intracellular (within the cells), and 
extracellular (outside the cells). All medical implants are in contact typically with 
extracellular fluids. Extracellular fluids have two main subcategories: intravascular (within 
the veins and arteries, i.e. blood plasma) and interstitial fluid (outside the vascular system). A 
comparison between the compositions of the intravascular (i.e. blood plasma) and interstitial 
fluid is presented in Table 1. These solutions are similar, are kept in an homoeostatic 
equilibrium by the Gibbs-Donnan effect [21], but there are the following key differences:  
 Blood plasma may have a slightly lower concentration of HPO42- 
 Blood plasma has a slightly higher concentration of Ca2+ and Mg2+ 
 Blood plasma has between 2-4 times the concentration of proteins   
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Whilst there are some other small differences between these two solutions, these three listed 
differences have the most significant influence on biocorrosion based on our understanding of 
the Mg biocorrosion mechanism (summarised in section 1.3). The differences in these 
solutions are also germane to the discussion of how best to mimic the in vivo biocorrosion 
environment with a SBF in vitro.  
1.2. In vitro immersion tests 
As previously mentioned, the recent literature on Mg biocorrosion [12] identified the 
following components of the solution as most important to the Mg biocorrosion mechanisms:  
 Chloride ions (Cl-) break down the partially protective corrosion product layer and 
facilitate Mg biocorrosion 
 Bicarbonate ions (HCO3-) are an important part of the buffer system used to maintain 
solution pH, but do not need to be included to the same concentration as in blood 
 Magnesium, calcium, and phosphate ions (Mg2+, Ca2+, H2PO4-, and HPO42-) inhibit 
corrosion by forming (Mg,Ca)-P corrosion products on the surface of the specimen. 
These corrosion products are more dense and stable than other corrosion products, 
and thereby are more effective at retarding corrosion. P represents phosphate 
containing products.  
 The other ions (Na+, K+, and SO42-) play a minimal role in Mg biocorrosion  
 Vitamins, amino acids, and proteins, at relevant concentrations, are believed to 
increase the Mg biocorrosion rate; however this result is not as well supported or 
understood.  
These points indicate that the differences between blood plasma and interstitial fluid create 
potentially quite different biocorrosion environments, particularly because of the differences 
in Ca2+, Mg2+, PO42-, and protein concentration. In particular, attention is drawn to the final 
point concerning the influence of vitamins, amino acids, and proteins. The primary source of 
this conclusion is the study of Walker et al. [16]. In this study, a range of Mg alloys were 
implanted subcutaneously into male Lewis rats. The corrosion rates of these Mg alloys were 
compared to Mg alloy specimens immersed in Earle’s Solution (EBSS, comparable to 
E7510), a Minimum Essential Medium (MEM, comparable to M0268; which can be 
considered EBSS plus amino acids and vitamins), and MEM with 40 g/L protein added in 
order to mimic blood plasma (i.e. EBSS plus (amino acids plus vitamins) plus protein).  
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The addition of amino acids and vitamins (from EBSS to MEM) increased the corrosion rates 
of all Mg alloys, and the corrosion rates increased still further with the addition of protein 
(from MEM to MEM + protein). However, these increased corrosion rates were in poor 
agreement with the corrosion rates from in vivo samples (and were much greater than the in 
vivo corrosion rates), whereas the in vivo corrosion rates better matched the corrosion rates in 
the simpler EBSS quite well. There was also an issue that the ratio of specimen surface area 
to solution volume was less than ideal. 
This was a surprising result, as making SBFs more similar to a bodily fluid (by including 
amino acids, vitamins, and proteins) was expected to improve the comparison between in 
vitro and in vivo biocorrosion. However, Walker et al. [16] compared the SBFs used directly 
to blood plasma, whereas the in vivo samples were implanted subcutaneously, meaning that 
their in vivo environment would be expected to be better described as in contact with 
interstitial fluid. As discussed in section 1.1, these two body fluids have subtle but important 
differences. Chief among them, the protein content is far higher in blood plasma as shown in 
Table 1. Additionally, the SBFs used in this study (EBSS and MEM-M2068) contained only 
H2PO4-, with no HPO42-. This is another difference between the SBFs and the body fluids, as 
is clear from Table 1. While some of H2PO4- dissociates into HPO42-, the low dissociation 
constant (Ka) of this weak acid indicates the amount dissociated is small. Finally, MEM 
contains both vitamins and amino acids, meaning it is not possible to decouple their influence 
on the corrosion rate.  
As a result, the present study seeks to build on the good foundational work of Walker et al. 
[16], to better understand the biocorrosion mechanism in vivo, and in vitro. The present study 
measured the in vivo biocorrosion rates and manifestations, and compared these to the 
corrosion rates and manifestations measured in a series of SBFs in vitro. Balanced salt 
solutions containing HPO42- (HBSS) and without this ion (EBSS) were compared to the in 
vivo data to determine which gave the best approximation of the in vivo biocorrosion. 
Subsequently, the superior SBF was modified to include an amino acid, to determine its 
relative influence on the biocorrosion in vitro. L-glutamine was selected, as it is the most 
abundant amino acid in the MEMs listed in Table 1 (and in the study of Walker et al. [16]) by 
a factor of 10 or more. By testing an amino acid in isolation, its influence can be decoupled 
from that of vitamins.  Finally, protein was be added to the SBF, in quantities similar to those 
in interstitial fluid, to clarify its influence on biocorrosion in vitro.  
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It is hoped that this study helps to clarify factors that influence the biocorrosion mechanism 
both in vivo and in vitro, and improves our ability to mimic the former in the latter.  
1.3. Research aims 
In summary, this study aims to:  
1. Better characterise the in vivo biocorrosion environment and measure the corrosion 
rates of a range of Mg alloys in this environment. 
2. Compare the in vivo biocorrosion behaviour of a range of Mg alloys to their corrosion 
behaviour in common SBFs to determine how well the in vivo biocorrosion is 
modelled in vitro. Particular interest is on the influence of the initial concentration of 
PO42- in the solutions.   
3. Determine the influence of amino acid (glutamine) and protein (albumin) on the 
biocorrosion behaviour of Mg alloys in vitro. These organic components are included 
at similar concentrations as in interstitial fluid.  
2. Materials and methods  
2.1. Specimen preparation  
Table 2 presents the compositions of the Mg alloys used in this study: ZX00, WE43 and High 
Purity (HP) Mg. The composition of each alloy was determined by inductively coupled 
plasma atomic emission spectroscopy (by Spectrometer Services Pty Ltd, Australia). 
Table 2: Chemical composition (wt.%) of alloys in this study  
Element ZX00 WE43 HP-Mg 
Mg  Balance  Balance  Balance  
Zn 0.56 0.009 0.030 
Ca 0.52 0.021 0.035 
Zr 0.010 0.480 <0.005 
Al 0.010 0.029 0.018 
Si 0.010 0.010 0.010 
Mn 0.021 0.012 0.008 
Fe 0.003 0.002 <0.002 
Y <0.002 3.750 <0.002 
Gd <0.002 0.420 <0.002 
Ce <0.002 0.035 <0.002 
La <0.002 0.002 <0.002 
Nd <0.002 2.160 <0.002 
Pr <0.002 0.004 <0.002 
Ni <0.002 <0.002 <0.002 
Cu <0.002 0.005 <0.002 
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ZX00, and similar alloys, have received significant consideration for medical applications 
[22-25]. The main alloying elements (zinc and calcium) are essential body nutrients and also 
improve material properties at appropriate concentrations [1, 24]. Alloys relating to WE43 
have been also been extensively studied [26, 27], and have been tested in stents [28] and 
orthopaedic screws [5]. HP Mg was included to allow easy comparison to literature data [29]. 
HP Mg provides a Mg alloy that allows analysis free from alloying elements. Figure 1 
presents optical micrographs of each alloy. ZX00 had uniform equiaxed grain structure with 
an average size of ~200-400 μm. WE43 also had a uniform grain structure but with a smaller 
average size of ~50-150 μm. HP Mg had substantially larger grains (note change in the scale 
bar) with an average size of ~4000-5000 μm (4.0-5.0 mm).   
 
Figure 1: Optical micrographs of (a) ZX00, (b) WE43, and (c) HP Mg (reprinted with permission from [57]). 
Please note the changed scale bar. 
1000 µm 
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As-cast specimens of each alloy were machined into cylindrical rods (~6 mm diameter, ~15 
mm length). The edge of the in vivo specimens were rounded with 4000 grit SiC grinding 
paper to avoid causing irritation once implanted. Specimens were sorted in a cool, dry 
desiccator until testing. These specimens were sterilised via gamma irradiation, as previous 
research found this to be suitable for Mg alloys, as it has no influence corrosion rates [30]. 
Specimens received a dose of 25 kGy from a Cobalt-60 source in accordance to ISO 11137-
1:2006. The specimens were sterilised by Steritech, Pty Ltd, Australia.  
2.2. In vivo 
Sprague-Dawley rats were the in vivo model, as they have been frequently employed in Mg 
biocorrosion studies [25, 31-33]. Rats were ~8 weeks of age at the time of Mg specimen 
implantation. Rats were randomly assigned between the Mg alloys and time points (t = 1 and 
4 weeks). The mass of each rat was measured before implantation, and before sacrifice. The 
average mass (and standard deviation) of the rats is presented in Table 3.  
Table 3: Average mass, with standard deviation, of the rats. Initial mass of each rat was measured just prior to 
implantation, and just before sacrifice at weeks 1 and 4. 
Sex Time point  Average mass (g)  Standard deviation  
Male Initial  323 32 
Week 1 337 31 
Week 4 413 36 
Female  Initial 195 21 
Week 1 199 16 
Week 4 250 25 
Mg alloy specimen were implanted subcutaneously as recommended by the ASTM and ISO 
standards for the short term evaluation of medical devices [34-36]. Two specimens were 
implanted into the left side of each rat, as indicated in Figure 2. There were three rats per Mg 
alloy, sex, and time point (t = 1 and 4 weeks), which yielded n = 6 for each alloy, sex, and 
time point. All procedures were approved by the UQ animal ethics committee (approval 
number MME/161/17), in accordance with the Animal Care and Protection Act Qld (2002), 
and the Australian Code for the Care and Use of Animals for Scientific Purposes (8th Edition 
2013), published by the Australian National Health and Medical Research Council.  
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Figure 2: CT images indicating the positon of the samples once implanted. Samples were implanted near the left 
fore leg (upper) and left hind leg (lower). Samples were implanted in line with the animal’s spine initially, as 
shown in (a). However, as the samples were not fixed, some did move or rotated from the original positon, as 
shown in (b).  
Rats were anaesthetised with an initial mask induction dose of isoflurane (4%) and 
maintained by face mask on 1-3% isoflurane for the duration of the surgery. Once a surgical 
plane of anaesthesia was achieved, the surgical area was clipped and the surgical sites were 
disinfected using a combination of povidone-iodine and ethanol. A small linear full thickness 
skin incision (less than 10 mm) was made and the specimen was implanted subcutaneously. 
The skin was closed with a simple interrupted pattern using non-absorbable sutures. 
Rats were administered both meloxicam (1.0 mg/kg SC) and buprenorphine (5.0 ug/kg SC) 
analgesia before they recovered from isoflurane anaesthesia. The rats were housed in cages in 
groups of three until sacrifice, and their daily monitoring indicated continued good health. 
Water and a standard rodent pellet diet were given ad libitum.  
Prior to sacrifice, computer tomography (CT) scans were used to produce 3D images of the 
rats and implanted Mg specimen, as shown in Figure 2. These images also visualised any gas 
pockets surrounding the samples, which is a key issue as Mg alloys produce hydrogen (H2) 
gas during corrosion.   
The overall reaction for Mg corrosion in a medical environment is presented in equation (1): 
Mg(ୱ) + 2HଶO(୪) → Mg(OH)ଶ(ୱ) + Hଶ(୥)  (1) 
 
 
This equation indicates that the corrosion of Mg produces hydrogen gas. If hydrogen is 
produced too quickly, bubbles or pockets may form [17, 27, 33].  
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For implants, particularly those used in orthopaedics, excessive hydrogen evolution can be a 
significant issue [24, 33, 37, 38]. As such, monitoring and assessing hydrogen pockets in the 
animals were important components of the assessment.  
To examine the hydrogen gas pockets in situ, CT scans produced 3D images of the rats, Mg 
specimen, and any gas surrounding the specimen. Rats were scanned immediately prior to 
sacrifice using a preclinical Inveon Multimodality PET/CT scanner (Siemens Medical Soln., 
Knoxville, TN, United States) at the Centre for Advanced Imaging at The University of 
Queensland. The CT images were obtained using an Inveon Acquisition Workstation 
software (IAW version 2.1, Siemens). The X-ray source voltage was 80 kV and the current 
was 500 µA. The scans were conducted using 360° rotation with 360 rotation steps using a 
low magnification and with a binning factor of 4. The exposure time was 230 ms and the 
CT scanning took approximately 15 min. The CT images were reconstructed using a 
Feldkamp reconstruction software (Siemens) resulting in an isotropic voxel dimension of 
106 µm. The CT data were calibrated in Hounsfield units (HU) defined such that water and 
air have 0 and -1000 HU values, respectively. The images were analysed using an Inveon 
Research Workstation software (IRW version 4.2, Siemens). 
The criteria sheet for the size of the hydrogen gas pocket is presented in Table 4. Examples of 
CT images displaying the range of hydrogen scores are presented in Figure 3. Please note the 
CT images were 3D, and the gas surrounding all sides of the specimen was taken into 
account. However, for ease of viewing the specimen images in Figure 3 are presented in the 
same plane.  
Table 4: Hydrogen gas pocket score sheet  
Number Designation (Description) 
0 Nil (Effectively no hydrogen pocket surrounds the implant).  
1 Slight (There is a small amount of hydrogen).  
2 Moderate (A clear and obvious hydrogen pocket surrounds the implant).   
3 Substantial (A large hydrogen pocket surrounds the implant). 
At the predetermined time points, the animals were sacrificed via an injection of sodium 
pentobarbital (Lethabarb, Virbac Pty LtD) and the Mg specimens were carefully extracted 
and stored in a dissector until corrosion analysis.  
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Figure 3: Example CT images indicative of the hydrogen gas bubble rating system presented in Table 4 (a) 0, 
(b) 1, (c) 2, (d) 3. 
2.3. In vitro 
For comparison to in vivo corrosion, specimens of the same alloys (n = 3 for stage 1, n = 6 for 
stage 2) were of the same shape and were immersed in a range of simulated body fluids 
(SBFs) in conditions designed to mimic the conditions in vivo, using fishing line specimens 
[30, 39-41]. A body of solution (10 L) was mixed in a container, with a pump used to slowly 
mix the solution in order to keep it homogenous. This container was placed in a water bath to 
maintain the temperature at ~37 C.  
The pH of the solution was maintained between ~7.35-7.45 with the CO2-bicarbonate buffer 
system [30, 40, 41]. The ratio of sample area to solution volume was well above the 
recommended level for immersion tests of this nature [12, 13]. Specimens were immersed for 
seven days (168 hours) and monitored multiple times daily. The solution pH and temperature 
were also monitored and adjustments were made where necessary. Pure water was added 
daily to compensate for evaporation. Following the immersion test, specimens were dried 
with hot air and stored in a cool, dry, desiccator pending corrosion analysis.  
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Stage 1 tested two balance salt solutions: HBSS (H1387), and EBSS (E7510) (Sigma 
Aldrich). The compositions of these solutions are given in Table 1. The SBFs selected do 
have differences to interstitial fluid, most notably a higher Cl- content. However, no “off the 
shelf” SBF could be found that was a better match. Therefore, a determination was made to 
use readily available SBF to ensure repeatability. This also reduced the number of variables 
that were being altered in one step, as well as easing comparison to previous work.   
Specimens were suspended with finishing line in the solution. HBSS was the better of the two 
solutions at mimicking in vivo corrosion rates and corrosion products (discussed in detail in 
Section 3.2), and was used as the basis for further testing in stage 2. Stage 2 used the HBSS 
(H1387) modified as follows: 
 HBSS + AA: HBSS (H1387) plus 0.292 g/L of the amino acid L-Glutamine (Sigma 
Aldrich)  
 HBSS + P: HBSS (H1387) plus 14-20 g/L protein. The protein was introduced by 
substituting 2.5 L of pure water with 2.5 L of new-born calf serum (Sigma Aldrich) 
which contains between 5.5-8 g/L proteins.   
During the tests using the modified HBSS solutions, penicillin and streptomycin (Thermo 
Fischer Scientific, 100 units/mL and 100 μg/mL respectively) was added to prevent microbial 
growth [42].  
2.4. Corrosion analysis  
Prior to implantation or immersion, each specimen was dried, weighed and measured. Once 
testing was complete, the specimens were again dried and sorted in a desiccator until 
imaging. Prior to cleaning to remove corrosion products, the surfaces of the specimens were 
imaged using a TM 3030 desktop scanning electron microscope (SEM) in order to 
characterise the morphology of the surface corrosion products, and a chemical analysis of the 
corrosion products was conducted with Energy-dispersive X-ray spectroscopy (EDX) to 
better understand these corrosion products. Following this imaging and chemical analysis, the 
specimens were cleaned via immersion in a chromic acid solution (20% wt CrO3+ 2% wt 
AgNO3) until there was no visible reaction. Chromic acid removes the corrosion products 
from the surface of Mg alloys, without reacting with the underlying, un-corroded Mg sample 
[43].  
After cleaning, the specimens were cleaned with ethanol, dried with hot air, stored in a 
desiccator for a minimum of 24 hours to ensure the specimen was dry, and weighed and 
measured.  
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The pre- and post-implantation weights allowed evaluation of the corrosion rate [11, 30, 40, 
41, 44] with equation (2):  
𝑃୫ = 2.1
Δ𝑚
𝐴𝑡
  (2) 
where the corrosion rate (Pm) is measured in mm/y, the change in weight (Δ𝑚) is measured in 
mg, the exposed surface area (A) is measured in cm2 and the time (t) is measured in days. 
Corrosion rates may be measured in other units (such as mg/cm2/day) and require a simple 
conversion factor for comparison to corrosion rates presented in different units such as mm/y.  
Following chromic acid cleaning, the specimens were returned to the TM 3030 SEM for 
characterisation of the corrosion morphology. The corroded surface of the specimens (free 
from biological material and corrosion products) was imaged and analysed in order to study 
the corrosion morphology.  
2.5. Statistical analysis 
Variables that may influence the corrosion rates were analysed using a two-way analysis of 
variance (ANOVA) with replication. Statistical significance was defined as a probability of 
p < 0.05 (two tailed).  
An ANOVA determines if an independent variable (i.e. animal sex or implantation time) is 
associated with a change in the mean value of a dependent variable (i.e. corrosion rate). A 
two-way ANOVA considers the influence of two independent variables on one dependent 
variable simultaneously.  
Additionally, the interaction between the independent variables is also considered. An 
interaction occurs when the influence of one independent variable (i.e. animal sex) on the 
dependent variable (i.e. corrosion rate) is conditional or effected by the other independent 
variable (i.e. implantation time). For example, in this study the null hypothesis for interaction 
(p > 0.05) of the variables previously mentioned would indicate that (i) the influence of 
animal sex was consistent across both time points and/or (ii) the influence of implantation 
time was consistent with both males and females.  
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3. Results  
3.1. In vivo  
3.1.1. In vivo corrosive environment 
The biocorrosion environment in vivo is not a monolith, but is in fact dependent on the 
location of the implant in the body. In this study Mg specimen were implanted 
subcutaneously as this is the suggested location for exploratory study of biomaterials [34-36], 
particularly when no single application is intended. Care should be taken to properly 
characterise the particular in vivo biocorrosion environment, as the flow rate and volume of 
body fluid exposed to the implant would be expected to be markedly different for a 
cardiovascular implant when compared to an orthopaedic or subcutaneous specimen.  
As previously stated, subcutaneous implants are in contact with interstitial fluid as opposed to 
blood plasma. As such, this form the basis of the in vivo biocorrosion environment. 
Additionally, the Mg specimens were not immersed in this solution in vivo, but instead the 
environment would be better described as damp or wet. The solution volume in contact with 
the Mg specimen alters the immediate availability of ions and organic components, as well as 
influencing charge and mass transfer possible across the surface of the specimen. However, 
unlike in vitro, where a low solution volume results in a depletion of ions and an increase in 
solution pH, the body fluids in vivo are regulated and replenished. Therefore, the precise 
effect the lower volume of fluid has on biocorrosion in vivo has not been studied, as hitherto, 
it has been assumed that the in vivo environment is equivalent to total immersion in the 
appropriate body fluid. The present observations indicate that the subcutaneous in vivo 
environment is not equivalent to total immersion in the appropriate body fluid. Similar 
conclusions can be drawn for orthopaedic implants.  
3.1.2. Corrosion rates  
The corrosion rates and hydrogen evolution scores for ZX00, WE43, and HP Mg specimens 
implanted in the rats for 1 and 4 weeks are presented in Figure 4 (a-c). The data are presented 
by the sex of the animal, and implantation time.  
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Figure 4: Hydrogen evolution score compared to in vivo corrosion rate (Pm) for (a) ZX00, (b) WE43, and (c) 
HP Mg. 
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The data indicate the following trends: 
 Corrosion rates decreased with increased implantation time for all Mg alloys.  
 Hydrogen scores also decreased with implantation time for all alloys. This indicated 
that the evolved hydrogen did not simply accumulate in the gas pocket, rather much 
of the hydrogen gas was absorbed between weeks 1 and 4.  
 In general decreased hydrogen scores were correlated with the decreased corrosion 
rates for each Mg alloy, as expected from the corrosion reaction, Eq(1). 
 However, the ZX00 samples had a similar or slightly higher corrosion rate than the 
WE43 samples, but a lower H2 score on average.  
 A corrosion rate of 0.3 mm/y or less tended to produce either nil or minimal H2 gas 
pockets for all alloys. 
 An outlier is indicated for the data of specimen ZX00-17, which had a corrosion rate 
much higher than the other samples of similar condition (male, 4 weeks). ZX00-17 
had a large iron impurity particle, which increased the corrosion rate substantially. A 
detailed analysis is presented in Appendix A. As there was a clear reason for the high 
corrosion rate of this specimen, and this reason was outside the scope of this study, 
the data from this specimen was excluded from the further analysis.  
The average corrosion rates for the remaining specimens, by alloy, sex of the animal, and 
implantation time, are presented in Table 5. The variation between the corrosion rates were 
assessed via a Two-Way ANOVA, which considered the sex of the animal and implantation 
time as variables.  
Table 5: Average corrosion rates (Pm) are presented for each alloy, time point (1 or 4 weeks), and sex of the 
animal (M = male, F = Female). The standard error (Sm) is also presented. N = 6 for all data points, except 
ZX00 (male, 4 weeks) where N = 5 (indicated by *). A two-way analysis of variance (ANOVA) (with replication) 
was evaluated for each alloy. These ANOVAs considered the sex of the animal (sex), and the length of time the 
sample was implanted (time) as variables. The interaction between these two variables was also considered. 
Each measurement had 1 degree of freedom, and an F critical score of 4.35. Statistical significance was defined 
as a probability of less than 5% (p < 0.05), in addition to F > Fcritical. 
Alloy Implantation 
time (week) 
Animal 
sex 
Pm  
(mm/y) 
Sm 
(mm/y) 
Two-way ANOVA  
Sex Time Interaction 
ZX00 1 M 0.51 0.044 p = 0.52, 
F = 0.42 
p << 0.01, 
F = 24.55 
p = 0.36, 
F = 0.86 F 0.52 0.043 
4 M 0.27* 0.006 
F 0.25 0.020 
WE43 1 M 0.44 0.036 p = 0.027, 
F = 5.66 
p << 0.01, 
F = 45.37 
p = 0.80, 
F = 0.06 F 0.51 0.029 
4 M 0.26 0.013 
F 0.33 0.014 
HP 
Mg 
1 M 0.33 0.014 p << 0.01, 
F = 18.74 
p << 0.01, 
F = 56.87 
p = 0.18, 
F = 2.51 F 0.42 0.020 
4 M 0.23 0.010 
F 0.27 0.013 
*1 sample (ZX00-17) was excluded due to a large iron impurity particle. Details are provided in Appendix A. 
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The results from the average corrosion rates and statistical analysis using ANOVA is 
summarised as follows: 
 The corrosion rate was significantly lower over 4 weeks compared to over 1 week for 
all Mg alloys. This decrease was of the order of ~50% (i.e. from ~0.5 mm/y to  
~0.25 mm/y). 
 The corrosion rates for the ZX00 specimens were similar between samples implanted 
in males and females, across both time points. No significant difference was identified 
between these values. 
 The WE43 and HP Mg specimens implanted in females corroded faster by ~15-30% 
than those implanted in males, and consistently across both time points. The corrosion 
rates for specimens implanted in females were significantly higher, across both time 
points, for both Mg alloys.  
3.1.2. Corrosion characterization  
Figures 5 and 6 show representative SEM images of specimens before chromic acid cleaning 
(i.e. still with biological material attached to the surface). Before cleaning the SEM analysis 
for the alloys was predominately consistent across the three alloys. SEM analysis focussed on 
the length of the cylindrical specimen, as this represented the bulk of the specimen’s exposed 
surface area.  
Figure 5 presents an elemental map produced via EDX analysis of the corroded surface 
covered by the corrosion products. All three alloys had similar corrosion product layers, and 
Figure 5 can be considered representative. This map indicates that the corrosion product 
layers are dominated by light grey areas consisting of (Ca, Mg)-P and dark grey areas 
consisting of predominately Carbon (C). The (Ca, Mg)-P layer is expected considering the 
high PO42- content of interstitial fluid, as shown in Table 1. Carbonates often form in the 
corrosion product; however these compounds also contain a cation (Ca2+ or Mg2+). The lack 
of overlap between Carbon and these cations, as shown in Figure 5, identifies this carbon-rich 
dark grey area as organic material. This identification was consistent with visual inspection of 
the specimens, as sections of each specimen surface were coated with organic materials. 
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Figure 5: SEM image, with EDX elemental mapping, of HP Mg sample implanted subcutaneously in a male 
Sprague-Dawley rat are 1 week. Areas rich in Magnesium (Mg), Carbon (C), Phosphorus (P), and Calcium 
(Ca) are indicated. 
There was little overlap between the (Ca, Mg)-P corrosion products, and the organic material. 
This is consistent with the results of Gray-Munro [45], where the presence of protein on the 
Mg specimen surface was found to inhibit the deposition of the (Mg, Ca)-P corrosion product 
layer in that area. These results were supported by the line analysis presented in Figure 6, 
where a magnified section shows the C count was high in the dark grey area but low in the 
light grey area, with the reverse being true of Ca and P.  
 
Figure 6: SEM image with EDX line analysis of a ZX00 sampled implanted subcutaneously in a female 
Sprague-Dawley rat for 4 weeks. Phosphorus (P), Calcium (Ca), and Carbon (C) peaks indicated on line scan. 
Please note that Mg followed a similar pattern to Ca, but was not included to improve the clarity of the image, 
as the strong signal from the Mg substrate made the other signals difficult to interpret.  
Finally, it is noteworthy that the (Ca, Mg)-P product layer covered more of the specimen 
surface at the later time point (Figure 6, t = 4 weeks) compared to the earlier time point 
(Figure 5, t = 1 week). Again, this result was consistent across all Mg alloys. Moreover, the 
(Ca, Mg)-P and organic layer produced in vivo appear to have had a similar effect on the 
corrosion morphology.  
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Figures 7-9 present images of surface of the corroded surface of the ZX00, WE43, and HP 
Mg specimens, respectively. Representative images of specimens implanted in males and 
females, across both time points, are presented for each alloy. Analysis of the surface 
corrosion morphology free from corrosion products informs understanding of the corrosion 
mechanisms. Similar scale images are presented, with additional images presented where a 
wider scope was required. The broadly consistent corrosion morphology for each alloy 
indicates that neither the (Ca, Mg)-P or the in vivo organic layer allowed significant localised 
corrosion, or caused a significantly different corrosion morphology. The localised corrosion 
that was evident was much more common for the specimens implanted in females, as 
compared to males. This is consistent with the corrosion rate analysis.  
 
Figure 7: Representative images of ZX00 corrosion morphology after subcutaneous implantation into Sprague-
Dawley rats. (a) male 1 week, (b) female 1 week, (c) male 4 weeks, and (d) female 4 weeks. 
Figure 7 presents images of the corroded surfaces of the ZX00 specimens. These specimens 
had similar morphologies for both sexes and time points. The dominant morphological 
features were small pits or depressions, spread evenly across the specimen surface. The 
consistency between the sexes supports the similar corrosion rates presented in Table 5.   
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Figure 8 presents images of the corroded surfaces of the WE43 specimens. As with ZX00, the 
common features of the WE43 specimens were small pits or depressions across the surface. 
These were slightly deeper for the female specimens. Additionally, the WE43 specimens also 
had areas which were largely untouched by corrosion. These areas were markedly smaller in 
the females, compared to the males, and also reduced in size over time for both sexes. The 
smaller regions with lower levels of corrosion in the specimens implanted in the females, 
coupled with the deeper pits (or depressions), were consistent with the higher corrosion rates 
for females as presented in Table 5.   
 
Figure 8: Representative images of WE43 corrosion morphology after subcutaneous implantation into Sprague-
Dawley rats. (a) male 1 week, (b) female 1 week, (c) male 4 weeks, and (d) female 4 weeks. 
Figure 9 presents images of the corroded surfaces of the HP Mg specimens. Again, as with 
the ZX00 and WE43 specimens, the dominant features for these specimens were pits or 
depressions spread evenly across the surface. However, the HP Mg specimens implanted in 
female rats also presented some select areas of heavy, localised lamellar corrosion (as 
depicted in Figure 9c and 9f). These areas were almost exclusively associated with the female 
HP Mg specimens, and were also consistent with the higher corrosion rate. The lamellar 
corrosion appeared to stop at the grain boundaries. However, the mechanism causing this 
type of corrosion is currently not well understood. 
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Figure 9: Representative images of HP Mg corrosion morphology after subcutaneous implantation into 
Sprague-Dawley rats. (a) male 1 week, (b & c) female 1 week, (d) male 4 weeks, and (e & f) female 4 weeks. A, 
b, d, and e are all typical images. C and f indicate areas of localised corrosion that were disproportionally more 
common in female samples (please note changed scale).  
3.2. In Vitro Stage 1: HBSS and EBSS  
3.2.1. Corrosion rates  
The corrosion rates measured from mass loss (Pm) for ZX00, WE43, and HP Mg specimens 
immersed in HBSS and EBSS for 1 week are presented in Table 6. The corrosion rates for the 
same alloys implanted subcutaneously in male and female Sprague-Dawley rats for 1 week 
are also presented to ease comparison.  
Table 6: Average corrosion rates as measured from mass loss (Pm) for 1 week immersion in Hanks’ Balance 
Salt Solution (HBSS) and Earle’s Balanced Salt Solution (EBSS). In vivo corrosion rates for 1 week 
implantation, in male (M) and female (F) rats, are also presented to ease comparison.  
Alloy Environment  Pm (mm/y) 
ZX00 HBSS 0.42 
EBSS 0.97 
In vivo (1, M) 0.51 
In vivo (1, F) 0.52 
WE43  HBSS 0.56 
EBSS 1.02 
In vivo (1, M) 0.44 
In vivo (1, F) 0.51 
HP Mg HBSS 038 
EBSS 0.83 
In vivo (1, M) 0.33 
In vivo (1, F) 0.43 
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There are two clear trends from the data in Table:  
 All three alloys corroded slower by a factor of two in HBSS when compared to EBSS. 
 The corrosion rates measured in HBSS were a much better match to the in vivo 
corrosion rates than those measured in EBSS.  
3.2.2. Corrosion characterization  
The clear difference between the corrosion rates in HBSS and EBSS can be attributed to the 
clear difference between the two solutions: HBSS contains both H2PO4- and HPO42-, whereas 
EBSS only contains H2PO4-. This is significant as phosphate containing corrosion products, 
often denoted as (Mg,Ca)-P, are a vital component of Mg biocorrosion [17, 46]. The 
(Mg,Ca)-P corrosion products are much denser than the corrosion products, such as Mg(OH)2 
that form in chloride solutions, and thus provide much better protection to the underlying 
metallic Mg and slow the corrosion rate. For this layer to form, the divalent Mg2+ and Ca2+ 
must associate with HPO42-. While some of the H2PO4- in EBSS does dissociate, this does not 
make up for the readily available HPO42- in HBSS or interstitial fluid in vivo.  
This difference is illustrated in the SEM images of the corrosion products on the surface of 
ZX00 specimens immersed in HBSS and EBSS in Figure 10, along with EDX maps of the 
phosphate (P) and calcium (Ca) concentrations on their surface. The light grey areas are 
identified as corresponding to (Mg,Ca)-P corrosion products. These (Mg,Ca)-P corrosion 
products  on the surface of the HBSS specimen (Figure 10a) is more dense and widely spread 
than that on the EBSS specimen (Figure 10b). There were similar trends for the WE43 and 
HP Mg specimens. The more substantial presence of the (Mg,Ca)-P corrosion product layer 
explains the slower corrosion rate of the HBSS specimens. It might also explain the better 
match with the in vivo corrosion rates, as this layer was prevalent in vivo as well (Figure 5). 
Representative SEM images of the corrosion morphology after removal of the corrosion 
products for ZX00, WE43, and HP Mg specimens immersed in HBSS and EBSS for 1 week 
are present Figures 11, 12, and 13 respectively. Please note the different scale for the WE43 
specimens presented in Figure 12, as the corrosion morphology features of this alloys 
required a wider view. Images of the in vivo morphology with the same scale are presented 
for reference in Figure 12.  
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Figure 10: SEM images, with EDX elemental maps, of ZX00 samples immersed in (a) HBSS, and (b) EBSS, for 
1 week. Elemental maps of Magnesium (Mg, top left), Carbon (C, top right), Phosphorus (P, bottom left), and 
Calcium (Ca, bottom right) are presented. Similar trends were also seen in the WE43 and HP Mg samples.  
The ZX00 specimens immersed in HBSS (Figure 11a) had a similar corrosion morphology to 
the specimens in vivo (Figure 7), with the dominant feature being small, even pits or 
depressions across the samples surface. However, there were more instances of localised 
corrosion in the HBSS as compared to in vivo, as shown in the right hand side of the Figure 
11a (arrowed). These areas of localised corrosion were also in the sample immersed in EBSS 
(Figure 11b). The general corrosion was also deeper in EBSS, as evidenced by the mesas, 
such as that in the bottom right corner. There were also long, narrow trenches of localised 
corrosion, possible along grain boundaries.  
 
Figure 11: Representative SEM images of corroded surfaces of ZX00 samples from the following 1 week 
immersed in (a) HBSS, and (b) EBSS.  
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The WE43 specimens immersed in HBSS (Figure 12a) had a similar corrosion morphology to 
the specimens implanted in vivo (Figure 12c-d), with areas of general corrosion as well as 
areas largely untouched by corrosion. As noted earlier, the areas untouched by corrosion were 
smaller in the specimens implanted in females (Figure 12d) as compared to the males (Figure 
12c). The areas of general corrosion were also substantially deeper in the specimen immersed 
in HBSS. The areas protected from corrosion were also small in the specimen immersed in 
EBSS (Figure 12b), and there was also more evidenced of localised corrosion. In all samples 
there was evidence of corrosive attack along the grain boundaries.  
 
Figure 12: Representative SEM images of corroded surfaces of WE43 samples from the following 1 week 
immersed in (a) HBSS, and (b) EBSS. Please note: to give full context to the morphological features present in 
the corrosion of this alloy, a wider scale was require. The same scale for in vivo samples are presented for 
samples implanted for 1 week in (c) male, and (d) female, Sprague-Dawley rats.   
The HP Mg specimens immersed in HBSS (Figure 13a) and EBSS (EBSS 13b) can be 
compared to those implanted in in vivo (Figure 9). These specimens had the largest deviation 
from the specimens in vivo, with the HBSS specimens showing areas of general corrosion 
interspersed with areas of lamellar corrosion, which were not present in the in vivo 
specimens.  
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Figure 13: Representative SEM images of corroded surfaces of HP Mg samples from the following 1 week 
immersed in (a) HBSS, and (b) EBSS.  
The EBSS specimens had a reasonable approximation for in vivo corrosion except for the 
deep areas of localised corrosion, which also had different features to the localised corrosion 
in vivo in the specimens implanted in females (Figure 9 c, f). The general corrosion was also 
deeper in these samples, as evidenced by the high corrosion rate (Table 6), and the mesas 
indicated in the far right edges of the image.   
For these reasons, HBSS was the superior model of in vivo corrosion as the corrosion rates 
and morphologies were a closer match than EBSS. As such, HBSS was selected as the base 
solution for the stage 2 in vitro analysis in which the corrosion behaviour was characterised 
for the Mg alloys immersed in (i) HBSS plus an amino acid, and (ii) HBSS plus protein.   
3.3 In vitro stage 2: influence of amino acid and protein 
3.3.1.  Corrosion Rates  
Figure 14 presents the average corrosion rates of ZX00, WE43, and HP Mg specimens 
subjected to the following corrosion environments: (i) subcutaneously implanted in Sprague-
Dawley rats (data from Table 5), (ii) immersed in HBSS and EBSS, and (iii) immersed in 
HBSS plus amino acid, and HBSS plus protein. For the specimens implanted in rats, as 
outlined previously, the corrosion rates decreased significantly as the implantation time 
increased from 1 week to 4 weeks. Further comparative analysis focuses on the corrosion 
rates from 1 week implantation, as they are the most directly comparable to the in vitro 
corrosion rates.  
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Figure 14: Average corrosion rate (Pm) for ZX00, WE43, and HP Mg samples subjected to a variety of medical 
corrosion environments. In vivo samples were implanted in Sprague-Dawley rats. The remaining samples were 
tested in vitro via immersion for 1 week in a range of SBFs at 37 °C and pH of ~7.4.  
AA: Amino Acid (0.292 g/L of L-Glutamine), P: Protein (14-20g/L). 
As outlined previously, the corrosion rates from the specimens immersed in HBSS match the 
in vivo corrosion rates more accurately than those immersed in EBSS. This is attributed to the 
HPO42- content of HBSS being closer to that of interstitial fluid.  
The data in Figure 14 indicate the following trends:  
 The addition of L-glutamine (the most common amino acid in bodily fluids and most 
MEM) to HBSS increased the corrosion rate of all three alloys by a factor of ~3.  
 The addition of protein (albumin) to HBSS also increased the corrosion rate of all 
three alloys by a factor of ~3.  
 The addition of either of these organic materials made the in vitro corrosion rates 
substantially less comparable to those in vivo.   
3.2.3. Corrosion characterisation  
Figure 15 presents representative SEM images (with corrosion products), and EDX elemental 
maps, of ZX00 specimens after immersed for 1 week in HBSS+AA (a), and  HBSS + P (b 
and c). There were similar trends for the WE43 and HP Mg specimens. A comparison to the 
specimens immersed in unmodified HBSS (Figure 10a) is logical, as well as to in vivo 
specimens (Figure 5). The introduction of amino acids (Figure 15a) increased the presence of 
carbon on the specimen surface, suggesting some of the organic material has been deposited 
or dried from the solution.  
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Figure 15: SEM images, with EDX elemental maps, of ZX00 samples immersed for 1 week in (a) HBSS+AA, 
and (b & c) HBSS+P. Elemental maps of Magnesium (Mg, top left), Carbon (C, top right), Phosphorus (P, 
bottom left), and Calcium (Ca, bottom right) are presented. Similar trends were also seen in the WE43 and HP 
Mg samples. 
There was also an increase in calcium, with voluminous Ca-P corrosion product at the base of 
the image. The carbon content increased even further with the addition of protein to the 
HBSS (Figure 15b), and was more evenly incorporated across the samples surface. However, 
there were also instances of the corrosion products and carbon containing organic 
components being quite separate, as in the in vivo specimens (Figure 5), as presented in 
Figure 15c. The calcium content on the specimen surface also increased and there were also 
voluminous Ca-P corrosion products, shown in the bottom left of Figure 15b.  
The voluminous corrosion products as presented in Figures 15 (a-b) suggest that the 
corrosion product layer is less densely packed and more porous compared to other corrosion 
environments. This was determined visually, across a number of samples for each alloy.  
- 113 - 
 
Representative SEM images of the corrosion morphology (without corrosion products) for 
ZX00, WE43, and HP Mg specimens immersed in HBSS+AA and HBSS+P for 1 week are 
present in Figures 16, 17, and 18 respectively. As with Figure 12, please note that the WE43 
specimens presented in Figure 17 have a different scale.  
Amino acids deepened the general corrosion in the ZX00 samples (Figure 16a), as evidenced 
by the mesas. There was localised corrosion, as well as additional deeper pits of localised 
corrosion. Proteins also deepened the localised corrosion and there were trenches of deep, 
narrow localised corrosion.  
 
Figure 16: Representative SEM images of corroded surfaces of ZX00 samples from the following 1 week 
immersed in (a) HBSS+AA, and (b) HBSS+P. 
Amino acids and proteins had a similar influence on the WE43 specimens (Figure 17). The 
corrosive attack along the grain boundaries became more prominent. There were also more 
instances of localised corrosion, and fewer mesas (particular in Figure 17b).  
 
Figure 17: Representative SEM images of corroded surfaces of WE43 samples from the following 1 week 
immersed in (a) HBSS+AA, and (b) HBSS+P. 
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Amino acids also deepened the general corrosion in the HP Mg specimens (Figure 18a), as 
evidences by the mesas, as well as increasing the instances of localised corrosion. Proteins 
(Figure 18b) caused deep pits of localised corrosion, as well as areas of deeper lamellar 
corrosion.  
 
Figure 18: Representative SEM images of corroded surfaces of HP Mg samples from the following 1 week 
immersed in (a) (a) HBSS+AA, and (b) HBSS+P. 
4. Discussion  
4.1. Subcutaneous environment 
The subcutaneous biocorrosion environment can be loosely described as ‘damp’ or ‘wet’, and 
does not contain a body of solution as such. As such, Mg specimens implanted 
subcutaneously were not fully immersed in interstitial fluid solution. This is a new 
observation that has significant implications for understanding the Mg biocorrosion 
mechanism. Clearly, the reduced amount of solution in contact with the specimen implanted 
subcutaneously is expected to provide a substantial decrease in the in vivo corrosion rate 
compared with the corrosion rate for a specimen totally immersed in the same solution. This 
opens up a new avenue for future research. Care should be taken when considering the in vivo 
environment that is being studied. Different areas of the body will have different biocorrosion 
environments. This can include the body fluid/s that form the corrosive medium (discussed in 
detail in section 4.3), as well as the level of interaction between this medium and the implant. 
Subcutaneous and orthopaedic implantation may have similar levels of fluid flow across the 
specimen surface, depending on the vasculature of the bone. However, a cardiovascular 
implant will have continuous, pulsating fluid flow across its surface.  
Additionally, it should be noted that all samples were lightly encased in organic material 
(likely fibrosis) when removed from the animal. This casing was easy to remove and was 
slightly thicker after 4 weeks compared to 1 week. The only exception was ZX00-17, which 
was heavily encapsulated, as discussed in Appendix A.  
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4.2. Amino acids and proteins  
A comparison between the average corrosion rates (Figure 14) in HBSS, HBSS+AA, and 
HBSS+P yielded a simple conclusion: the addition of these organic components (amino acids 
and protein) substantially increased the corrosion rate of all three alloys. On closer 
examination, the organic components increased the corrosion rate ZX00 more than WE43, 
indicating that the influence depends on the alloy and/or is manifest in a slightly different 
way or to a different extent. Nevertheless, the ~3 x increase in the corrosion rate is a strong 
indication of a significant influence that these components have on the biocorrosion 
behaviour. There was also more localised corrosion and deeper general corrosion after 
immersion in the HBSS+AA and HBSS+P, as compared to immersion in the unmodified 
HBSS, supporting the increased corrosion rates.  
The complexity of organic components and the myriad of ways they can interact to influence 
the biocorrosion environment (both in vitro and in vivo) has stymied efforts to elucidate their 
influence on Mg biocorrosion. The recent review analysed the research conducted in this 
area, and it was noted that much of the research produced contradictory results [12].  
There is generally a consensus that the introduction of amino acids into SBFs increases the 
rate of Mg corrosion [16, 47, 48]. However, there is opportunity to clarify these results as 
previous works have often introduced amino acids and vitamins in the same solution. The 
present study avoided this complication, in order to decouple their influence on Mg 
biocorrosion.  
Whereas the influence of amino acids is a predominately a settled topic, there is much debate 
over the influence of proteins. Some results suggested that the introduction of protein inhibit 
corrosion by cleating to the samples surface [47, 49, 50], while others found that organic 
components disrupt the corrosion product layers [45] and therefore result in an increase in 
corrosion rate [16]. It should be noted that many of the studies which found a decrease in 
corrosion rate with the addition of proteins have relied almost solely on electrochemical 
methods, and it is worth noting that electrochemical methods often give corrosion rates for 
Mg that do not agree with corrosion rates measured by weight loss [51].  
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The results of the current study strongly support that proteins and amino acids facilitate Mg 
corrosion, and as such suggest that electrochemical methods may not be reliable in this 
instance. Future studies would do well to include mass/weight loss measurements, for 
comparison and validation.  
The influence of organic components is often characterised by their effect on the Ca-P 
corrosion product layer. Ca-P corrosion products are more densely packed than other 
common corrosion products such as Mg(OH)2. The density of the layer reduces the charge 
and mass transfer between the corrosive medium and the underlying Mg alloy, thus reducing 
the corrosion rate. There have been reports that proteins both encourage [52] and inhibit [45, 
53] the deposition of Ca-P layers on the Mg specimen surface. Amino acids are reported to 
disrupt the corrosion product layer by chelating to the metal cation to form a complex [47], as 
well as positively charged sites bonding to negative components of the corrosion product 
layer (OH or P) [54].  
A comparison of the EDX maps presented in Figure 10a and Figure 15 supports that proteins 
do encourage the deposition of Ca-P, with a larger area covered by these corrosion products. 
However, this corrosion product layer had areas that were much less dense in the HBSS+AA 
and HBSS+P solutions, when compared to the unmodified HBSS. The porosity of the Ca-P 
layer in both modified HBSSs may explain the greater degree of general corrosion in these 
solutions. A more porous Ca-P layer provides less protection from the corrosive medium, 
leading to a higher corrosion rate. The presence of protein has been found to introduce 
porosity in the Mg corrosion product layer previously [55], and a similar result have been 
suggested for the introduction of amino acids [47].  
Despite some areas where there was a stark contrast between the organic layer and corrosion 
products (Figure 15c), the majority of the stage 2 in vitro corrosion products had more carbon 
incorporated into the corrosion product layers (Figure 15a&b), as compared to in vivo (Figure 
5 & 6). The protein used in the in vitro component (albumin) undergoes a neutral-acid 
transition in the pH ranged tested (~7.4), becoming negatively charged in the processes [54]. 
These negatively charged proteins interact with the Ca ions. This process is regulated by the 
carboxyl groups of the proteins. As previously mentioned, a similar interaction occurs with 
the amino acids, which can interact with both positive [47] or negative [54] components of 
the corrosion product layer.  
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The incorporation of amino acids and proteins into the corrosion product layers in vitro, 
suggests that the patches of C in the in vivo EDX maps may be another protein, or organic 
material such as fibrosis. The uneven incorporation of proteins and amino acids into the 
corrosion product layer is a potential cause for the increased localised corrosion in the 
samples immersed in HBSS+AA and HBSS+P.  
The addition of the amino acid (glutamine) and protein (albumin) to the HBSS increased the 
corrosion of ZX00, WE43, and HP Mg samples in vitro. The disruption of the corrosion 
products, in particular Ca-P, likely resulted in more mass and charge transfer, increasing 
general corrosion. The uneven incorporation of the amino acid and/or protein on the 
specimen surface or corrosion product layer may also explain the increased incidence of 
localised corrosion. However, it is unclear why this localised corrosion was not seen in vivo. 
It is possible due to the samples being encapsulated, as has been previously suggested [17], or 
the organic material on the samples surface in vivo could be a difference protein or organic 
material all together such as fibrosis. The exact mechanism is still unclear and deserves 
considerable future testing. 
While this amino acid and protein are the most prevalent in vivo, as well as in many common 
SBFs, the influence of others should not be overlooked. Amino acids in particular deserve 
attention. Glutamine is the most prevalent in interstitial fluid and blood plasma by a factor of 
10, but this is not true of all SBFs. This disparity could prove pivotal when comparing in vivo 
to in vitro results, and further underscores how important it is to carefully select the SBF used 
in vitro. Additionally, while other amino acids are present in lower quantities, they may still 
have a measurable influence. It is worth noting that in this study, in keeping with interstitial 
fluid, proteins were added to 13-20 g/L, while the glutamine concentration was 0.292 g/L. 
The influence of vitamins has also not been considered in this study, as it was an important 
aim to decouple their influence from amino acids. A comparison between the increase herein 
when purely amino acids were included, and previous work which has introduced vitamins 
and amino acids simultaneously [16], suggests that the influence of vitamins may be small. 
However, to be introduced to an SBF vitamins are often bonded to HCl, so consideration 
could be warranted.   
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Finally, it should be noted that this study did not consider the interaction between the organic 
elements introduced. This was intentional. As previously mentioned, past studies have 
introduced multiple elements simultaneously, and this has led to some confusion around the 
results. The influence of organic components on the biocorrosion of Mg alloys is an area in 
need of clarity. As such, consideration of the influence of the most prevalent amino acid 
(glutamine) and protein (albumin) individually provides this clarity.  
Further investigation into how these organic materials, and others, interacted is recommended 
but was ultimately outside the scope of this work.  
The results presented herein indicate that the presence of amino acids and proteins in vitro 
increases the biocorrosion rate and incidence of localised corrosion. However, this increased 
corrosion rate and localised corrosion made for a poorer comparison to the in vivo corrosion 
rates, and corrosion morphology, when compared to unmodified HBSS. As body fluids in 
vivo do contain organic components such as glutamine and albumin, this suggests there are 
additional factors that influence (likely reduce) Mg biocorrosion in vivo that are not 
accurately captured by in vitro immersion tests. This remains an open question, and is 
discussed further in Section 4.3.  
4.3. In vitro solutions as models for in vivo biocorrosion  
The average biocorrosion rates in vivo followed the general pattern of:  
ZX00 = WE43 > HP Mg 
There was some variability within this trend (e.g. for male rates after 1 week ZX00 > WE43, 
whereas for female rats after 4 weeks this was reversed to WE43 > ZX00), however in 
general the alloys ZX00 and WE43 performed similarly with the HP Mg samples corroding 
more slowly. This was partially reflected in the in vitro tests, as the HP Mg samples 
consistently had the lowest corrosion rate. The best approximation of the magnitude of the in 
vivo corrosion rates was found in the unmodified HBSS by a significant margin. However, 
the general trend in this solution can be given as follows: 
WE43 > ZX00 > HP Mg 
This is a departure from the in vivo corrosion rates, as ZX00 corroded more slowly than 
WE43. The addition of proteins and amino acids to HBSS produced corrosion rates which 
can be summarised as: 
ZX00 > WE43 > HP Mg 
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Again, this inversion of the previous trend (with WE43 corroding more slowly than ZX00), is 
not consistent with in vivo results where both alloys performed similarly. The trend in EBSS 
was consistent with in vivo, however the magnitude of the corrosion rates was ~2x that in 
vivo. This result supports the use of SBFs which contain PO42- initially, as this is an essential 
component for a physiologically accurate corrosion product layer.  
By the magnitude of the average corrosion rates, HBSS had a far superior comparison to in 
vivo results compared to all other in vitro environments tested. The addition of protein and 
amino acid to HBSS did produce more Ca-P corrosion products, in keeping with the in vivo 
corrosion products. However, the porosity of this layer in vitro produced a much higher 
corrosion rate, deeper general corrosion, and a higher incidence of localised corrosion. In 
broad terms, the corrosion morphology of the HBSS samples was also consistent with in vivo 
morphology, or at the very least more consistent than EBSS, HBSS+AA, or HBSS+P. 
However, there were still notable deviations in the HBSS morphology.  
There was a high degree of localised corrosion in the ZX00 specimens, and the general 
corrosion was deeper and less even in the WE43 specimens. The most noticeable difference 
was the lamellar corrosion in the HP Mg specimens immersed in HBSS. The exact causes of 
this type of corrosion is currently not known and is a worthy topic of future research. 
However, despite these differences the HBSS corrosion morphology was still more consistent 
to the in vivo morphology than any of the other in vitro solutions. The lack of PO42- in EBSS 
caused a higher incidence of localised corrosion and deeper general corrosion. The addition 
of amino acid and protein to HBSS also promoted localised corrosion attack, with deep pits in 
some specimens, as well as grain boundary attack in the WE43 specimens in particularly. The 
depth of the general corrosion was also deeper.   
Several recent studies have also considered the influence of organic components on the 
corrosion of Mg alloys [53]. Hou et al. [52] found a strong influence of organic components 
on corrosion products in cell culture conditions, and recommended their inclusion in future 
testing. Based on the results presented in the current study, we cannot agree with the general 
inclusion of proteins and amino acids in standard SBF for biocorrosion testing. The poor 
comparison between corrosion rates, corrosion products, and corrosion morphologies 
produced by these solutions compared to in vivo results precludes them as standard SBFs for 
biocorrosion testing. Additionally, care must be taken when employing cell culture conditions 
for in vitro biocorrosion testing, as these conditions often do not control pH.  
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The solution pH has been found to be an important in vitro parameter, which can alter the 
stability of Mg corrosion products [40]. In this context, the solution pH is also important for 
the interaction of biological elements, such as glucose and amino acids which can form a 
reactive species at elevated pH [48], as well as the neutral to acid conversion of proteins 
previously mentioned [54].  
The ideal outcome for in vitro immersion testing is to perfectly mimic the in vivo 
biocorrosion mechanism/s. To do this the in vitro test must match the in vivo: (i) corrosion 
rate, (ii) corrosion products, and (iii) corrosion morphology. Until this is achieved, it is not 
accurate to say the in vivo mechanism/s have been fully recreated.  
This begs the question: is it possible to perfectly mimic in vivo corrosion in vitro? The answer 
has been elusive. It may be possible in the future to accurately predict all facets of in vivo 
corrosion with an in vitro test, but currently that has not been not feasible. The best that can 
be achieved, with diligent testing, is a good approximation of the three categories listed 
(corrosion rate, products, and morphology).  
This study has shown that the best candidates to do this are SBFs such as HBSS (H1387 or 
H6316). It is essential these solutions contain PO42- initially. If a more complex solution is 
desired, a cell culture such as Minimum Essential Medium (M9288) which contains this ion 
is recommended. The influence of amino acids and proteins should continue to be studied, 
however because their inclusion did not improve comparisons to in vivo corrosion, we cannot 
recommend their inclusion for general biocorrosion testing. As such, the current state of the 
art is that HBSS provides a reasonable simulation of the in vivo biocorrosion environment.  
An often ignored aspect of biocorrosion assessment is the different corrosive environments 
present in vivo. As outlined in Section 1.1, there are a number of bodily fluids that may form 
the basis of the corrosive environment in vivo. While many previous studies have focussed on 
blood plasma, other extracellular fluids such as interstitial fluid may also be relevant, 
depending on the location of the implant. Indeed, depending on the application an unusual 
bodily fluid such as bile [56] or urine [57] may form the basis for the corrosive environment. 
As such, a careful consideration of the in vivo corrosion environment should be considered 
before in vitro comparisons are draw or tests designed.  
The results of this study also present interesting challenges for Mg alloys in different 
applications. As blood plasma has a much higher protein content compared to interstitial 
fluid, it is possible that the corrosion rates would be higher in this environment [58].  
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Therefore, an implant in contact with blood plasma may need to be more robust than those in 
contact with interstitial fluid. Alternatively, different Mg alloys may prove more effective in 
different applications, as the ZX00 samples proved more susceptible to the presence of 
proteins and amino acids than the WE43 samples. Table  7 provides a range of possible 
applications for Mg alloys, and the likely bodily fluid/s that are relevant to this application. If 
conducting general biocorrosion testing, or if the intended application is still unknown, 
general SBFs such as HBSS are applicable. However, if there is an intended application, a 
careful consideration of the in vivo biocorrosion environment is recommended.  
Table 7: A selection of potential medical applications for Mg alloys and the associated bodily fluid that will  
likely form the basis for the in vivo biocorrosion environment. 
Implant or Application Bodily Fluid Reference 
Orthopaedic surgery  
(e.g. screws, pins, plates) 
Interstitial fluid and blood plasma (due to the 
vasculature in the bones).  
[58, 59] 
Cardiovascular stent Blood plasma. [8, 60]  
Staples, and sutures Interstitial fluid, and potentially blood plasma if 
they are intended to pierce a blood vessel.  
[61] [59] 
Tracheal/ oesophageal 
stent  
Saliva, and interstitial fluid. [62, 63] 
Biliary stent Bile. [56] 
Urinary stent Urine. [57] 
Gastrointestinal Surgery  Gastrointestinal fluid.   [64, 65] 
For the current study, there are a number of factors that are now apparent which may have 
improved the in vivo comparison.  Table 1 indicates that that blood plasma has a higher PO42- 
and lower Cl- content than HBSS. These two ions have opposing influences on Mg corrosion, 
with the former slowing corrosion and the latter increasing it. Thus, an increase in PO42- and a 
decrease in Cl- both slow corrosion. Additionally, in vitro biocorrosion testing is traditionally 
an immersion test, where the samples are submerged in a body of fluid.  
However, as previously discussed in Section 4.1, the specimens implanted subcutaneously 
were not immersed in solution. In fact this in vivo environment can be loosely described as 
‘damp’ or ‘wet’, but does not contain a body of solution as such. This reduced body of 
solution is expected to slow the corrosion rate, as there would be less charge or mass transfer 
across the specimen surface. The combination of these factors may have counteracted the 
increase in corrosion promoted by the presence of organic material such as protein and amino 
acids. Future testing could consider how best to apply this type of corrosive environment to 
an in vitro setting, and test whether it better mimics in vivo biocorrosion.  
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However, such deviations from established immersion practices should consider the 
application of the implant and the related biocorrosion environment being mimicked. For 
example, placing the Mg specimen on an absorbent, porous material (i.e. a sponge, or cotton 
wool) which is kept damp by a flow of SBF from a water bath, may better mimic certain in 
vivo conditions such as subcutaneous implantation, and possibly orthopaedic applications but 
will likely be a poor model for cardiovascular applications. In the case of cardiovascular 
applications, pulsating flow of SBF would likely more accurately simulate in vivo conditions. 
Regardless, as such testing would require significant departures from current in vitro 
methods, it is considered a fruitful topic of future study and outside the scope of the current 
study.  
4.4. In Vivo Considerations 
4.4.1. Implantation time 
All alloys tested had significantly slower corrosion rates after 4 weeks of subcutaneous 
implantation when compared to 1 week. The increase surface area covered in (Mg, Ca)-P as 
the tests progressed likely partially protected the specimens for further corrosion, slowing the 
corrosion rate. The success of Mg medical implants depends on their corrosion resistance 
throughout their lifecycle. The initial corrosion resistance (in the first week) is vital as this 
period is often the associated with higher hydrogen gas production (discussed in detail in 
Section 4.3.2.). These results suggest that the corrosion rates slow with increasing 
implantation time, and as such, if the initial rates are acceptable the implant should continue 
to performance within parameters in the future. However, medium and long term corrosion 
rates should not be ignored during testing. The results presented herein do not constitute long 
term corrosion, and such testing would require implantation of 3-6 months or longer. 
Additionally, the presented results caution direct comparison and extrapolation between 
corrosion rates evaluated at different implantation time points.  
4.4.2. Hydrogen gas  
The production of hydrogen (H2) gas during Mg corrosion is a well noted concern for Mg 
medical implants, as too rapid production of this gas can create gas pockets. These gas 
pockets were studied via CT-imaging prior to explanation. These pockets were often irregular 
in size and therefore calculating the exact volume of gas was difficult. Consequently, a 
qualitative scale was employed, which described the size of the pocket numerically. This 
methodology can be improved in future; however, for the current study it is convenient.  
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There is a clear pattern from Figure 4 as the H2 pockets reduced in size with increasing 
implantation time. This indicated that the gas pockets did not simply grow in size with 
additional hydrogen production through Mg corrosion, but that there was a decrease in gas 
pocket size indicating gas dissolution in the surrounding tissue and dissipating through these 
tissues. The decrease in gas pocket size for each alloy also correlated with a decrease in 
corrosion rate, which was significantly lower for all alloys at 4 weeks compared to 1 week, 
for each alloy. There was some correlation between a lower corrosion rate and a small H2 gas 
pocket, however this did not apply across the different Mg alloys. The ZX00 and WE43 
specimens had similar corrosion rates, but the ZX00 specimens had a tendency to have lower 
H2 pocket scores when compared to the WE43 specimens. However, the HP Mg specimens, 
which had the lowest corrosion rates, also had the lowest H2 pocket scores.  
Corrosion rates below 0.3 mm/y tended yield a H2 gas pocket score of below 2, and is 
therefore a good target to reduce the influence of hydrogen evolution. Gas production is not 
ideal in any application, however it is most problematic when involving hard tissue such as 
orthopaedic implants [33, 66]. Soft tissues are able to absorb the H2 gas gradually, whereas if 
hard tissue remodels around the gas pocket it may trap the gas or simply become porous 
which harms the tissue. 
4.4.3. Animal sex 
Perhaps the most surprising result from the in vivo section concerns the influence of animal 
sex on the corrosion rates of the specimens. There was no significant difference for the ZX00 
specimens between specimens implanted in male and female rats. However, the WE43 and 
HP Mg specimens implanted in female rats corroded significantly more quickly compared to 
the males. This increased corrosion rate was consistent across both time points, and was 
associated with an increase in localised corrosion. The higher corrosion rates and changed 
corrosion morphology in the WE43 and HP Mg specimens implanted into female animals 
suggests there was a difference in the biocorrosion environment between the males and 
females. However, the consistent corrosion rates and morphology in the ZX00 samples did 
not appear to be influenced by this difference. This poses something of a conundrum. The 
lack of influence in the ZX00 samples does not eliminate the evidence for such an influence 
in the other two alloys, at both time points and substantiated by statistical analysis. 
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Therefore, a theory is proposed to explain the changed biocorrosion conditions which 
resulted in higher corrosion rates and higher incidence of localised corrosion in the WE43 
and HP Mg samples. Subsequently, it is explained why these changed conditions did not 
similarly influence the ZX00 specimens.  
The biocorrosion environment can be influenced by a number of factors [12] including (i) 
solution pH, (ii) temperature, (iii) solution flow across the samples surface, and (iv) solution 
composition. The increased corrosion rate, and change in morphology, are more likely to be 
caused by a changing solution composition, as compared to the other variables listed. The pH 
of bodily fluids is strictly regulated by a number of physiological systems. Small changes in 
core temperature are unlikely to affect subcutaneously implanted samples substantially, and 
the thicker skin of the larger male rats would provide greater insulation, which would suggest 
a reversal of the trend seen herein (i.e. higher corrosion rates in males not females).  
A similar reasoning can be applied to solution flow rate, which, if it was a factor, would be 
expected to favour the larger male animals. As such, the higher corrosion rate is most likely 
due to a change of solution composition, and there is evidence to support this hypothesis.  
The limited solubility of corrosion products such as Mg(OH)2 in the bodily fluids allows 
these compounds to collect on the surface of the Mg samples. This provides something of a 
barrier between the corrosive environment and the underlying metallic Mg, reducing mass 
and charge transfer, thereby slowing corrosion. As the concentration of Mg ions in the body 
fluids decrease, the solubility of the corrosion products increases, potentially destabilising 
sections of corrosion product. This mechanism is reminiscent of the body’s own stores of Mg, 
which are primarily located in the skeletal system. When excess Mg, and other minerals, are 
present in the extracellular fluid they are deposited on the surface of the hydroxyapatite as 
crystals. These crystals are kept as a reservoir and are redissolved into the fluid when the 
mineral levels (e.g. Mg2+ concentration) decrease [67-69].  
Subcutaneous implants are in contact with interstitial fluid, a subset of extracellular fluid 
whose composition is kept in a state of homeostatic equilibrium with blood plasma by the 
Gibbs-Donnan effect. It therefore follows that a decrease in the Mg2+ concentration in either 
extracellular fluid (blood plasma or interstitial fluid, as they are in equilibrium) would 
increase the solubility of the Mg corrosion products and consequently result in an increased 
corrosion rate and increase incidence of localised corrosion.  
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Fluctuations in the concentration of ions in bodily fluids can be triggered by a number of 
factors including diet, age, and exercise [68, 70, 71]. However, these factors were consistent 
between the males and females in this study and thus would not explain the difference in 
corrosion rates. 
However, there is evidence of changes in Mg2+ concentrations in human females, and this is 
linked to a cyclic event: their menstrual cycle [72]. The increased need for Mg2+ during 
pregnancy is well documented [73], as pregnancy is frequently associated with a decrease in 
Mg2+ concentration in body fluids [74-77]. Similarly, certain parts of menstrual cycles are 
associated with a greater need for Mg ions in cellular reactions, and these correspond to a 
decrease in extracellular fluid Mg2+ concentration [72]. This decrease in serum Mg2+ 
concentrations would destabilise the corrosion product layer sufficiently to produce the 
increased corrosion rates seen in this study. 
All of the rats studied herein were of breeding age and a normal oestrus cycle (the equivalent 
cycle for non-primate species) for Sprague-Dawley rats is ~4-5 days [78], suggesting a 
minimum of one cycle for each rat studied at the 1 week time point. 
An analogous process is common in mammals during lactation [79]:  
“The demand for calcium during lactation is high, and mammals uniformly call on skeletal  
reserves in order to meet the demands of milk production.” 
Alternatively, the oestrous cycle could cause changes in the subcutaneous mammary gland 
tissue commonly found in Sprague-Dawley rats [80, 81]. Fluctuations in mammary gland 
cycling and perfusion could also cause changes in interstitial fluid [82], thus changing the 
biocorrosion environment.  
The ZX00 samples were not influenced by the mechanism which caused the increased 
corrosion rates in the WE43 and HP Mg female specimens. The ZX00 specimens had an 
initial corrosion rate higher than the HP Mg samples.  
The lower corrosion rate for HP Mg yields a thinner corrosion product layer, which is more 
susceptible to small perturbations in the in vivo biocorrosion environment. The WE43 male 
samples also corroded more slowly initially than the ZX00 male specimens. Additionally, the 
WE43 specimens had a much less even corrosion morphology, with many areas that had 
relatively little corrosion and thus would also have had a thin corrosion product layer.  
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The ZX00 samples on the other hand had an even morphology, suggesting a uniform 
corrosion product layer. This thicker, more even corrosion product layer mitigated the 
influence that the changes in Mg2+ concentration had on the ZX00 samples. Thus a subtle, 
delicate mechanism is suggested that operates for the Mg alloys with low corrosion rates with 
relatively poorly protective surface films, but whose influence decreases for an alloy with a 
thicker surface film. 
At this stage of research, the mechanism by which sex of the animal (or patient) influences 
the biocorrosion environment, and thereby the biocorrosion rate and morphology still needs 
refinement. Living organism are extremely complex biological systems, and as such it can be 
challenging to identify the mechanism. This is not unprecedented in the field of biomaterials. 
Mg alloys were found to promote bone regrowth when used in orthopaedic applications [27]. 
However, instances of this phenomena  occurring were reported for more than a decade 
before a full mechanism was clarified and described [3]. 
The exact mechanisms or cause of the disparity notwithstanding, these results have 
substantial impacts on the future biocorrosion testing. These results highlight the need of 
further small animal, large animal, and possibly clinical trials studying the influence of sex on 
the biocorrosion of Mg (and potentially other biodegradable metals).  
Sex bias in medical research has been a subject of much interest in recent years. The 
tendency to preference one sex (usually male) in animal and clinical trials has been identified 
as a key issue in a number of biomedical (and related) fields [83-89]. At the clinical level this 
is quite concerning, as it has been shown that women and men can react quite differently to 
drugs [90, 91] and medical devices [92]. These varying reactions, and the underlying causes, 
cannot be adequately studied if a sex is excluded from the testing cohort. Furthermore, this 
bias is not only an issue for clinical trials, but is often also present during animal and pre-
clinical trials [93]. The issue with such a bias, even at a fundamental or preliminary stage of 
research, is succinctly described by Yoon et al. [89]: 
“Because biomedical research serves as the foundation for subsequent clinical 
research and medical decision-making, it is imperative that this disparity be addressed because 
conclusions derived from such studies may be specific to only one sex.” 
Also highlighted are the potential challenges that can be raised by only studying a single sex 
during an in vivo trial.   
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An all-male study of the same three alloys would likely conclude that WE43 outperformed 
ZX00, while an all-female study would struggle to differentiate the two alloys. Analysis of 
the corrosion morphology (Figure 3-5) would also have yielded very different interpretations 
depending on the sex of the animals used in testing, particularly in the case of HP Mg where 
a much higher incidence of localised corrosion was present in samples implanted into 
females. As such, it is suggested that future studies include both male and female animals 
wherever possible. If they are unable to do so, it is suggested to use females as they have 
been shown to be the more stringent model, in terms of both corrosion rate and corrosion 
morphology. 
A survey of 30 in vivo studies of Mg alloys found (i) 13 used only male animals [16, 17, 25, 
31-33, 37, 38, 94-98], (ii) 11 used only female animals [3, 27, 58, 99-106], and (iii) six did 
not specify the sex of the animal [15, 107-111]. These results do not appear to show a strong 
bias towards one sex, however, they also indicate that the potential influence of sex on 
biocorrosion has not been adequately considered.  
4. Conclusions  
A range of in vitro biocorrosion environments were compared to in vivo biocorrosion in an 
effort to better understand the relevant Mg corrosion mechanism.  ZX00, WE43, and HP Mg 
specimens were implanted subcutaneously into male and female Sprague-Dawley rats. 
Initially these sample alloys were compared to simple SBFS, HBSS and EBSS (in vitro stage 
1). HBSS was found to be the superior model to in vivo biocorrosion, and was used as the 
base solution to which an amino acid (glutamine) and protein (albumin) were included to 
similar levels as interstitial fluid (in vitro stage 2). 
 The key conclusions can be summarised as follows:  
1. The specimens implanted subcutaneously (in vivo) were not immersed in a solution. 
In fact this in vivo environment can be loosely described as ‘damp’ or ‘wet’, but does 
not contain a body of solution as such. This reduced body of solution is expected to 
slow the corrosion rate.  
2. The corrosion of the WE43 and HP Mg specimens was significantly faster in the 
female rats compared to the male rats. This was associated with a higher degree of 
localised corrosion.  
3. All specimens corroded substantially more quickly in EBSS compared to HBSS or in 
vivo. EBSS was also associated with more localised corrosion. The presence of PO42- 
initially in the HBSS produced a more extensive (Mg,Ca)-P covering on the specimen 
surface, slowing the rate of corrosion. For future in vitro testing, care should be taken 
to select an SBF which contains PO42-. 
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4. The addition of glutamine (amino acid, 0.292 g/L) and albumin (protein, 13-20 g/L) to 
HBSS increased the corrosion rate by a factor of ~3. The depth of general corrosion 
and incidence of localised corrosion was also increased. Both organic components 
increased the deposition of the Ca-P on the samples surfaces, however this Ca-P layer 
was porous and therefore did not inhibit the corrosion substantially. Both organic 
components also appeared to disrupt the corrosion product layer further by 
incorporating into it. This uneven incorporation likely caused the increase in localised 
corrosion.  
5. Accurately mimicking in vivo biocorrosion with in vitro immersion tests remains 
challenging, as the biological environment is complex. HBSS was the most 
successful, however the high incidence of localised corrosion prevents this from being 
a perfect model. This solution nevertheless has the advantage of simplicity. 
6. A fruitful research direction is to explore the insight that the subcutaneous 
environment is damp rather than wet, and is not analogous to complete immersion in 
an interstitial fluid. 
 
Appendix A: ZX00-17: Iron Impurity  
One of the ZX00 samples had a corrosion rate more than double the average of the other 
samples from the same sex (male) and time point (4 weeks), as indicated in Table A1. This 
sample was heavily encapsulated in Fibrosis which was difficult to clean from the surface. 
Table A1: Corrosion rate (Pm) measured in mm/y of the average corrosion rate of the other five ZX00 samples 
implanted in the same sex animal (male) and for the same time point (4 weeks), compared to the outlier sample 
ZX00-17.  
Average ZX00 
(male, 4 weeks) 
0.27 
ZX00-17 
(male, 4 weeks) 0.60 
 
 
This prompted an investigation of the specimen corrosion morphology using a Scanning 
Electron Microscope (SEM), in order to determine the cause of the anomalously high 
corrosion rate. This analysis identified a large iron (Fe) impurity, as shown in Figure S1.  
 
Figure A1: Iron impurity in ZX00-17 (male, 4 weeks) identified by the high Fe concentration. This Fe-impurity 
particle was identified as the cause for the high corrosion rate of this sample (more than double the average of 
the five similar samples). As such, this sample was excluded from analysis. 
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The tendency for Fe impurities to negatively influence the corrosion of Mg alloys is well 
known [112-114]. The Fe particle acts as a cathodic site to the surrounding Mg, which acts 
anodically and thus corrodes more quickly.  This micro-galvanic reaction causes deep 
localised corrosion (as seen to the left of the impurity in Figure S1) and thereby increases the 
average corrosion rate of the sample. As this impurity provided a clear reason for the 
increased corrosion rate and the changed morphology of this sample, it was considered an 
outlier and excluded from further analysis. 
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Chapter 5: Forming of Wire & the Influence of Surface 
Condition on Corrosion 
 
This study considers a new form of Mg alloy: cold-drawn wire. Mg wire has a number of 
applications in medical devices, such as surgical tacks (explored in Chapter 6). Prior to 
exploring these options however, the Mg alloy needs to be formed into wire, and the effect 
this forming has on the corrosion properties must be understood.  
This chapter builds on my understanding the literature (Chapter 2), as well as previous in 
vitro biocorrosion testing (Chapter 3 and 4), to understand the corrosion of Mg alloy wire. 
ZX00 was selected as the candidate alloy as it had desirable mechanical, and corrosion 
properties, while also being alloyed only with biocompatible components.      
The authors listed contributed to this chapter as follows:  
Contributor Design 
Experiment 
Conducted 
Experiment 
Analysed 
data 
Wrote 
Paper 
Edited 
Paper 
Sean Johnston 70% 80% 70% 100% 60% 
Zhiming Shi  15% 10% 10% - 15% 
Matthew 
Dargusch 
5% 5% 5% - 10% 
Andrej Atrens 10% 5% 15% - 15% 
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Abstract  
Corrosion of extruded and cold drawn XHP-ZX00 wire samples was studied using immersion 
in CO2-bicarbonate buffered Hanks’ solution. Six surface conditions were studied: as 
extruded, as drawn, annealed, mechanically cleaned, chemically polished and cleaned with 
acetic acid. Cold drawing introduced some iron impurity particles onto the wire surface, 
however the low corrosion rates suggest that the amount of these particles was low. 
Corrosion was evaluated by mass loss, hydrogen evolution and radius reduction, an adapted 
corrosion evaluation method. There was good agreement between the corrosion rates 
evaluated from mass loss and radius reduction. Mechanically cleaning produced the lowest 
corrosion rate.   
Keywords: A. Magnesium, B. Weight Loss, B. SEM.  
1. Introduction 
Wires form the basic building block for numerous biomaterial applications, including 
orthopaedic K-wires and sutures in wound closure. Magnesium (Mg) alloys were considered 
for wire based applications more than a century ago, but did not gain acceptance because of 
(i) lack of ductility in the available Mg alloys, and (ii) high corrosion rates [1], now known to 
have been caused by high levels of impurity elements [2]. In recent years, Mg alloys have 
again received significant interest as absorbable biomaterials [3-10]. Biodegradable metals, 
such as Mg, are being developed as they possess superior mechanical properties to polymers, 
while also being absorbable, unlike permanent metallic biomaterials such as titanium and 
stainless steel [3]. However, Mg alloys generally have poor corrosion resistance, which leads 
to complications with mechanical integrity and hydrogen gas evolution. Unlike permanent 
implants, a degradable implant would steadily lose strength in service.  
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Therefore, for a degradable implant to be successful it must have a sufficiently low corrosion 
rate to maintain mechanical integrity for the time it takes to fulfil its required function, and 
for the body to heal. The corrosion of Mg is also associated with the evolution of hydrogen 
gas [11], and there is concern that pockets of hydrogen gas could impede or negatively 
impact healing [12-14]. To ensure the success of Mg biomaterials, a large body of research 
has been conducted in understanding and controlling the corrosion of Mg alloys in a medical 
environment [2, 11, 14-31].  
Mg alloys are intrinsically reactive, and as such, are susceptible to galvanic and micro-
galvanic corrosion [2], which causes them to be sensitive to the level of impurity elements 
such as iron, nickel, copper and cobalt [32, 33]. Relatively low concentrations of these 
impurities can cause significant increases in the corrosion rates of Mg alloys [34]. A potential 
breakthrough in this area has come from the development of Ultra-High-Purity (XHP) Mg 
[35]. This alloy was developed with a novel distillation method [36], and has shown superior 
corrosion resistance compared to conventional HP Mg, attributed to the reduction in impurity 
levels [35, 37]. Alloying XHP-Mg with relatively low concentrations of zinc (Zn) and 
calcium (Ca) has been shown to improve the mechanical properties, while maintaining good 
biocompatibility and corrosion resistance [38]. The Mg-Zn-Ca alloy system has been studied 
extensively, both in crystalline [39-43] and amorphous forms [12, 44-46]. Zn and Ca are 
widely studied alloying elements for Mg bio-alloys predominantly because they are both 
essential nutrients commonly found in the body [3], and have little influence on the corrosion 
rate if in solid solution.  
The corrosion behaviour of Mg alloys can also be controlled by surface treatment [2]. 
Mechanical treatments such as grinding or polishing [47] and chemical treatments such as 
acid baths [48] or chemical cleaning [49] have been shown to improve the surface condition 
and/or remove impurities from Mg alloys, and thereby improve their corrosion performance 
[50]. The selection of an optimal surface treatment may be particularly important for wire 
forms of XHP-Mg alloys due to wire production processes. The wires tested in this study 
were cold drawn, as this is a method that has shown good potential for Mg alloys [51, 52]. 
However, there is the potential for impurity elements such as iron to be introduced into the 
surface of the alloy during cold drawing, which could adversely influence the corrosion 
resistance of the XHP-Mg alloy wire [50, 53, 54]. 
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Maintaining a low corrosion rate is integral to the success of XHP-Mg alloys in wire 
applications. Thus, this study aims to determine the influence of various surface conditions 
and treatments on the corrosion behaviour of XHP-ZX00 Mg alloy wires intended for 
biomaterial applications. XHP-ZX00 is XHP-Mg alloyed with 0.45 wt% Zn and 0.45 wt% 
Ca.    
2. Methodology and Materials 
2.1.  Material and wire drawing  
The alloy used in this study is designated as XHP-ZX00. Ultra-high-purity Mg (XHP-Mg) 
was produced via distillation [35, 36] and was alloyed with 0.45% wt Zn (of 99.99% purity) 
and 0.45% wt Ca (of 99.99% purity). This alloy was prepared by the same procedure as the 
XHP-ZX10 alloy outlined by Hofstetter et al. [38], with a few minor adjustments. The 
extrusion temperature and speed were 345 °C and 0.2 mm s-1. The extrusion diameter was 3 
mm, which resulted in an extrusion ratio of ≈70:1.  
The extruded samples were manually cold drawn through a series of dies with reducing 
diameters (reduction ratio ~0.95) into wire of ~0.77 mm diameter over ~25 passes through 
the die. Periodically (every 2nd or 3rd diameter reduction) the wire was annealed for 5 min at 
340 °C, quenched in running pure water and cleaned with ethanol. A total of 10 annealing 
treatments were completed. Beeswax was used as a lubricant during cold drawing.  
Three surface conditions were tested: as extruded (AE), as drawn (AD), and heat treated 
(HT). HT samples were annealed at 340 °C for 5 min, quenched in running pure water, and 
washed with ethanol.  
2.2. Surface treatment   
Three surface treatments were tested on sections of HT wire: (i) mechanical cleaning with 
grinding paper (MC), (ii) a phosphoric acid based chemical polish (CP), and (iii) acetic acid 
cleaning (AA). Several other surface treatments such as hydrofluoric acid [48] and sulphuric 
acid [50] were considered as they have shown promise with other Mg alloys. However they 
were found to react too aggressively with the surface of the wire, removing too much 
material. 
The mechanically cleaned (MC) samples were (i) manually ground with 1200 grit SiC paper, 
(ii) cleaned with ethanol, (iii) dried with hot air, and (iv) stored in a desiccator until testing 
commenced. Grinding with SiC paper is a commonly used method of cleaning the surface of 
Mg samples [15, 31]. 
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The chemically polished (CP) samples were cleaned with a 1:1 mixture of phosphoric acid: 
ethanol by volume. The samples were (i) cleaned with hexane, (ii) immersed in the chemical 
polish for one minute, (iii) immersed in dimethyl sulfoxide for one minute to remove the 
oxide layer, (iv) cleaned with ethanol, (v) dried with hot air, and (vi) stored in a desiccator 
until testing commenced. Phosphoric acid treatments have been found to improve the 
corrosion resistance of Mg alloys [54].  
The acetic acid (AA) cleaned samples were (i) cleaned with hexane, (ii) immersed in 300 g L-
1 acetic acid for 10 seconds, (iii) were cleaned with ethanol, (iv) dried with hot air and (v) 
stored in a desiccator until testing commenced. Acetic acid surface treatment has been shown 
to improve the corrosion resistance of Mg alloys [53].  
2.3. Immersion Testing 
The corrosion behaviour of XHP-ZX00 samples with the six surface conditions outlined in 
section 2.1 (AE, AD, HT, MC, CP and AA) were evaluated by in vitro immersion testing in a 
simulated body fluid. Each sample type was tested in triplicate. The tests were conducted in 
two batches for practical reasons, with the samples being separated into untreated (AE, AD 
and HT) and surface treated (MC, CP and AA) samples. The immersion testing was 
conducted in CO2-bicarbonate buffered Hanks’ solution at the physiological temperature of 
37 °C and pH of 7.4, as this solution has been found to provide good agreement with in vivo 
corrosion rates for slowly corroding Mg samples [14]. The immersion tests were conducted 
over a period of 7 days.  
The weight, length and cross sectional diameter of the samples were measured prior to 
immersion. The cross sectional values were calculated as an average of several readings to 
ensure an accurate measurement. Each sample was placed in a beaker with 500 mL of Sigma 
H6136 10X1L Hanks’ solution sourced from Sigma-Aldrich, with composition as shown in 
Table 1. 500 mL is considered to be more than sufficient surface-area-to-solution-volume 
ratio for even the largest samples used in this study [55]. The beakers were placed in a water 
bath set at sufficient temperature to heat the Hanks’ solution to the physiological temperature 
of 37 °C. The beakers were placed in the water bath several hours prior to testing to ensure 
the homogeneity of the solution, as well as adequate solution temperature and pH. The pH of 
the solution was adjusted to the physiological pH of 7.35-7.45 ±0.1 [56] with the addition of 
either NaOH or CO2 gas as in our prior research [31].  
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Table 1: Chemical compounds used to make the Sigma H6136 10X1L Hanks’ solution (mmol L-1). NaHCO3 
was added as part of the buffer to maintain the pH of the solution. 
CaCl2 
(anhydrous) 
MgSO4 
(anhydrous) 
KCl KHPO4 
(anhydrous) 
NaCl NaH2PO4 
(anhydrous) 
D-
glucose 
Phenol 
Red-Na 
NaHCO3 
1.26 0.81 5.37 0.44 136.89 0.22 5.55 0.03 4.20 
The samples were tied with fishing line and suspended beneath an inverted burette (Pyrex 
burette with PTFE stopcock and solution graduations of 0.1mL) to capture the hydrogen gas 
evolved during corrosion [32, 57]. The samples were monitored at least once daily to measure 
the hydrogen evolution, temperature, pH and solution level. Where necessary, adjustments 
were made to the (i) temperature of the solution by altering the temperature of the water bath, 
(ii) solution pH with the addition of either NaOH or CO2 gas, and (iii) solution level with the 
addition of distilled water to compensate for evaporation, at which time each beaker was 
stirred to help maintain the homogeneity of the Hanks’ solution.  
2.4. Corrosion Evaluation 
The corrosion of the samples was evaluated using corrosion rates calculated from the: mass 
loss (Pm), hydrogen evolved during corrosion (PH), and the reduction in the cross sectional 
radius (Pr). Mass loss and hydrogen evolution are two commonly used corrosion evaluation 
methods [2, 58]. Radius reduction was investigated as a potential method of evaluating the 
corrosion of wire samples.  
Upon completion of the in vitro test the corrosion products were removed from the surface of 
the samples by immersion in chromic acid (20 %wt CrO3 + 2 %wt AgNO3) until there was no 
visible reaction. This cleaning solution has been shown experimentally to remove a negligible 
amount of the un-corroded metallic Mg [37, 57, 59]. Each specimen was washed with pure 
water, ethanol and dried with hot air. The post-test weight, length and diameter were 
recorded. As with the pre-test measurements, the cross sectional values were calculated as an 
average of several readings to ensure an accurate measurement.  
The corrosion rates from mass loss, Pm (mm y-1), were evaluated using [2]: 
𝑃௠ = 2.1
Δ𝑚
𝐴𝑡
  (1) 
where Δ𝑚 is the decrease in mass (mg), A is the average exposed surface area (cm2), and t is 
the immersion time in days.  
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The overall corrosion reaction for magnesium, including in a physiological environment, is 
given by [11, 14-16, 28, 60]: 
Mg + 2 HଶO → Mgଶା + 2OHି + Hଶ   →  Mg(OH)ଶ + Hଶ (2) 
Equation (2) indicates that for every mole of Mg that corrodes, a mole of hydrogen gas is 
evolved. This relationship allows for the amount of Mg corroded to be evaluated from the 
amount of hydrogen evolved.  
The corrosion rates from the evolved hydrogen, PH (mm y-1), were evaluated using [2]:  
𝑃ு = 2.088
𝑉ு
𝐴𝑡
 (3) 
where VH is the volume of hydrogen evolved in mL, A is the average exposed surface area 
(cm2), and t is the immersion time measured in days. 
The corrosion rates could also be calculated from radius reduction, Pr (mm y-1) because of the 
simple (and exact) cylindrical geometry of the wire samples, and the fact that the samples had 
a constant initial radius. The derivation is provided in appendix A. The concept of this 
method was stimulated by the work of Bowen et al. [18].  
The corrosion rates from radius reduction, Pr (mm y-1), were evaluated using [18] : 
𝑃௥ =
𝑟௢ − 𝑟௙
𝑡
     (4) 
where ro is the initial average radius in mm, rf is the final average radius in mm and t is the 
immersion time in years. All radii measurements were made in triplicate with digital calipers.    
Each sample condition was tested in triplicate to allow estimation of the experimental error. 
Each corrosion rate was expressed in the same unit of mm y-1. Expressing each measure of 
the corrosion rate in the same units allows easy direct comparison between the different 
methods, and facilitates comparison to other studies in the field [2, 3, 14]. 
2.5. Microstructure and surface analysis  
The microstructures of the untreated samples (AE, AD and HT) were examined using a JEOL 
6060LA scanning electron microscope (SEM). The samples were cold mounted in resin, 
polished to 0.5 μm and carbon coated to improve the conductivity of the sample surface.  
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A JEOL 6060LA SEM was also used to examine the surface of AD, MC, CP and AA 
samples of the XHP-ZX00 wire. This analysis was conducted to examine the influence each 
surface treatment had on the surface condition and composition of the cold drawn wire.     
The samples were cleaned with ethanol, blow-dried with hot air and mounted on an 
aluminium stub with conductive carbon tape. Energy-dispersive X-ray spectroscopy (EDX) 
was used to analyse the chemical composition of points of interest on the surface of the 
samples. The condition of the samples surface, any impurities that had been introduced 
during wire drawing, and how successful each surface treatment was at removing these 
impurities was recorded.  
After the chromic acid cleaning, the corroded surface of all the samples (AE, AD, HT, MC, 
CP and AA) were analysed and documented with a Leica DFC 295 digital microscope 
camera.  
3. Results  
3.1.  Microstructure 
Figure 1 presents SEM images of the typical microstructure of a longitudinal section of the 
untreated (AE, AD and HT) specimens. In each case the longitudinal section was analysed as 
it was expected that the longitudinal microstructure would dominate the corrosion of the long, 
narrow wire samples. Figure 1 indicates that the grain size was small for all three conditions, 
and suggests that XHP-ZX00 is a possible candidate for bio-corrosion applications as a fine 
grain structure has been linked to better corrosion and mechanical properties [61]. The AE 
sample had a grain size of between 2-5 μm, with evidence of extrusion pores. These extrusion 
pores had been stretched in the AD and HT samples. The grain size of the AD sample was 
between 5-20 μm and was larger than that of the AE condition, likely due to the intermediate 
anneals between cold working of the sample causing some grain growth. Moreover, the 
grains were much less uniform than those of the AE sample.  Nevertheless, this grain size 
was still quite small. The heat treated (HT) sample had a smaller grain size at ~5 μm, and a 
much more uniform grain size distribution than the AD sample, due to the combined 
influence of the amount of prior strain and the annealing conditions producing a finer 
recrystallised grain size. This uniformity is key to the ductility of the alloy, which is why it is 
expected that the annealed condition of the sample is the most likely service condition for the 
XHP-ZX00 wire.   
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Figure 1: SEM images of typical Longitudinal-sections of XHP-ZX00 in the following conditions: (a) as 
extruded, (b) as drawn to wire and (c) wire annealed at 340 °C for 5 min. 
3.2.  Surface Condition  
Figure 2 presents SEM images of the as drawn (AD), mechanically cleaned (MC), chemically 
polished (CP) and acetic acid cleaned (AA) XHP-ZX00 wire samples. Points of interest were 
analysed using EDX to determine chemical composition, and the resulting EDX plots are 
adjacent to the relevant SEM image. Carbon and oxygen peaks were present in all of the 
EDX analysis, which was expected because (i) the samples were mounted on conductive 
carbon tape to improve the quality of the images, and (ii) a small amount of magnesium at the 
magnesium surface was believed to have reacted with atmosphere to form magnesium oxide.    
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Figure 2: SEM images of the longitudinal surface of XHP-ZX00 wire samples in the following conditions: (a) as 
drawn, (b) mechanically cleaned, (c) chemically polished and (d) cleaned with acetic acid. Circled points of 
interested were analysed with energy-dispersive X-ray spectroscopy (EDX), and the resulting EDX plots are 
presented adjacent to the relevant SEM image. 
The surface condition of the as drawn (AD) wire was smooth and even, which was expected 
for a cold drawn wire. The point of interest was identified as an iron impurity. This surface 
impurity suggested that cold drawing using ferrous equipment can cause some iron impurities 
to be introduced into the surface of the sample. The potassium and chloride peaks were 
unexpected, and are presumed to be from a small amount of contamination on the surface of 
the sample.  
(c) 
(d) 
(b) 
(a) 
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The mechanically cleaned (MC) sample retained the smooth and even surface of the as drawn 
(AD) wire, with the addition of some small surface cracks. EDX analysis of the point of 
interest identified it as an iron impurity, suggesting that MC was not able to remove all of the 
impurities collected from wire drawing. The small calcium peak was unsurprising as calcium 
was an alloying element. The potassium and phosphorous peaks were again presumed to be 
from a small amount of laboratory contamination.  
The surface of the chemically polished (CP) sample was uneven, with many shallow pits. 
These pits seem to be centred on particles, which were identified by EDX to be a calcium rich 
secondary phase. This suggests that the CP solution caused some micro-galvanic corrosion 
between the Mg matrix and second phases [62], or iron particles picked up in the cold 
drawing operation. The small phosphorus peak was expected as the base of the chemical 
polish was phosphoric acid. There was no evidence of iron impurities on the surface of the 
CP sample, which indicated that this solution may be able to remove these iron particles. The 
lack of iron particles on the surface of the CP samples is encouraging but not conclusive. It is 
possible that there were no iron particles in this specific sample to begin with. The amount of 
iron particles present on the other samples was small to begin with, with one or two iron 
impurities found after extensive searching.   
The surface of the sample cleaned with acetic acid (AA) was rough, with visible evidence of 
corrosion prior to immersion testing. The point of interest was identified to be stainless steel, 
as chromium was identified as well as iron. This piece was also much larger than the iron 
particles, suggesting that it was instead a fragment from the clamps used during wire 
drawing. There were no pure iron impurities on the surface of the AA sample, suggesting that 
it may be able to clean the surface of iron particles, but not particles of stainless steel. 
However, as with the CP sample, this was encouraging but not conclusive. The presence of 
the stainless steel particle also suggests that there were two sources of surface particles: the 
stainless steel clamps and the iron drawing die.  
3.3.  Corrosion Morphology  
Figure 3 presents typical images of the corroded surfaces for the surface conditions (AE, AD, 
HT, MC, CP and AA) after the immersion test in CO2-bufferred Hanks’ solution for 7 days.  
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Figure 3: Digital microscope images of the corrode surfaces of XHP-ZX00 extruded and wire samples after 
immersion in CO2-bicarbonate buffered Hanks’ solution at 37 °C and pH of 7.4 for 7 days with the following 
surface conditions: (a) as extruded, (b) as drawn, (c) annealed at 340 °C for 5 min, (d) mechanically cleaned, 
(e) chemically polished and (f) cleaned with acetic acid. 
The corrosion morphology of the AE samples was generally even across the surface of the 
sample, with some isolated areas with pitting in evidence. The AD samples also had even 
corrosion across the samples surface. The HT samples had significantly more locally intense 
areas of corrosion than the other untreated samples. The MC samples experienced relatively 
minimal and uniform corrosion. In contrast, both the CP and AA samples displayed sections 
of intense and localised corrosion. The CP samples had deep pitting, and heavy corrosion on 
the edge of the sample where it fragmented during testing. As with most Mg corrosion [2], 
the localised corrosion was not particularly deep, as compared with the pitting corrosion of 
stainless steels. This is evidenced by the fact that the method of radius reduction gave values 
of the corrosion rate similar to those by weight loss, see Figure 4 and Table 2. 
3.4.  Immersion tests  
Table 2 presents the data from the immersion tests. This table specifies the initial and final 
radius, length and mass for each sample. The final and maximum volume of hydrogen 
evolved by each sample is also presented. These two evolution volumes would be expected to 
be the same, however it was found in this study that, for slower corroding samples, the 
hydrogen volume tended to fluctuate. This was consistent with slower corroding samples in 
the authors previous work [31]. The average pH of the solutions over the 7 day immersion 
period was within the physiological region of 7.35-7.45 [56].  
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Figure 4: Average corrosion rates of XHP-ZX00 extruded and wire samples immersed in CO2-bicarbonate 
buffered Hanks’ solution at 37 °C and pH of 7.4 for 7 days with the following surface conditions: as extruded 
(AE), as drawn (AD), annealed at 340 °C for 5 min (HT), mechanically cleaned (MC), chemically polished (CP) 
and cleaned with acetic acid (AA). Corrosion rates were calculated from mass loss (Pm), radius reduction (Pr) 
and maximum hydrogen evolution (PHmax). Standard error bars were calculated for all measurements. 
Table 2: Immersion test data for XHP-ZX00 wire and extruded specimens immersed for 7 days in CO2-buffered 
Hanks’ solution at the physiological temperature and pH. Length, mass and average radius of the samples were 
measured before and after testing. The final and maximum volumes of hydrogen gas evolved were measured and 
normalised for surface area. Corrosion rates were calculated from mass loss (Pm), radius reduction (Pr) and 
maximum hydrogen evolution (PHmax). 
Specimen   Initial Final H2 
Final 
(mL  
cm-2) 
H2  
Max 
(mL  
cm-2) 
Avg. 
pH 
Pm 
(mm 
y-1) 
Pr 
(mm 
y-1) 
PHmax 
(mm 
y-1) 
Avg. 
Radius  
(mm) 
Length 
(mm) 
Mass 
(mg) 
Avg. 
Radius  
(mm) 
Length 
(mm) 
Mass 
(mg) 
AE1 1.428 52.80 606.7 1.418 52.73 598.2 0.8 0.8 7.41 0.53 0.52 0.23 
AE2 1.430 49.50 564.6 1.420 49.38 557.8 0.2 0.3 7.41 0.45 0.52 0.07 
AE3 1.423 48.29 549.1 1.415 47.92 541.7 0.9 0.9 7.43 0.50 0.43 0.28 
AD1 0.385 51.34 44.2 0.370 51.29 40.9 0.2 0.6 7.42 0.81 0.78 0.06 
AD2 0.398 51.01 44.8 0.387 50.81 41.9 0.0 0.5 7.43 0.69 0.61 0.14 
AD3 0.383 51.77 44.3 0.370 51.66 41.6 0.0 0.4 7.45 0.66 0.70 0.12 
HT1 0.383 51.89 44.2 0.362 50.98 39.4 4.1* 4.1* 7.44 1.19 1.13 - 
HT2 0.383 52.25 43.7 0.370 52.18 40.9 0.2 0.6 7.45 0.67 0.70 0.29 
HT3 0.383 45.78 38.4 0.372 45.67 35.8 0.1 0.5 7.46 0.71 0.61 0.14 
MC1 0.390 56.33 47.2 0.382 55.59 45.5 0.1 0.1 7.39 0.37 0.43 0.02 
MC2 0.377 51.33 43.1 0.367 51.45 41.1 0.0 0.2 7.38 0.50 0.52 0.07 
MC3 0.382 54.06 46.8 0.375 54.50 45.5 18.5* 18.5* 7.42 0.30 0.35 - 
CP1# 0.368 52.82 40.0 0.347 37.84 25.0 3.3 3.3 7.43 4.36 - 0.98 
CP2# 0.372 51.93 42.0 0.352 41.12 30.0 3.8 3.8 7.42 3.37 - 1.14 
CP3# 0.378 52.95 43.8 0.358 42.24 31.9 2.2 2.2 7.45 3.21 - 0.67 
AA1 0.375 48.15 39.8 0.355 47.83 36.0 0.2 0.2 7.41 1.03 1.04 0.05 
AA2# 0.373 54.84 45.1 0.348 52.85 38.4 1.5 1.5 7.40 1.63 1.30 0.46 
AA3 0.377 56.68 47.6 0.347 55.25 39.8 1.3 1.3 7.40 1.83 1.56 0.40 
*Higher than anticipated hydrogen evolution. #Sample fragmented during testing. 
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Several of the chemically treated samples (CP1-3 and AA2) fragmented during testing. The 
final lengths of these samples were calculated using the sum of their respective parts. The 
difference between the initial and final lengths of AA2 was consistent with the rest of the 
samples. This was not the case with the CP samples, as there was a large change between 
initial and final lengths of the samples. This was significant as the application of equation (4) 
hinges on the assumption that the length of the sample was constant (as discussed in appendix 
A). Therefore it was not appropriate to use equation (4) to analyse the corrosion of the CP 
samples. As the change in length of AA2 was consistent with the unbroken samples it was 
believe that the assumption still held for this sample.  
The hydrogen evolution of HT1 and MC3 was unexpectedly high for the samples size and 
change in mass. It should be noted that the burette for HT1 was changed after 24 hours, as it 
was found to have a leak. This means that it would be expected for volume measured from 
HT1 to actually be higher than was evolved. The measured values for these samples were 
significantly higher than for other comparable samples. The immersion tests were run in two 
batches, and these two samples were in the same position, using the same burette. The fact 
that the measured amount of hydrogen was much higher than expected for both samples, and 
both samples were tested using the same burette, suggests that there was a fault/leak with the 
burette. As such, the analysis of the hydrogen evolution using equation (2) for these samples 
would not be appropriate.  
3.5.  Corrosion rates  
Excluding the samples outlined in section 3.4, the immersion data was analysed using 
equations (1), (3) and (4) to generate corrosion rates from mass loss (Pm), radius reduction 
(Pr) and maximum hydrogen evolution (PHmax). These corrosion rates are included in Table 2. 
The use of the maximum amount of hydrogen evolved is a slight adaptation to the standard 
procedure. As mentioned previously, it would be expected that the final and maximum 
amount of hydrogen evolved should be the same. However, in this study many samples 
actually experienced a decrease in hydrogen volume, as shown in Table 2. For this reason, the 
maximum hydrogen evolution level was used to evaluate the corrosion of the samples.   
Figure 4 presents the average values for each corrosion rate and sample condition.  
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4. Discussion 
4.1. Corrosion morphology 
The qualitative evaluation of the corroded surface of the samples gave the following ranking 
of the corrosion rates: MC < AE < AD < HT < AA < CP.  
Localised corrosion would likely damage the integrity of any Mg bio-implant, as these areas 
can act as stress concentrators. This may cause an implant to fail before it has achieved its 
desired purpose. As such, a uniform corrosion morphology is desired for a Mg bio-implant. 
Of the untreated samples, the surface morphologies of the AE and AD samples were 
encouraging, however the AD samples were found to be brittle (qualitatively) in comparison 
to the HT samples. As most wire applications require a degree of formability, the samples 
will likely need to be annealed (such as the HT condition) before they can be formed into the 
desired implant geometry. The localised corrosion present in the HT samples suggests that 
surface treatment will be a necessary part of the process, in order to ensure the XHP-ZX00 
wires are both formable and have good corrosion resistance.  
Of the surface treated samples, the heavy, localised corrosion displayed by the CP and AA 
samples suggests that these are not suitable surface treatments. The even and generalised 
corrosion surface of the MC sample was encouraging, and suggests that this is likely the best 
surface treatment for XHP-Mg alloy wires. This qualitative assessment was complemented by 
a quantitative analysis of the corrosion rates of each sample.    
4.2 Corrosion rates 
The corrosion rates Pm and Pr in Figure 4 had the same ranking as that expected from the 
corrosion morphology: MC < AE < AD < HT < AA < CP. There was some minor variation in 
the rankings of PHmax in comparison to the other corrosion rates, however the trends were 
predominately consistent.  
There was good agreement between Pm and Pr for all of the samples that were evaluated with 
both methods, except at the higher corrosion rates as presented in Figure 5, where the solid 
line indicates the condition of equality. This suggests that radius reduction is an appropriate 
method for corrosion evaluation of samples with slow corrosion rates, simple geometries, 
high aspect ratios, and which do not experience significant length reduction.  
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Figure 5: Comparison of corrosion rates calculated from radius reduction (Pr) and mass loss (Pm) for XHP-
ZX00 extruded and wire samples immersed in CO2-bicarbonate buffered Hanks’ solution at 37 °C and pH of 7.4 
for 7 days with the following surface conditions: as extruded (AE), as drawn (AD), annealed at 340 °C for 5 min 
(HT), mechanically cleaned (MC), and cleaned with acetic acid (AA). Solid line represents the condition of 
equity between the two rates.  
In contrast, although there was a qualitative correlation, the quantitative agreement between 
PHmax and Pm was quite poor. The AE samples exhibited an average ratio of ~40% between 
PHmax and Pm, which was consistent with previous results for Mg alloys tested in buffered 
Hanks’ solution at physiological temperature and pH [31, 58, 62]. For the wire specimen, the 
average ratio was much lower at ~22%. This low level of consistency between techniques 
supports the recommendation of Atrens et al. [11] that, wherever possible, it is advisable to 
avoid relying on a single corrosion evaluation method.  
4.3.  Hydrogen Evolution  
The hydrogen evolved from the surface of the sample was measured at least once daily, via 
the displacement of the Hanks’ solution in the inverted burette [32, 57]. While the 
quantitative agreement between PHmax and the other corrosion evaluation techniques was not 
good, the hydrogen evolution data gives important time-specific information about the 
corrosion of the sample, which was not discernible from either of the other methods used.  
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Figure 6 presents the volume of hydrogen evolved from each sample, normalised for surface 
area. The immersion tests were conducted in two batches, and to improve the clarity of the 
Figure 6, the evolution data has been split into the data for the untreated (Figure 6a) and the 
surface treated samples (Figure 6b). The data for HT1 and MC3 were not included in these 
plots as the faulty burette, discussed in section 3.4, had rendered the data gathered unusable. 
Hydrogen measurements for Mg alloys in simulated body fluid (SBF) such as Hanks’ 
solution have been known to be problematic at low corrosion rates [31, 58]. There was 
evidence of this in this study as many samples experienced fluctuating evolution volumes, 
and the MC samples displayed almost no hydrogen evolution. The slow corrosion rate of the 
MC samples is potentially the cause of this low measured hydrogen evolution, as a slow 
corrosion rate allows more time for the hydrogen to be absorbed into the Mg matrix [2, 63].  
 
Figure 6: Hydrogen evolution data for XHP-ZX00 extruded and wire samples immersed in CO2-bicarbonate 
buffered Hanks’ solution at 37 °C and pH of 7.4 for 7 days. Samples were tested in (a) untreated (AE, AD and 
HT) and (b) surface treated (MC, CP and AA) conditions.  
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There were a range of corrosion behaviours. AE1 and AE3 both experience a sharp, fairly 
rapid evolution in the first 24-72 h of the test, before plateauing for a period of time and then 
experiencing a second period of steady evolution until the end of the test. The difference with 
these samples was in the plateauing time: AE1 experienced minimal evolution for at least 100 
h, while AE2 only plateaued for a period of approximately 24 h. This delayed period of 
corrosion suggests that a partially protective film formed on the surface of the sample, 
slowing the corrosion of the sample for a period of time.  
Further evidence of such a partially protective film is suggested by the hydrogen evolution 
data for AE2, AD1-3 and HT2-3. These samples also experienced a relatively stable 
hydrogen evolution up to a plateau 24-72 h into the test. However, instead of exhibiting 
another period of steady hydrogen evolution, the total volume of gas evolved decreased, in 
some cases back to the initial level. Fluctuations of this nature have been experienced by the 
author previously [31] and are thought to be caused by temperature changes as the fluid in the 
burette cools to room temperature. Changes in room temperature and atmospheric pressure 
are also suspected to cause fluctuations in gas volume readings [64].  
Nevertheless, the presence of the plateau region in these slow corroding samples further 
supports the formation of a partially protective oxide film on the surface of the samples.  
The high corrosion rate of the chemically cleaned (CP and AA) samples produced consistent 
hydrogen evolution rates for all but one sample; AA1. AA1 exhibited low hydrogen evolution 
throughout the test, and also experienced the lowest corrosion rate of the chemically cleaned 
samples. The rough surface quality produced by the chemical cleaning methods may have 
impeded the creation of a stable oxide film on the surface of the samples, which could 
explain the poor corrosion resistance of the chemically cleaned samples.  
4.4.  Influence of surface Conditions 
Figure 4 indicates that surface condition was correlated with the corrosion resistance of the 
XHP-ZX00 samples. The untreated samples (AE, AD, HT) had relatively low corrosion rates. 
The AE samples exhibited lower corrosion rates than either AD or HT, which may be a result 
of the impurities introduced to the wire samples during cold drawing or changes in texture 
due to processing. It was expected that the HT samples would exhibit lower corrosion rates 
than the AD sample due to their more uniform grain size. This was not the case, with AD 
displaying slightly lower corrosion rates than the HT samples. Again, this may be a result of 
texture change due to processing.  
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The compressive stresses or changes in texture induced in cold drawing may have been a 
factor in increasing the corrosion resistance of the AD samples. Regardless, all three sample 
conditions exhibited low corrosion rates compared to many alternative Mg alloys [14], 
suggesting that XHP-ZX00 is a possible candidate for bio-corrosion application. This good 
corrosion resistance is attributed to the small grain size [61], and low impurities levels [35, 
38]. The low corrosion rates also suggest that the amount of iron particles introduced into the 
surface of the sample during wire drawing was minimal.  
One of the key aims of this work was to determine which surface treatment would decrease 
the corrosion rate of the XHP-ZX00 wire samples. The data in Figure 4 indicates that both 
the chemical surface treatments (CP and AA) increased the corrosion rates of the wire 
samples. Despite showing evidence of removing the iron impurities from the surface of the 
samples, the uneven surface condition produced with the chemical treatments appears to have 
caused the samples to corrode faster than the untreated samples. The pitting around the 
second phase caused by the CP treatment is also suspected to have caused the severe sample 
fragmentation in these samples. The mechanically cleaned samples had the lowest corrosion 
rate of all the samples tested.  
Despite being shown to not remove all of the iron impurity particles from the surface of the 
sample, the MC samples had corrosion rates lower than even the AE samples. This indicates 
that there were in fact few iron impurity particles introduced through cold drawing. The low 
corrosion rates, and even corrosion morphology, indicates that MC is the best surface 
condition of XHP ZX00 alloy wires, compared to the other conditions: AD, HT, CP or AA.  
Adjustments to chemical concentrations or immersion times may prove to increase the 
viability of the chemical cleaning methods for high surface area samples such as wire. 
However, if there is still concern relating to the iron impurities in the surface of the wire 
samples, it is recommended that a ceramic or polymer wire drawing apparatus be employed 
as an alternative to the ferrous equipment used in this study.  
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5. Conclusions 
1. XHP-ZX00 extruded and wire samples had low corrosion rates in CO2-bicarbonate 
buffered Hanks’ solution at the physiological temperature of 37 °C and pH of 7.4.    
2. Annealing the wire samples produced a uniform, fine grain structure. However, it was 
also associated with a slight increase in corrosion rate. The as extruded samples had a 
lower corrosion rate than either as drawn or heat-treated wire samples.   
3. Chemically cleaning the surface with either a phosphate based chemical polish or 
acetic acid had the potential to remove iron impurity particles (but not stainless steel) 
from the surface of the samples. However, the chemical polish induced micro-
galvanic corrosion on the surface of the sample and the acetic acid cleaning produced 
a rough surface finish. Both of these techniques were associated with an increase in 
corrosion rate.  
4. Mechanically cleaning produced the best surface condition for XHP-ZX00 wire 
samples. Despite being found to not fully remove all iron impurity particles from the 
wire surface, the resulting smooth surface produced an even corrosion morphology. 
The mechanically cleaned samples also exhibited the lowest corrosion rates of all the 
surface conditions present in this study. This suggests that the level of iron impurity 
particles introduced during cold drawing was low.   
5. There was good agreement between the corrosion rates evaluated from mass loss and 
radius reduction. This indicates that for samples with simple geometries, low 
corrosion rates, high aspect ratios, and which do not experience significant length 
change during testing, radius reduction is an appropriate method of corrosion 
evaluation.  
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Appendix A 
Derivation of the corrosion rate Pr for small wire samples.  
The uniform corrosion for a sample of simple geometry is defined as: 
𝑃 =
Δ𝑚
𝜌𝐴𝑡
 (A.1) 
where P is the corrosion rate, Δ𝑚 is the change in mass of the sample at time t, 𝜌 is the 
density of the material, A is the exposed surface area of the sample. Δ𝑚 ÷  𝜌 can be 
simplified to Δ𝑉, the change in volume. 
The samples used in this study were wires than can be assumed to be long, thin cylinders 
(length to radius ratio: ~35 for extruded samples, ~65 for wire samples). As such, the ends of 
the cylinder provide minimal addition to the surface area when compared to the shaft. 
Therefore, the surface area of the samples can be simplified to 2𝜋𝑟𝑙, where r and l are the 
radius and length of the cylinder respectively. Assuming that there is also minimal change to 
the length of the cylinder, as the bulk of the corrosion also occurs along the shaft of the 
sample, Eq. (A.1) can be simplified as follows: 
𝑃 =
Δ𝑉
𝐴𝑡
=
𝑙ΔA
2𝜋𝑟𝑙𝑡 
=  
ΔA
2𝜋𝑟𝑡 
=  
𝜋(𝑟௢ଶ − 𝑟௙ଶ)
2𝜋𝑟𝑡 
 
(A.2) 
 
where ro and rf are the initial and final radius of the sample respectively.  
This derivation is consistent with that of Bowen et al. [18]. However, the denominator 
assumes that the radius of the sample is constant. This is clearly not accurate. The simplest 
method to circumvent this issue is to assume that the radius changes linearly with time as is 
to be expected for uniform corrosion, and to take an average value of ro and rf. This may seem 
to be an overly simplistic model, however absent a better and more consistent model for r(t), 
a linear relationship is the most sensible approximation. Factoring this into Eq. (A.2), the 
following relationship is established: 
𝑃 =
𝜋(𝑟௢ଶ − 𝑟௙ଶ)
2𝜋𝑟𝑡 
=  
𝜋(𝑟௢ଶ − 𝑟௙ଶ)
2𝜋 ൬
𝑟௢ + 𝑟௙
2  ൰ 𝑡 
=
(𝑟௢ଶ − 𝑟௙ଶ)
൫𝑟௢ + 𝑟௙  ൯𝑡 
=  
(𝑟௢ + 𝑟௙)(𝑟௢ − 𝑟௙)
൫𝑟௢ + 𝑟௙ ൯𝑡 
=
𝑟௢ − 𝑟௙
𝑡
 
(A.3) 
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Limitations of the radius reduction model 
This model requires there to be no significant corrosion along the length of the sample. 
Should the sample experience significant change in length during the test, this would suggest 
that corrosion has occurred along the length of the sample and would void the model at 
simplification displayed in (A2). The assumption that the radius changes linearly with time is 
equivalent to assuming that the corrosion rate is constant. Even if the corrosion rate is not 
constant, it is expected that the assumption that the radius changes linearly with time is 
expected to be valid for small amounts of corrosion. 
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Chapter 6: Prototype Mg Surgical Tack 
 
This chapter builds on the consideration of Mg alloy wire provided in Chapter 5 by 
considering this wire in a previously unreported application.  
A prototype Mg surgical tack is produced and compared against commercially available 
titanium and PLGA tacks. The fixation strengths of the tacks are compared in an in situ lap 
shear pull-out tests using porcine abdominal muscle tissue.  
This work utilises the Mg alloy wire previously developed and studied (Chapter 5), and 
provides evidence of the applications that Mg alloys can find as temporary medical devices.  
The authors listed contributed to this chapter as follows:  
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Abstract  
A prototype magnesium (Mg) surgical tack is tested comparatively against commercially 
available tacks made of titanium (ProTacktm, Medtronic) and PLGA (AbsorbaTacktm, 
Medtronic). The pull-out force is measured in situ in a lap-shear pull-out test, using porcine 
abdominal muscle tissue as a model. The Mg tack had a pull-out force comparable to those of 
the commercially available tacks. The majority of the Mg tacks also had a more ductile 
failure mode (i.e. the tacks deformed prior to failure), compared to the commercial tacks 
which pulled directly from the tissue with no deformation. The Mg tacks deformed as they 
were removed from the tissue, causing less damage to the tissue in the process. This is the 
first reported use of a Mg alloy in this application, and the proof of concept indicates that this 
is an area that deserves further interest and study.  
Keywords: Magnesium, Surgical Tack, Laparoscopic, Hernia   
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1. Introduction 
Hernias occur when an organ forces through the tissue or muscle holding it in place.Hernia 
repair is thought to be one of the most common causes for general surgery [1].An estimated 
20 million inguinal hernia repairs were performed globally each year [2-5], and this number 
is only expected to have increased, especially as this style of surgery becomes more 
accessible to patients in developing countries [6]. As well as naturally occurring, hernias can 
also be a complication caused by surgery. Incisional hernias occur in between 2-20% of 
abdominal surgeries [7-11]; approximately 360,000 incisional hernia repairs are performed 
annually in the USA [12]. The current treatment for a symptomatic hernia is surgical repair 
[1], and mesh repair has emerged as the superior method of hernia repair, as compared to 
more traditional repairs that involved directly suturing the wound [13-17]. 
Mesh repair can be performed laparoscopically or via open repair. A number of studies [18-
24] and meta-studies [25-27] have compared the two techniques, and have found that 
laparoscopic repair is associated with a lower rate of recurrence, a reduction in chronic pain, 
and a shorter recovery interval allowing patients to return to normal activity sooner.  
The fixation method or device used to secure the mesh during laparoscopic mesh repair is a 
frequently researched topic, and as yet there is no “gold standard” approach. Sutures are the 
strongest fixation method [28-31]. However surgical tacks are considered a viable alternative 
as they provide adequate fixation strength [28-31] while being far easier and quicker to apply 
than sutures [32, 33]. Tacks have also been found to have a lower rate of infection [28] and 
adhesion formation [33] compared to sutures. Adhesives have been suggested as a non-
invasive fixation method. However, adhesives have been associated with significantly lower 
fixation strengths [34] and more intense inflammatory reactions [35] when compared to 
tacks.    
Commercial surgical tacks come in a range of geometries and materials [34]. Examples are 
presented in Figure 1 and compared with a magnesium (Mg) prototype developed for this 
study. Broadly speaking, the tacks can currently be separated in two categories: (i) permanent 
metallic tacks, such as the Protacktm in Figure 1a, and (ii) absorbable polymer tracks, such as 
the Absorbatacktm in Figure 1b. The mechanical and degradation properties of common 
medical implant materials used in surgical tacks, as well as many other devices, are presented 
in Table 1 for reference.  
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Figure 1: Surgical tacks used in laparoscopic hernia repair. (a) ProTacktm a Titanium tack produced by 
Medtronic, (b) AbsorbaTacktm a polymer (PGLA) tack also produced by Medtronic, (c) a prototype Mg Tack 
produced for this study.  
Table 1: Comparison of mechanical and degradation properties of common medical implant materials. ZX00 is a Mg alloy 
containing small amounts of Zn and Ca [36]. 
Material Ultimate Tensile 
Strength (MPa) 
Elastic 
Modulus 
(GPa) 
Elongation 
at break 
(%) 
Bio-absorbable Loss of 
Strength* 
(weeks) 
Loss of 
mass** 
(Months) 
Magnesium alloys 185-280[37, 38] 41-45[38, 39] 1.7-25[38, 40] Yes 12-24[41] >6[41] 
ZX00 (extruded) 257.6 41-45# 18.4 Yes 12-24# >6# 
Titanium alloys 550-985[42] 100-105[42] 10-15[40] No - - 
Stainless steels 480-834[42] 193[42] 30-40[40] No - - 
Nitinol 310-590[43] 29.7-48.3[43] 14-16[44] No - - 
L-PLA 28-50[45] 1.2-3[45] 6[46] Uncertain [47] >50 [48] 18-60[46] 
D,L-PLA 29-35[45] 1.9-2.4[45] 6[46] Yes 5-8[48] 12-16[47] 
PGA 70[46] 6.9[46] < 3[46] Yes 5-8[48] 6-12[47] 
*Loss of strength is defined as a 50% reduction from the initial tensile strength.  
**Loss of mass is taken as complete, or near to complete (>90%), loss of mass (i.e. sample disintegration).  
#Taken to be similar to other Mg alloys. Rationale provided in Appendix A.  
Titanium (Ti) spiral tacks, presented in Figure 1a, are the most traditional tack fixation 
method [29] and are often used as a standard of comparison [31, 49]. Titanium is 
biocompatible but not absorbable, and as such, the tacks are permanent and remain in the 
body after their fixation function has been fulfilled. Permanent tacks have been linked to 
increased morbidity and adhesion formation (presented in 2) in a number of studies [29, 50-
52]. A proposed alternative to the spiral titanium tack are absorbable polymer tacks, such as 
those presented in 1b. Absorbable polymers tacks are designed to be degraded and be 
absorbed by the body in 6-12 months after implantation [34, 47] to avoid the morbidity 
associated with permanent tacks. These tacks are often made from PGLA, a polymer 
combination of PLA and PGA which has properties between PLA and PGA determined by 
the ratio of the mix. While significantly stronger than PLA, PGA has been found to degrade 
more quickly, and produce acidic, inflammatory products when it is the sole polymer in the 
implant [47]. It has been stated that “most tissue complications with bioabsorbable implants 
are caused by PGA polymers” ([47] p.158-159).  
(a) (b) (c) 
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For these reasons, PGLA copolymers are common in medical devices, as they avoid the 
degradation and inflammatory issues associated with pure PGA, while still retaining some of 
the desirable strength and stiffness of the pure polymer [47].  
 
Figure 2: Adhesion formation between a ProTacktm and the liver of a Sprague–Dawley rat [30]. 
Melman et al. [34] conducted a comparison of fixation strengths provided by (i) 
polypropylene sutures, (ii) three permanent metallic tacks, (iii) four absorbable polymer 
tacks, and (iv) two fibrin sealant adhesives. They reported “No significant differences were 
seen between the various absorbable constructs… or between the various metallic constructs” 
[34]. This suggests that the effect tack geometry has on fixation strength is secondary 
compared to material properties within the materials tested. It was also found that the metallic 
tacks provided on average more than twice the fixation strength compared to the absorbable 
tacks [34]. This result has been supported by a number of studies which have found that Ti 
spiral tacks have fixation strength higher than absorbable tacks [29, 30, 34, 49, 53]. It has 
even been shown that an incorrectly placed titanium spiral tack has comparable fixation 
strength to a correctly placed absorbable screw tack [53]. These results clarify why many 
clinicians have shown a preference for metallic tacks. The high fixation strength they provide 
gives confidence in their ability to fulfil the primary function, outweighing the potential 
increased chance of implant related complications [29, 50-52].  
However, the market for an absorbable surgical tack is apparent from the variety of 
commercially available polymer tacks [34]. There are a range of potential issues or 
complications associated with hernia repair that are well documented [54-56], and some are 
directly related to the permanent nature of current metallic tacks. It has been noted that 
“symptoms [have been] relieved as long as 6 months after the initial repair after removal of a 
tack or irritating mesh” [54]. An absorbable tack would have been almost completely 
absorbed 6 months following surgery, and likely negating the need for removal (and the 
associated second surgery).  
ProTacktm Adhesion 
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An absorbable, metallic tack has the potential to combine the best aspects of both Titanium 
and PLGA tacks, suggesting biodegradable metals in this application are worthy of 
consideration. Alloys of magnesium (Mg), Iron (Fe), and Zinc (Zn) are being considered for a 
range of temporary medical applications and devices [57-59]. With the ability to safely 
degrade once implanted, these materials combine the mechanical properties of traditional 
metallic biomaterials (chiefly strength and toughness), with absorbability, previously 
associated primarily with polymers. The recent clinical success of Mg alloys in orthopaedic 
[60, 61] and cardiovascular [62, 63] surgical applications suggest Mg and its alloys are an 
excellent candidate material for an absorbable, metallic tack. The absorption profile of Mg 
alloys is expected to be compare to that of absorbable tacks, as presented in Appendix A.  
As such, this study examines the use of Mg wire in a previously unreported application: as a 
surgical tack. Mg alloy wire was used to produce a prototype Mg tack, which was compared 
against the commercially available tacks presented in Figure 1. The fixation strength of each 
tack was assessed via an in situ lap-shear test to provide a proof of concept for this material in 
this novel application.   
2. Methodology & Materials  
2.1. Material & Tack Production  
The Mg alloy wire used to form the prototype tacks in this study has been described 
previously [36]. The alloy was produced from ultra-high-pure (XHP) Mg alloy produced via 
distillation [64]. XHP-Mg was alloyed with 0.45% calcium and 0.45% zinc to improve the 
mechanical properties to produce XHP-ZX00. The alloy is similar to the XHP-ZX10 
described previously [65], with some minor parameter changes. The extrusion temperature 
and speed were 345 ◦C and 0.2 mm/s respectively. The extrusion diameter was 3 mm, which 
resulted in an extrusion ratio of ≈70:1. 
The extruded XHP-ZX00 rod was manually cold drawn through a series of wire drawing dies 
into wire with a diameter of ∼0.77 mm using beeswax as the lubricant during cold drawing. 
Mg alloys have a limited tolerance for cold work. To compensate, the samples were 
periodically (every 2nd or 3rd dimeter reduction) annealed by heating to 340 ◦C for 5 min, and 
quenching in cool running water, before being dried with ethanol. This annealing relaxed the 
sample and allowed it to be drawn to a small diameter without fracturing. The samples used 
in this study were mechanically cleaned with SiC grinding paper, as this was determined to 
be the optimum surface condition for this wire [36].  
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The Mg prototype tacks were based on the Protacktm, as is evident by comparing the 
ProTacktm in Figure 1a to the Mg prototype tack in Figure 1c. The Mg wire was wound 
around a rod with the same diameter as the inner diameter of the ProTacktm Coil. The Mg 
wire coil was then cut to the correct number of spirals. One end was coiled inward slightly to 
help lock the tack into the mesh. The other end was cut at ∼45◦ with wire cutters to produce a 
point to allow easy entrance into the porcine abdominal tissue. Both the Mg tack and the 
ProTacktm had a wire length of ∼3 cm when uncoiled and a diameter of ∼0.75-0.80 mm. 
When coiled their diameter was ∼5 mm and height of ∼4 mm. The AbsorbaTacktm had a 
length of ∼4 mm and a screw head size of ∼5 mm. 
2.2. Porcine Samples 
Porcine tissue was selected as it is a good approximation for human tissue [66]. Samples of 
porcine abdominal tissue were collected from adult “large white” (Sus scrofa domestica) 
breeding sows. Sows were sourced from the UQ Gatton Piggery and were sacrificed 
following a caesarean delivery of preterm piglets (for an unrelated project).  Abdominal 
muscle tissue was collected under ethics approval number ANRFA/MME/170/17 from the 
sow post mortem following euthanasia with an intravenous dose of sodium 
pentobarbital. All procedures were approved by the UQ animal ethics committee (approval 
number ANRFA/MME/170/17), and in accordance with the Animal Care and Protection Act 
Qld (2002), and the Australian Code for the Care and Use of Animals for Scientific 
Purposes (8th Edition 2013), published by the Australian National Health and Medical 
Research Council. Tissue samples were sectioned into work pieces ~3 cm thick, ~5 cm wide, 
and ~15 cm long.  As muscle tissue has anisotropic mechanical properties care was taken to 
ensure tissue samples were sectioned and tested consistently with regard to the orientation of 
the muscle fibres.   
2.3. Lap-Shear Pull-out Tests  
A common method of testing the effectiveness of a fixation method and device for mesh 
repair is an in situ lap-shear test [34, 53, 67]. The fixation method or device (in this case a 
surgical tack) is used to secure strips of mesh to a piece of abdominal tissue, as presented in 
Figure 3. This assembly is loaded into a tensile testing apparatus, with the flesh and the mesh 
gripped by opposing clamps. The mesh is then withdrawn at a constant rate.  
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The test is considered to end when either (i) the tack is removed from the tissue, (ii) the tack 
and a portion of the tissue is removed from the remaining tissue clamped at the base, or (iii) 
the mesh breaks. This method was base on, and is consistent with, similar standard lap-shear 
testing of adhesives [68].  
  
Figure 3: Photograph of the in situ lap-shear pull-out test.   
The testing was conducted on an Instron 5584 universal testing machine, equipped with 
pneumatic grips and a 100 N load cell. Strips of Symbotex composite mesh (Medtronic) 1 cm 
wide and ∼5 cm long were cut and attached to pieces of porcine abdominal tissue with either 
a prototype Mg tack, a Titanium (Ti) ProTackTm, or a polymer (PLGA) AbsorbaTacktm. The 
base of the tissue was secured in the lower grip, and the free end of the mesh was secured in 
the upper grip. The reference point of the test was set such that the sample was held upright 
but only under a minimal amount of force. The upper grip(mesh) was moved at a constant 
speed (2 mm/min) away from the lower grip (tissue) until the tack failed. The force and 
extension were measured. Each tack was tested in quadruplicate (n = 4).  The reported 
variables were the maximum force, the maximum extension, and the extension at the 
maximum force.  
Tack 
Tissue 
Mesh
Clamps 
Clamps 
Test 
Direction
 
 Tack 
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2.4. Statistical Analysis  
A series of one-way analysis of variance (ANOVA) was conducted on each of the variables: 
(i) maximum force, (ii) maximum extension, and (iii) extension at the maximum force. These 
ANOVAs considered how the Mg tack performed against each of the commercially available 
tacks, as well as how the commercial tacks performed against each other. Statistical 
significance was defined as a probability of p ≤ 0.05. A probability between 5% and 10% 
(0.05≤ p ≤ 0.10) was deemed to be potentially significant. No direct conclusions should be 
directly inferred from a potentially significant comparison; however, such a result may 
suggest an area warranting further examination.   
 
A one-way ANOVA was also conducted within the extension data for each tack to determine 
if the maximum extension, and extension at maximum force were significantly different. This 
was to better understand the nature of the failure (i.e. did the tack reach a maximum force and 
immediately pull out, or did the displacement reach a maximum force and continue to extend 
at it deformed and extended further?).  
3. Results 
3.1. Failure Modes 
As previously stated, the in situ lap-shear pull-out tests were considered to end when either (i) 
the tack detached from the tissue, (ii) the tissue attached to the tack was removed from the 
remaining tissue, or (iii) the mesh ruptured. Two distinct failure modes were presented during 
testing, which were termed “brittle” and “ductile”. Brittle failure was defined as a test which 
ended with the minimal deformation of the tack, whereas ductile failure was defined as a test 
where the tack deformed prior to the end of the test.   
The Ti and PLGA tacks were found to have consistently experience brittle failure, as 
presented in Figure 4 & Figure 5. These tacks pulled free from the attacked tissue, or in some 
instances pulled some tissue free from the majority, without significant deformation or 
change in shape. The failure modes for the prototype Mg tack are presented in Figure 6. 
Unlike the commercial tacks, the Mg tacks exhibited both distinct failure modes. The 
majority of the tacks failure in a ductile manner, reaching a maximum force, and then 
deforming slightly as they were pulled from the tissue (Figure 6a). However, some tacks 
failure brittlely, pulling free with minimal deformation (Figure 6b), similar to the Ti tacks in 
Figure 4. 
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Figure 4: Failure mode of Ti (ProTacktm). The tacks pulled free from attached porcine tissue without deforming.  
 
Figure 5: Failure mode of PLGA (AbsorbaTacktm). The tacks pulled free from attached porcine tissue without 
deforming 
.    
Figure 6: Failure modes of Mg prototype tack. (a) The majority of the Mg tacks deformed once the maximum 
force was reached, however some (b) pulled free from the tissue with minimal deformation.     
 
(b) (a) 
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3.2. Force & Extension  
To visualise the failure modes presented in Section 3.1, typical force-extension graphs for 
each mode and material are presented in Figure 7. The failure modes which involved limited 
deformation (Mg failure mode 2, Ti, and PLGA) all reached a maximum force, and then the 
force rapidly decreased as the sample was removed from the tissue. This can be thought of as 
analogous to brittle fracture in tradition tensile testing. Mg failure mode 1, which involved 
some deformation, reached a maximum force and then continued to extend at a decreasing 
force level until it ultimately failed. This can be considered analogous to ductile failure in 
traditional tensile testing.   
 
Figure 7: Typical Force-Extension curves of the Mg, Ti, and PLGA surgical tacks 
tested in situ in a porcine model. The Mg samples were found to have two modes of failure, 
and examples of each are presented.  
Please note that the maximum extension of the Ti and Mg samples had some variability, 
however the shape of the curves can be considered representative. To give a more complete 
picture, the average force and extension results for lap-shear pull-out tests are presented in 
Table 2 and Figure 8. The maximum extension, extension at maximum force, and maximum 
pull-out force of the prototype Mg surgical tack are compared to commercially available Ti 
(ProTacktm) and PLGA (AbsorbaTacktm) tacks. A series of one-way ANOVAs were run on 
this data and the p values from this analysis presented alongside the data in Table 2.  
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Table 2: The average results from the in situ pull-out tests are presented for Magnesium (Mg), Titanium (Ti) 
and PLGA (Polymer) tacks. Standard error was calculated for each value. A series of one-way ANOVAs were 
run on the data and the associated p values between the various tacks are presented. Statistical significance was 
defined as a probability of p ≤ 0.05(*). A probability between 5% and 10% (0.05≤ p ≤ 0.10) was deemed to be 
potentially significant (#). 
Test Variable Mg Ti Polymer p values (ANOVA) 
Max Force (N) 4.6 ± 0.6 5.9 ± 0.6 3.2 ± 0.2 
p (Mg vs Ti) = 0.17 
p (Mg vs Polymer) = 0.06# 
p (Ti vs PLGA) = 0.01* 
Max Extension 
(mm) 19.5 ± 2.2 18.5 ± 1.9 10.0 ± 0.7 
p (Mg vs Ti) = 0.51 
p (Mg vs Polymer) = 0.01* 
p (Ti vs PLGA) = 0.01* 
Extension at Max 
Force (mm) 13.5 ± 1.0 15.4 ± 1.7 9.5 ± 0.8 
p (Mg vs Ti) = 0.39 
p (Mg vs Polymer) = 0.02* 
p (Ti vs PLGA) = 0.02* 
 
 
Figure 8: Maximum pull-out force, extension at maximum force, and maximum extension of  
Mg, Ti, and PLGA surgical tacks tested in a porcine model. Standard error bars 
were calculated for each parameter.  
The difference between the extension at maximum force and the maximum extension within 
each material was also considered. The results can be summarised as follows: 
 Extension at Maximum Force vs Maximum Extension: There was no significant 
difference between the extension at maximum force and the maximum extension for 
the Ti (p = 0.44) or PLGA tack (p = 0.65). However, the maximum extension was 
significant longer in for the Mg tacks (p = 0.047).  
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4. Discussion 
As tacks are often placed in a more complex arrangement in clinical use, and the biological 
environment has a number of complex factors, it is difficult to settle on an exact value above 
which the tacks can be considered successful in a lap-shear tests. For a 1 cm strip of mesh, a 
2N load has been suggested [69]. Based on this figure, all of the tacks in this study provide 
sufficient fixation strength.  
The average maximum pull-out force of the tacks can be summarised as follows: 
Ti > Mg > PLGA 
The ANOVA analysis showed that the Ti tack had significantly higher pull-out force than the 
PLGA. This is in keeping with previous results comparing permanent metallic and absorbable 
polymer tacks in similar tests [29, 30, 34, 49, 53]. The Mg tack also provided a higher 
average maximum fixation force compared to the absorbable PLGA tack. However, this 
result only found to be potentially significant (p = 0.06). There was some variability with the 
Mg fixation strength, with most samples providing similar to the Ti tacks, while some few 
were lower and more comparable to the PLGA tacks. These few data points closer in range to 
the PLGA fixation strength likely made distinguishing the two data sets more difficult 
statistically. As these Mg tacks are prototypes, some degree of variability was unavoidable. 
As the process becomes more refined, it is expected that this variability will become less 
pronounced. Regardless, the Mg tack provided a comparable fixation strength to both the Ti 
and PLGA tacks, and the absorption profile is expected to be comparable to the PLGA tacks, 
as presented in Appendix A and Table 1. As such, these results strongly suggest that an 
absorbable metal such as Mg is suitable for this application. 
Both metallic tacks had significantly larger maximum extension compared to the polymer 
tack. This can be considered an advantage for the metallic tacks as, combined with the 
average fixation strengths, this suggest the tacks will be harder to dislodge in service. The 
“brittle” failure mode of the commercial tacks was that the tacks pulled free of the tissue once 
maximum load was reached, and was also more damaging to the tissue. This was particularly 
true for the Ti tacks, as shown in Figure 4 where a substantial piece of tissue is removed with 
the tack. The “ductile” failure mode of the Mg tacks (Failure mode 1) was far more forgiving 
to the affected tissue.  
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The slight deformation of the Mg tacks as they are removed from the tissue reduces the 
damage to the tissue, as the tacks tended to slide out gradually, as opposed to being torn free. 
It is expected that if a tack were to fail during clinical use, it would be advantageous to 
minimise the damage to the adjacent tissue.  This difference in the failure modes is 
highlighted by the difference between the maximum extension, and the extension at 
maximum load for each tack. The commercial tacks had no significant difference between the 
two values, showing they failed quickly once reaching maximum loading. The Mg tack, 
continued to extend significantly after it was loaded fully, in the majority of cases. The 
maximum force in all of these samples was above the 2N limit for a mesh strip this size, 
meaning the Mg tacks do not fail early. This ductile failure simply serves as an additional 
protection to the body tissue if an excessive force is applied to the mesh area.  
These results suggest that a Mg tack can fulfil a desirable middle ground between the 
permanent metallic tacks (Ti) and absorbable polymer tacks (PLGA), as an absorbable 
metallic tack. Further study is recommended for Mg wire in applications such as this, which 
can be expanded in further study to include other surgical tacks such as those used in 
shoulder surgery [70-72].  
4.1. Future Work  
The success of the Mg prototype tacks presented in this study show that there is good 
potential for absorbable metals in this application. However, as this is a preliminary study 
there are a number of avenues were future work. As this work was a proof of concept, the 
mechanical testing was developed to be a simple representative of clinical use. As previously 
mentioned, when used clinically tacks are inserted in groups, often with complex patterns. 
Expanding the mechanical testing to include these groups of tacks would provide greater 
insight into in service performance. Additionally, a range of mesh materials are available for 
mesh repair [73]. The testing in this study was kept to one mesh to reduce the number of 
variables. However, different meshes may change the performance of the tacks [49] and as 
such, testing with a variety of mesh is a worthy consideration for future work.  
In addition to further laboratory or bench top testing, in vivo studies would provide valuable 
insight into the biocompatibility of the various tacks, as well as their absorption profiles and 
the effect this has on their mechanical properties and fixation abilities. 
Finally, consideration could be given to other absorbable metals such as Zn or Fe for use in a 
similar application [57, 74, 75].  
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5. Conclusions 
This study is the first reported use of Mg alloys as a surgical tack. Mg alloy wire was formed 
into a prototype and compared to a titanium (Protacktm, Medtronic) and a PLGA tack 
(AbsorbaTacktm, Medtronic). In situ lap-shear pull-out tests were conducted in a porcine 
model.  
1. The average maximum pull-out of the tacks can be summarised as follows: 
Titanium > Magnesium > PLGA 
The Ti tacks had a significantly higher pull-out force than the PLGA tacks (ANOVA). 
There was no significant difference between the pull-out force of the Mg tack and 
either of the commercial tacks (ANOVA).  All tacks were above the defined success 
limit of 2N, based on the 1 cm strips of mesh used.  
2. Both commercial tacks had similar failure modes, where the sample pulled from the 
flesh quickly after reaching maximum force. We identified this as a pseudo “brittle” 
failure, and it was identified by comparing the maximum extension to the extension at 
maximum force, which were similar for the Ti and PLGA tacks. This failure mode 
was often associated with damage to the attached tissue. Some of the Mg tacks also 
failed in this way, however the majority reached a maximum force and then deformed 
slightly before pulling out. This was identified as a pseudo “ductile” failure, by a 
significant difference between the maximum extension and the extension at maximum 
load. This failure mode was associated with less damage to the attached tissue, as the 
Mg tack deforming slightly allowed it to pull out more easily.  
 
3. These results suggest that Mg alloy wire is a good candidate for use in surgical tacks, 
and provide a good alternative to current materials, as an absorbable metallic tack. 
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Appendix A: Absorption profile and mechanical properties of  
XHP-ZX00 wire  
Magnesium alloys have consistent Young’s moduli [38], and as such we don’t expect this 
alloy to be significantly outside the given range.  
To determine the time taken for strength and mass loss, we take the corrosion rate (Pm) to be 
0.39 mm/y as per our previous study [36].  
The ultimate tensile strength (𝜎௎்ௌ) is given by force (F) divided by area (A), which for a 
wire is calculated from the radius (r): 
𝜎௎்ௌ =
𝐹
𝐴
=
𝐹
𝜋𝑟ଶ
 
∴  𝜎௎்ௌ  ∝  
1
𝑟ଶ
 
Therefore a 50% reduction in ultimate tensile strength only requires a √2 reduction in radius. 
The initial radius is taken as 0.385 mm (dimeter of 0.77 mm ÷ 2).  
To determine the time taken to lose strength (50% UTS), we need to first determine the radius 
at 50% UTS (𝑟ହ଴%). Assuming ideal mechanical behaviour:  
𝑟ହ଴% =
𝑟௢
√2
=
0.385 𝑚𝑚
√2
= 0.272 𝑚𝑚 
The time to reach this radius, assuming ideal corrosion behaviour:  
𝑇𝑖𝑚𝑒 =
𝑟௢ − 𝑟ହ଴% 
𝑃௠
=
0.385𝑚𝑚 − 0.272𝑚𝑚
0.39𝑚𝑚 𝑦ିଵ 
= 0.29 𝑦𝑒𝑎𝑟𝑠 = 15 𝑤𝑒𝑒𝑘𝑠 
This is within the time frame given for the other Mg alloys (12-24 weeks), and comparable to 
PLGA surgical tacks which see a significant absorption period between 3-5 months [76].    
  
This calculation also assumes that (i) the sample corrodes uniformly, with no defects or stress 
concentrators and that (ii) the corrosion rate remains at 0.39mm/y for the full 15 weeks. Both 
of these assumptions are not expected to be true. However, they will also likely have the 
opposite effect. The stress concentrators will obviously decrease the UTS faster. However, 
the corrosion rate is expected to decrease significantly at longer implantation times, as shown 
in Chapter 5. As such, we feel this approximation stands.  
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The intent is simply to show the XHP-ZX00 wire will perform similarly to other Mg alloys in 
vivo, and this calculation suggests that is likely to be true.  
The time taken for the sample to completely degrade:  
𝑇𝑖𝑚𝑒 =
𝑟௢
𝑃௠
=
0.385 𝑚𝑚
0.39 𝑚𝑚 𝑦ିଵ 
= 0.98 𝑦𝑒𝑎𝑟𝑠 > 0.5 𝑦𝑒𝑎𝑟𝑠 
Again, this assumes steady state corrosion but shows this alloy should perform similarly as 
those presented in Table 1.  
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Chapter 7: Practical Considerations for In Vitro 
Biocorrosion Immersion Testing 
This chapter builds on our understanding of the literature (Chapter 2) and combines this 
understanding with the practical lessons and experiences gathered studying the corrosion of 
Mg alloys in vitro (Chapters 3-5). This chapter is intended to bring together the more 
practical or applied lessons learnt through the previous in vitro investigations, and to provide 
context and guidance to future in vitro biocorrosion studies of Mg alloys. It presents the 
lessons learnt, and associated recommendations, for the in vitro biocorrosion study of Mg 
alloys.  
The authors listed contributed to this chapter as follows:  
Contributor Article 
Concept  
Reviewed 
Material  
Analysed 
data 
Wrote 
Paper 
Edited 
Paper 
Sean Johnston 70% 60% 70% 100% 40% 
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Jeffrey Vennezula - 10% 10% - 10% 
Cuie Wen  - 15% - - 10% 
Matthew Dargusch 10% 5% 5% - 10% 
Andrej Atrens 10% 5% 5% - 20% 
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Abstract  
Magnesium (Mg) alloys are achieving good clinical success in applications as temporary 
biodegradable medical implants. However, the study of the corrosion in medical 
environments (biocorrosion) is still ongoing. Much of this study is conducted via laboratory 
(i.e. in vitro) immersion tests, which can be challenging. We have outlined and updated a 
range of recommendations on the in vitro biocorrosion assessment of Mg alloys, based on our 
experience in the field and the lessons learnt through years of experiments. We hope these 
recommendations will help to improve future biocorrosion testing and provide insight both 
for researchers with experience in this field and those seeking to enter it.   
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1. Introduction 
Biodegradable metals are an emerging discipline in biomaterials which have received 
significant attention since the turn of the century [1-7]. With the ability to safely corrode in 
the body once implanted (i.e. biocorrosion), alloys of magnesium (Mg), zinc (Zn), and iron 
(Fe) have clear applications in temporary medical implants and devices [1, 8]. Mg alloys, in 
particular, have enjoyed good clinical success in recent years [9-12], showing that these novel 
materials have progressed from a research consideration into a viable class of medical 
materials.  
A key consideration for biodegradable metals is the study of biocorrosion. The ability to 
safely corrode in the body is what sets biodegradable metals apart from traditional metallic 
biomaterials such as Co-Cr alloys, stainless steels and titanium (Ti) alloys [3]. However, the 
biocorrosion must be sufficiently slow, controlled, and predictable, otherwise the implants 
may fail before the tissue has fully healed. For Mg alloys, this is of particular importance as 
Mg alloys are reactive with a tendency to corrode rapidly in aqueous environments [2, 13]. 
Additionally, Mg alloys with high corrosion rates have shown issues with excessive hydrogen 
gas (H2) evolution, which can cause issues for the surrounding tissue [14]. As such, 
characterising Mg biocorrosion has received a lot of attention [1, 2, 15, 16].  
Much of the work on biocorrosion is conducted via laboratory immersion tests (i.e. in vitro). 
Early work in the field by Witte et al. [17] showed that traditional immersion tests developed 
for auto corrosion, and which rely on simple NaCl solutions, were inadequate for predicting 
or characterising Mg biocorrosion. This required a necessary deviation from standard 
corrosion assessment solutions, such as those outlined in the ASTM [18]. As such, an 
understanding of the corrosion mechanisms for Mg alloys in vitro biocorrosion becomes 
vital.  
This review seeks to briefly outline the key factors pertinent to in vitro evaluation of Mg 
biocorrosion. This involves an overview of the key areas of literature, as well as a summary 
of the lessons learnt during our own research.  
Initially, we provide some context for Mg corrosion. Then we discuss in vitro testing and the 
biocorrosion environment. We also summarise our experience and provide recommendations 
for future work in this field. It is our hope that new and experienced researchers alike can find 
useful information when planning future in vitro biocorrosion investigations of Mg alloys.  
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2. Fundamentals of Mg Corrosion  
With a density of ~1.74 g/cm3, Mg alloys are lightweight metals. They exhibit high specific 
strength and stiffness, which has obvious weight saving capabilities in automotive and 
aerospace applications [19]. However, their widespread industrial application is limited by 
their low corrosion resistance [2, 19]. Mg is the most reactive of the engineering materials 
and corrodes readily in many environments [20, 21]. In many applications this corrosion is a 
significant disadvantage. However, in medical applications this inherent reactivity allows Mg 
alloys to corrode safely in the body and provides a key property for a temporary implant (or 
component). Nevertheless, understanding and controlling the rate of this corrosion is 
paramount to the success of Mg implants in medicine.  
The corrosion reaction for Mg in aqueous solutions is given by:  
Mg(ୱ)   + 2HଶO(୪) → Mg(OH)ଶ (ୟ୯) + Hଶ (୥)  (1) 
The corrosion products form a partially protective film on the sample surface of a thin layer 
of MgO above which is a thick, porous Mg(OH)2 layer [22].  The corrosion product film 
slows corrosion by reducing mass/charger transfer between the metallic Mg and the aqueous 
environment. However, the corrosion product film provides relatively poor protection to the 
surface of the samples. Additionally, the corrosion product film is broken down easily by Cl- 
ions present in the solution. In more complex solutions, such as the simulated body fluids 
(SBF) discussed in Section 3.1, more complex corrosion products form [23]. These corrosion 
products may be more stable and thereby provide more protection to the underlying metallic 
Mg. This is likely one of the reasons why simple NaCl solutions provide such a poor 
comparison to Mg biocorrosion [17].  
As well as changing the rate of corrosion, different corrosion conditions can also change the 
type of corrosion which occurs. In broad terms, corrosion can be: (i) “general”, where 
corrosion is present predominately evenly across the metal surface, or (ii) “localised”, where 
corrosion is located more commonly in one or more areas compared to the general surface. 
Examples are presented in Figure 1. For Mg alloys, localised corrosion is typically caused by 
the second phase causing corrosion of the Mg-matrix adjacent  to the second phase by a 
micro galvanic effect [2, 24]. Corrosion rates and morphologies can also be influenced by 
metallurgical factors and post-processing, as we have discussed in detail previously [2, 4, 25]. 
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Figure 1: Example of localised and general corrosion from a ZX00 sample immersed in Earle’s Basic Salt 
Solution (EBSS) for 7 days at 37 oC and pH 7.4. 
Effectively mimicking the in vivo corrosion mechanism involves these three components: (i) 
a similar corrosion rate, (ii) similar corrosion products, and (iii) a similar corrosion 
morphology. Only when in vitro results fulfil these three criteria (i.e. a similar corrosion rate, 
products, and morphology to in vivo) is it accurate to say the corrosion mechanism has been 
successfully recreated.  
3. The In Vitro Biocorrosion Environment  
Witte et al. [17] showed that a deviation from a simplified corrosion testing in a concentrated 
chloride solution was required. As such, a range of solutions have been tested and suggested 
in an effort to better mimic the biocorrosion environment within the body (i.e. in vivo). These 
synthetic body fluids (SBFs) are generally based upon cell culture solutions, mainly balanced 
salt solutions such as Hanks’ balanced salt solution (HBSS) or Earle’s (EBSS), or more 
complex solutions such as minimum essential medium (MEM). The high variability between 
corrosion rates measured in these solutions, and the immersion methodologies which have 
utilised them, has led to a general scepticism of in vitro biocorrosion results [15, 26]. In a 
recent review [15], we have summarised the influence on Mg corrosion of (i) the constituent 
elements of the SBFs, and (ii) the various aspects of the immersion methodology.  
In the following sections we summarise these results and recommendations, as well as our 
new findings and practical lessons learnt throughout our investigations.  
Localised  General 
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3.1. Simulated Body Fluids (SBF) 
Table 1 presents the composition of a range of common SBFs compared with the composition 
of blood plasma and of interstitial fluid.  
Table 1:  Comparison of the composition of various SBFs with blood plasma and interstitial fluid. Balanced Salt 
Solutions (e.g. Hanks-HBSS), and more complex cell cultures (e.g. Minimum Essential Medium-MEM) are 
typical SBFs. Simpler solutions such as 3.5% NaCl, or Phosphate Buffered Saline (PBS) should not be 
considered SBFs, as they are not sufficiently comparable to bodily fluids. 
 Component  Blood 
Plasma 
[27, 28] 
Interstitial 
fluid 
[29, 30] 
HBSS  
(H1387) 
HBSS 
(14175) 
EBSS 
(E7510) 
 
MEM 
(M9288) 
MEM 
(M0268) 
Inorganic 
Ions 
(mM) 
Cl- 100-
103 
115 145 143 125 145 125 
HCO3- 22-30 26 4.2 4.2 26 4.2 26 
H2PO4- 0.0-
0.08 
- 0.44 0.44 1.02 0.44 1.02 
HPO4-2 0.0-1.0 0.6-1.7 0.34 0.34 - 0.34 - 
SO42- 0.5 0.7 0.81 - 0.81 0.81 0.81 
Mg2+ 1.0-1.5 0.5-0.7 0.81 - 0.81 0.81 0.81 
Ca2+ 2.5 1.2-1.5 1.26 - 1.80 1.26  1.36 
Na+ 140-
142 
136-146 142 143 144.0 142 143 
K+ 5.0 4.0 5.81 5.81 5.37 5.81 5.37 
Organic 
Components 
(g/L) 
Protein  
(e.g. 
albumin) 
35-80 20 - - - - - 
Amino 
Acids 
0.25-
0.40 
0.25-0.40* - - - 0.87# 0.87 
Vitamins† µg-mg µg-mg* - - - 0.008 0.008 
Glucose 0.9-1.1 1.0 1.0 1.0 1.0 1.0 1.0 
*Assumed to be the same or similar to that of blood plasma. † Range provided. #L-Glutamine (0.292g/L) is added. 
Table 1 indicates that there is some degree of variability between the solutions in terms of 
both inorganic ions and organic elements. These differences change the biocorrosion 
environment, and thus must be taken into consideration. The influence of each element was 
considered in our recent review [15] and is summarised below: 
1. Cl- ions break down the partially protective corrosion product layer and thereby increase 
the corrosion rate and tend to increase the incidence of localised corrosion. 
2. HCO3- ions play an important role in the buffer system most applicable to Mg 
biocorrosion (CO2- HCO3-) and should be included in the solution. However, they do not 
need to be at the same concentration as in vivo.  
3. Phosphates (H2PO4- & HPO4-2) are an important part of the corrosion product layer that 
forms together with Mg2+ and Ca2+. The (Mg,Ca)-P corrosion product layer is more dense 
than the other corrosion products and thus provides more protection against corrosion. 
4. Na+, K+, and SO42- play minor roles in comparison to the other ions. 
5. Amino acids and proteins appear to increase corrosion rate, however there is still work to 
be done on this topic.  
- 191 - 
 
Before we continue we would like to draw the reader’s attention to point #3. At the time of 
writing the 2017 review [15] we considered the influence of both phosphates (H2PO4- & 
HPO4-2) to be comparable. However, we have since amended that point. To form the 
(Mg,Ca)-P corrosion product layer, the divalent Mg2+ and Ca2+ ions must bond with HPO4-2. 
Some of the H2PO4- included in many SBFs, as shown in Table 1, will dissociate to become 
HPO4-2. However this amount is small due to the low value of the equilibrium constant, Ka, of 
H2PO4-.  
We have recently confirmed the importance of HPO4-2 with a direct comparison between 
HBSS (H1387) and EBSS (E7510). Specimens of high purity (HP) Mg were immersed in 
both SBFs for one week, the pH was maintained at ~7.4 by CO2 bubbling and the temperature 
was maintained at ~37 °C via a water bath [24, 31, 32]. The average corrosion rates are 
presented in Figure 2. The specimens immersed in EBSS corroded twice as quickly as the 
samples immersed in HBSS. SEM analysis of the corrosion products on the samples surface 
(Figure 3) indicate that the presence of HPO4-2 in HBSS contributed to a more dominant 
(Mg,Ca)-P corrosion product layer, which significantly slowed the corrosion rate. As bodily 
fluids contain mostly HPO4-2 (Table 1), this constituted our first recommendation.  
Recommendation #1: SBFs should contain HPO4-2, as opposed to only containing H2PO4-. 
Additionally, it should be noted that different styles of the same type of SBF can have 
different chemical compositions. This is indicated in Table 1 by comparing M9288 and 
M0268. This can also be a problem with different types of HBSS [33]. As such, our second 
recommendation is as follows: 
Recommendation #2: Care should be taken when procuring SBFs. Small changes in 
product code (e.g. M9288 vs M0268) can have a substantial difference on the biocorrosion 
environment. H1387 and M9288 are preferred, as they contain HPO42-.  
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Figure 2: Average corrosion rates of HP Mg samples (n=3) immersed in HBSS (H1387) and EBSS (E7510) for 
1 week at ~37 °C and pH ~7.4. Both SBFs were buffered with CO2. 
 
Figure 3: Typical SEM images of HP Mg samples immersed in (a) HBSS and (b) EBSS. The EDX reading on the 
right hand side of each image indciates the presence of phoshphate on the samples surface (red/light grey). 
There is a more dense and widely-spread layer of phosphate containing corrosion products, likely (Mg,Ca)-P, 
on the surface of the HBSS sample. The presence of HPO42- in HBSS (as compared to H2PO4- in EBSS) produces 
a mucher thicker layer of (Mg,Ca)-P which protects the surface of the sample. This layer reduces the corrosion 
rate of the sample, as well as providing a better comparision to in vivo data. 
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We would also like to draw attention to the two bodily fluids indicated in Table 1: blood 
plasma and interstitial fluid. Blood plasma has been the most commonly used reference for 
SBFs traditionally [27, 28, 34], however, we have also included interstitial fluid for 
comparison, as it is arguably as important for biocorrosion comparison. Both blood plasma 
and interstitial fluid are extracellular fluids and are present in different areas of the body. 
They are kept in a state of homeostatic equilibrium by the Gibbs-Donnan effect [35], 
however, there are subtle differences between the fluids as shown in Table 1. Interstitial fluid 
has lower concentrations of Mg2+, Ca2+, HPO4-2, and proteins.  
As such, interstitial fluid creates a different biocorrosion environment in vivo than blood 
plasma. However, despite these differences, many studies have used blood plasma as a basis 
of comparison to specimens which were implanted in areas of the body where the samples 
would be in contact with interstitial fluid [23, 27] rather than in contact with blood plasma. 
This difference does by no means invalidate these studies, however, it is vital that future 
works consider strongly the bodily fluid they are trying to mimic during in vitro testing. 
Orthopaedic implants are likely to be in contact with interstitial fluid predominately, as well 
as blood plasma if the bone is heavily vascularised. Cardiovascular implants will be in 
contact almost exclusively with blood and blood plasma. Novel implants may be in contact 
with a less well studied solution, such as bile [36] or urine [37].  
Recommendation #3: Carefully consider which bodily fluid is being mimicked with SBF.  
Currently, SBFs and in vitro methodologies are not able to fully mimic in vivo biocorrosion 
mechanisms. As such, there is no “correct” SBF for each application. However, there are 
more and less correct solutions. A careful consideration of the in vivo biocorrosion 
environment, as well as the recommendations in this present study and our previous review of 
the field [15] will eliminate many of the common errors and mistakes that can limit the 
effectiveness of in vitro biocorrosion assessment.  
3.2. Experimental Factors  
In addition to SBFs, experimental factors can also have a significant influence on the 
biocorrosion environment in vitro.  
These factors were also considered in our previous review [15], and we summarise the 
recommendations as follows:  
1. pH should be maintained between ~7.35 and 7.45 with a CO2-HCO3- buffer system.  
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2. Solution temperature should be maintained at ~37 °C 
3. The ratio of sample area to solution volume should be kept above a minimum of ~50 
mL/cm2 
4. Solution flow rate should be kept slow to keep the solution homogenous, without 
significantly disturbing the specimens (unless testing specifically high flow conditions 
in which case efforts should be made to mimic the in vivo fluid flow conditions).  
We would like to expand on this discussion by including a number of more novel issues we 
have encountered. In the first instance: biological fouling. As previously stated, most SBFs 
are adapted cell culture mediums. This means they have the capability to grow cells, and in 
some cases will do so despite the experimenters’ best efforts. Application of best cell culture 
practice, including sterile and aseptic techniques [38-40], can mitigate the chance of 
contamination. And indeed, good lab practice and sterile technique has limited the occurrence 
of biological fouling to isolated incidences. The vast majority of our in vitro tests (and all of 
our reported data) has been untainted by biological contamination of the SBF. However, such 
techniques are not infallible, particularly for large bodies of solution which are often required 
for biocorrosion testing [41]. As such, isolated occurrence of biological fouling and organic 
contamination of solution can occur. 
This can prove challenging, as biological growths are a potential health hazard, as well as 
clogging or fouling instruments such as pumps used to maintain solution homogeneity. Some 
microorganism growth is also associated with a significant pH change. Figure 4 presents the 
same solution following a 1 day time lapse (left to right). The bacteria or microorganism 
growth was associated with a pH decrease of 3.5 (from 7.5 to 4.0), which caused the colour 
change due to the indicator used. The infected solution was also much less clear, as indicated 
by the almost indiscernible presence of the water pump in the bottom left corner of the 
photograph in Figure 4b. Such a significant pH drop will invalidate the biocorrosion data and 
as such must be mitigated. As this type of contamination often invalidates the test data, it is 
not often reported. However, from informal conversations at conferences and technical 
forums, the authors can attest that this is not an uncommon issue during biocorrosion testing.  
Marco et al. [41] suggested using a short wavelength ultraviolet (UVC) lamp and penicillin to 
sterilise the medium, and we have tried this with some success. However, as shown in the 
Figure 4, the effects of the UVC light are not guaranteed.  
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Additionally, if proteins are in the solution, a UVC light will likely damage or denature them 
[42], invalidating any biocorrosion data based on their effects. On the topic of proteins, we 
have found that biological growth and fouling are more common in SBFs which contain 
organic components (vitamins, amino acids, and proteins) as compared to simpler balanced 
salt solutions.  
Recommendation #4: Microorganism growth and biological fouling can invalidate 
biocorrosion data. Efforts should be made to minimise their effects, and affected data 
should be treated as suspect.     
Recommendation #5: UVC light and penicillin are useful for controlling microorganism 
growth in SBFs. However, a UVC light cannot be used in solutions containing proteins. 
  
Figure 4: Images of SBF after bacteria or microorganism growth. The colour change was caused by the 
indicator in the solution, due to a 3.5 pH drop from (a) to (b). A UVC light (pictured) was used to try and 
control the growth to some effect. The pump (indicated in both images) was visible below the solution level 
prior to the growth (a), but was not after (b). This indicates how opaque the solution became due biological 
fouling.   
Another unexpected outcome of microorganism growth can be gas creation or consumption, 
as this can influence the measurement of Mg corrosion. Hydrogen evolution can be useful as 
a cheap and easy way to set up measurement of the instantaneous corrosion rate. As shown 
by equation (1) 1 mole of Mg produces 1 mole of H2 gas. In theory, by collecting this gas 
(usually via an inverted funnel and burette [24, 43]) an effective approximation to the amount 
of Mg corroded should be forthcoming, and this has been shown to be effective for chloride 
solutions provided the corrosion rate is greater than ~1 mm/y [2, 24, 43]. 
 
 
(a) (b) 
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However, this assumes that (i) all the H2 produced by the Mg corrosion reaction is captured 
and measured in the funnel and (ii) the only gas introduced or removed from the funnel 
during the test is produced by the sample. Initially, we shall focus on point (ii), and return to 
point (i) in due course.  
Figure 5 shows a reference burette from a test which was aborted due to microorganism 
growth. This burette had no sample beneath it, and was used to adjust for small changes to 
atmospheric pressure and temperature [44]. The “zero” level for this reference burette is 50 
mL, but as shown in Figure 5 the solution level is several cm above this level. In isolation, 
this would suggest that several mL of gas have been consumed or displaced. We believe this 
disparity was caused by the microorganism in the SBFs. This is an additional reason to be 
wary of data which is gathered from tests which have experienced microorganism growth.  
However, returning to point (i), even had the reference been maintained it is unlikely that the 
H2 data from this test would have yielded accurate corrosion rates. While it has been shown 
to be effective in NaCl solutions at substantial corrosion rates [2, 43], hydrogen evolution has 
been found to be ineffective in SBFs such as Hanks’ solution due to the slower corrosion 
rates [24], as shown in Figure 6. This disparity is believed to be caused by the hydrogen gas 
being absorbed either by: (i) the Mg sample, (ii) the SBF, or (iii) a combination of both.  
While measuring the hydrogen evolution of a sample can provide some insight into the 
progression of corrosion during the test [32], direct conversion to a corrosion rate is not 
recommended. Additionally, any study which relies solely on hydrogen data to determine the 
biocorrosion rate should be treated circumspectly. We recommend that this technique be used 
in tandem with mass loss, which can be used to verify the findings. 
Recommendation #6: Hydrogen evolution data should not be converted directly into a 
biocorrosion rate, and should be treated circumspectly for samples which corrode slowly 
(less than 1 mm/y).   
Recommendation #7: Hydrogen evolution should not be the sole method of evaluating 
corrosion and should be used in tandem with mass loss.  
Finally, we consider the specimens themselves. We recommend that a minimum of three 
specimens be used per test, to account for variability. Additionally, regardless of the number 
of test specimens initially planned, it is suggested to add an extra run (i.e. if you plan to use 3, 
test 4 instead). This is especially useful in cases where some destructive testing is required. 
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For example, the cross sectional analysis of the specimen in the study of Marco et al. [33] 
yielded interesting results about the nature of the corrosion products on the samples surfaces. 
However, they invalidate these samples for use in mass loss assessment. Including an extra 
sample allows for more of this testing to be conducted. 
We recommend that wherever possible tests include as cast HP Mg samples for comparison 
to literature values. However, it is important that these HP Mg specimens contain no second 
phase particles, or erroneous conclusions can be drawn [4]. It is therefore important the 
samples be as cast, and have not undergone any thermal, thermomechanical or surface 
treatments. Such treatments can influence the corrosion properties of the sample [2, 45] and 
thus skew the data.  
Attention should be paid to literature values in similar solutions, and if biocorrosion rates 
deviate from these significantly it is likely the specimen is not as cast HP Mg and contains 
second phase particles or has undergone thermal, thermomechanical, or surface treatment. As 
an example, for HP Mg in HBSS (maintained at a temperature of ~37 °C, and pH of ~7.35-
7.45) corrosion rates of ~0.3-0.5 mm/y would be expected from literature values [24, 32, 
46].We source as cast HP Mg samples from Taiyuan Yiwei Magnesium Industry Co. Ltd., 
(10 YiFen St., 9th Floor Suite 910, Taiyuan, Shanxi, 030024, China).  
Recommendation #8: Include a minimum of 3 specimens to account for variability. Where 
possible, include an additional specimen more than was initial planned (i.e. 4 instead of 3) 
so that one can be used for destructive testing.  
Recommendation #9: Include as cast HP Mg specimens as often as possible for 
comparison to literature values, but ensure that the HP specimen contains no second phase 
particles and have a corrosion rate which is consistent with literature values. For HBSS 
(temperature ~37 °C and pH ~7.35-7.45) this rate is ~0.3-0.5 mm/y. 
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Figure 5: Reference burette which was effected by microorganism gas consumption. 50 mL was the original  
position of the fluid. As gas evolves, the solution level should drop as the solution is displaced by gas. 
However, due to the microorganism contamination present in this solution, the solution level increased 
several centimetres, invalidating the readings.  
 
Figure 6: Comparison between corrosion rates evaluated from hydrogen evolution (PH) and mass loss (Pm) from 
a number of studies which tested biocorrosion in similar in vitro conditions. The solid line is a 1:2 ratio (PH:Pm) 
where the dashed line is a 1:1 ratio.  Reprinted with permission from [24]. 
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4. Conclusions & Recommendations  
The study of Mg biocorrosion in vitro is a complex and nuanced endeavour. Throughout our 
many tests and experiments we have learned some important lessons and have iteratively 
improved both our understanding of Mg biocorrosion and our ability for accurate 
measurements. It is our hope that sharing some of the lessons learnt (and associated 
recommendations) during these tests helps to improve the in vitro biocorrosion assessment of 
Mg alloys. In addition to (or in the case of #1 in clarification of) the recommendations 
outlined in our previous review [15] we present the following:  
Recommendation #1: SBFs should contain HPO4-2, as opposed to only containing H2PO4-. 
Recommendation #2: Care should be taken when procuring SBFs. Small changes in 
product code (e.g. M9288 vs M 0268) can have a substantial difference on the biocorrosion 
environment. H1387 and M9288 are preferred, as they contain HPO42-. 
Recommendation #3: Carefully consider which bodily fluid is being mimicked with SBF.  
Recommendation #4: Microorganism growth and biological fouling can invalidate 
biocorrosion data. Efforts should be made to minimise their effects, and effected data 
should be treated as suspect.     
Recommendation #5: UVC light and penicillin are useful for controlling microorganism 
growth in solutions without proteins 
Recommendation #6: Hydrogen evolution data should not be converted directly into a 
biocorrosion rate, and should be treated circumspectly for samples which corrode slowly 
(less than 1mm/y)   
Recommendation #7: Hydrogen evolution should not be the sole method of evaluating 
corrosion and should be used in tandem with mass loss wherever possible.  
Recommendation #8: Include a minimum of 3 specimens to account for variability. Where 
possible, include an additional specimen more than was initial planned (i.e. 4 instead of 3) 
so that one can be used for destructive testing.  
Recommendation #9: Include as cast HP Mg specimens as often as possible for 
comparison to literature values, but ensure that the HP specimen contains no second phase 
particles and have a corrosion rate which is consistent with literature values. For HBSS 
(temperature ~37 °C and pH ~7.45) this rate is ~0.3-0.5 mm/y. 
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Chapter 8: Summary, Recommendations,  
and Future work 
This chapter summarises the most impactful results from the research carried out in this 
thesis. As each individual preceding chapter has a conclusions section, an effort was made to 
not simply repeat these conclusions here. Rather, the intent is to present the major findings of 
the thesis within the context of the wider research area, and to consider how these findings 
may influence future work to advance this field of study.   
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Considerations for In Vitro Biocorrosion Testing of Mg Alloys  
While in vivo and clinical testing are vital to further our understanding of Mg biocorrosion, 
the majority of research into Mg biocorrosion is currently, and will likely to remain, in vitro 
testing. In vitro tests are economic, easy to establish and repeat, and have a far lower ethical 
burden than in vivo testing. Whether they be immersion tests, electrochemical measures, or 
cell culture studies, in vitro experiments will continue to form the foundation of Mg 
biocorrosion study, and it is essential to produce results that are applicable to the service 
condition.  
The recommendations provided in Chapter 2 and Chapter 7 provided a solid foundation for in 
vitro testing, in particularly immersion tests. By following these guidelines, it is possible to 
minimise the errors common to in vitro tests. In summary: 
1. The SBF should contain ions similar to that of the bodily fluid they seek to mimic. 
Some ions are not vital to biocorrosion (SO42-, Na+, K+). However, others are vital to 
accurate biocorrosion testing. Ca2+ and PO42- form integral components of the 
corrosion product layer, as does Mg2+. HCO3- is essential not only to the corrosion 
product layer, but also to maintain the correct pH. 
2. Adequate pH control is essential for all in vitro experiments. The solution pH alters 
the stability of corrosion products, as well as the interaction of various components in 
the SBF. As pH is strictly regulated in vivo, it should not be allowed to deviate 
significantly during in vitro testing.  
3. To control the pH, the buffer of CO2-HCO3- should be used, as it best mimics the 
bodies pH control mechanisms.  
4. The temperature of the solution should be maintained at ~37 °C to mimic the human 
body temperature.  
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5. Organic components such as amino acids and proteins play an active role in Mg 
biocorrosion. However, attempts to include them in vitro have made for poorer 
comparisons to in vivo results. As such, it is recommended that they be not used in 
general testing, and only included when a specific component or interaction is being 
considered. This recommendation should be reconsidered once a better understanding 
of their influence is gained.  
6. An adequate (> ~50 ml/cm2) solution volume should be used for the surface area of 
the specimen. Inadequate solution volumes can cause depletion of relevant ions, and 
poor pH control. Solution replenishment can be used in conjunction with this protocol 
if a long term test is planned.  
7. If high flow conditions are being tested, they should be matched to service conditions 
in the body for that application. Otherwise, a slight flow rate to maintain solution 
homogeneity is recommended.  
A perfect in vitro methodology remains elusive, and adherence to the outlined 
recommendations do not yield perfect comparison to in vivo data. However, these 
recommendations yield a good approximation of the in vivo biocorrosion environment, and 
help to reduce discrepancy between tests. In particularly, it is vital for accurate testing that 
attention is paid to the specific in vivo biocorrosion environment that is intended to be 
mimicked. The focus on blood plasma has yielded interesting results, however further 
inspection suggests a comparison to interstitial fluid would have been more appropriate for 
many applications.  
Experience indicates that HBSS buffered with the CO2-bicarbonate buffer at 37 °C 
reproduces subcutaneous in vivo biocorrosion with a satisfactory degree of accuracy, and is a 
reasonable starting point for future testing. The good comparison to in vivo results presented 
in Chapter 6 gives confidence in the results of Chapters 3 and 5 where HBSS was used as an 
in vitro model. Further testing into the refining of the in vitro solution is recommended 
however. HBSS is effective as it is an “off the shelf” SBF which can be procured ready-
made, and in bulk. However, more specialised solutions may improve comparison to in vivo 
results. By specialising a solution to more accurately mimic interstitial fluid or blood plasma, 
specifically by decreasing [Cl-] and increasing [PO42-], a decrease in corrosion rate and 
localised corrosion will likely be achieved. This may allow the introduction of organic 
components such as amino acids and/or proteins into the SBF, thereby increasing corrosion 
rates, potentially back to levels which match in vivo rates.  
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A standard in vitro methodology would expedite any such testing, as it would make small, 
iterative improvement much simpler to complete, and reduce repetition and redundant testing. 
Such a standard has been discussed previously [1], and is under development at the time of 
writing. It is hoped that results from this thesis, and in particular the works contained in 
chapters 2, 4 and 7, prove useful for developing a standardised approach to biocorrosion 
assessment of Mg alloys.  
Considerations for In Vivo Biocorrosion Testing of Mg Alloys 
Often used as a benchmark of success and an analogy for the service condition, in vivo 
studies of Mg biocorrosion provide vital insight into the complex biocorrosion environments 
in the body. Moreover, in vivo tests are often used to validate in vitro results. As such, a 
considered approach must be taken to all in vivo tests to ensure the data gathered is accurate 
and useful. This is not only to safeguard the scientific rigor of the study, but also due to the 
ethical burdens intrinsic to in vivo animal studies.   
Sample preparation is a key factor in preparing for an in vivo study. All samples should have 
minimal sharp edges, as these may aggravate the tissue and skew the results. Additionally, all 
samples must be adequately sterilised before implantation. The results from Chapter 3 show 
that both ethylene oxide and gamma irradiation are applicable for use on Mg alloys.  
Care must also be taken when selecting the implantation site, and the experimenter must 
consider what data is needed from the study. If no particular application is intended, 
subcutaneous implantation is minimally invasive and therefore less technically strenuous, as 
well as having a lower ethical burden. However, if a particular application is intended, the 
Mg specimen should be implanted in a location as close to the service location as possible. 
As discussed in Chapter 4, the biocorrosion environments in vivo varies substantially for 
different applications.  
Hydrogen evolution continues to be a significant issue for Mg medical implants, and deserves 
further study. The study of how the gas interacts with the body tissue has yielded interesting 
results [2], as has the work in Chapter 4 visualising the size of the gas pocket. Quantifying 
the size of these pockets would be a valuable contribution, as this would allow for a more fine 
scale analysis of the corrosion rates. The interaction between hydrogen gas and various 
tissues, particularly hard tissue such as bone, would be valuable. Hydrogen gas has been 
found to be absorbed by various bone tissues [2], and an analysis of the physical and 
mechanical properties of this bone could yield interesting results.  
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From the statistical analysis presented in Chapter 4, the influence of animal sex on Mg 
corrosion deserves further consideration. Sex bias in biomaterials is a topic of much 
discussion in recent years, and it is suggested that future Mg biocorrosion studies include 
both male and female animals. Further work in this area directly should include a 
reproduction and/or expansion of the initial data set, with a follow up large animal trial to 
determine if this influence persists, and how substantive.  
Finally, a thorough analysis of the biocorrosion environment in a range of in vivo 
implantation sites is recommended. As previously mentioned, in vivo biocorrosion studies 
often form the cornerstone of Mg biocorrosion studies. However, our understanding of the 
biocorrosion environment in vivo is not as detailed or well documented as could be hoped. A 
detailed understanding of the body fluids in contact with the Mg in various environments, as 
well as in vivo specific factors such as specimen encapsulation, are vital to a deeper 
understanding of Mg biocorrosion in vivo and in service. If in vivo studies of Mg biocorrosion 
are to be used as a benchmark for other data, we need to understand the important factors that 
influence the biocorrosion environment in vivo so they can be studied, analysed, and properly 
reported.  
In Vitro models of in vivo corrosion  
The relationship between in vitro solutions and in vivo data has been a common theme in 
almost all the chapters of this thesis. As previously stated, if the recommendations in 
Chapters 2 and 7 are followed, it is believed that the in vitro results corresponded reasonably 
with in vivo data. And it is this data that was built on when applying the results of the in vitro 
testing in Chapters 3 and 5 into the further testing of Chapters 4 and 6 respectively. In vitro 
data, while not perfect, can provide a cost effective model of in vivo biocorrosion when the 
testing solution and parameters are considered carefully. This can also be done in a cost and 
time effective manner, with minimal ethical burden.  
That being said, in vitro to in vivo comparison is made substantially more effective by careful 
consideration of the in vivo environment that is being mimicked. Table 7 in Chapter 4, 
reprinted for reference here, outlines the various bodily fluids that implants may be in contact 
with in a variety of applications. All of these fluids have different concentrations of ionic and 
organic components, as well as solution pH, all of which influence the biocorrosion 
environment.  
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Table 7 (Chapter 4): A selection of potential medical applications for Mg alloys and the associated bodily fluid 
that will likely form the basis for the in vivo biocorrosion environment.  
Implant or Application Bodily Fluid Reference 
Orthopaedic surgery  
(e.g. screws, pins, plates) 
Interstitial fluid and blood plasma (due to the 
vasculature in the bones).  
[3, 4] 
Cardiovascular stent Blood Plasma. [5, 6]  
Staples, and sutures Interstitial fluid, and potentially blood plasma if 
they are intended to pierce a blood vessel.  
[7] [3] 
Tracheal/ oesophageal 
stent  
Saliva, and interstitial fluid. [8, 9] 
Biliary stent Bile. [10] 
Urinary stent Urine. [11] 
Gastrointestinal Surgery  Gastrointestinal fluid.   [12, 13] 
 
Tailoring in vitro testing to the specific in vivo environment is a topic that deserves 
considerable further study. As outlined in Chapter 4, the subcutaneous environment did not 
have a body of solution, but was rather more accurately characterised as ‘damp’ or ‘wet’. 
Therefore, an immersion test is likely not the optimum in vitro methodology for this 
environment. Specimens placed on or in an absorbent, porous material (i.e. a sponge or cotton 
wool) which is fed solution from a controlled system with the correct pH and temperature 
may yield more accurate comparisons. 
Similar adaptive testing could be considered for other applications. Immersion testing is 
suitable for cardiovascular applications; however, the use of a pulsating flow system is more 
accurate to these in vivo conditions. Cyclic, radial force to mimic arterial contractions may 
also prove useful, particularly for the study of fatigue and fatigue corrosion. The prototype 
Mg surgical tacks could be tested once implanted into absorbent materials, similar to the 
subcutaneous implants. Orthopaedic implants would likely need a less porous material, 
although their interaction with body fluids will be altered depending on the vasculature of the 
particular bone tissue.  
 
 
 
 
 
 
- 209 - 
 
Applying Mg Alloys to a Wider Array of Medical Applications 
As corrosion resistance is a significant limiting factor to the wider use of Mg alloys in 
medical applications, it is logical to consider it in depth. By developing a deep and full 
understanding of Mg biocorrosion, we can improve future testing, and aid development of 
corrosion resistant alloys and post-processing techniques to expand the application of Mg 
alloys in this novel application. However, thought should also be given to the applications 
themselves, and the types of medical implants that Mg alloys may be applicable for.  
Strong consideration has already been given to the fields of cardiovascular and orthopaedic 
surgery, and for good reason. These fields have already benefitted from the introduction of 
Mg implants, with successful clinical outcomes reported  [5, 14]. However, these applications 
represent a narrow band of what Mg alloys may be able to achieve in medical applications. 
The successful development, prototyping, and testing of the Mg surgical tack presented in 
Chapter 6 is evidence that considering Mg alloys in a wider array of applications can lead to 
exciting and positive results. Further consideration for Mg alloy wire in applications such as 
sutures [3], or staples [15, 16] is suggested for future research. More oblique aspects of 
cardiovascular or orthopaedic technology may also be worthy of consideration. A mesh made 
from Mg wire has been suggested for cranial surgery [17]. Spinal fusion cages [18-21] are 
also worthy of consideration.  
Final Thoughts  
In summation, Mg alloys have found a valuable niche as degradable, metallic biomaterials, 
and have considerable scope to grow in this application. Degradable Mg implants have 
already found clinical success in orthopaedic and cardiovascular surgery, and the results from 
this thesis show the potential of Mg alloys in novel applications such as surgical tacks. 
However, the limiting factor for Mg alloys in medical applications remains the poor 
understanding of their biocorrosion behaviour. The works presented herein show that there is 
still substantial study required before we have fully elucidated all the factors that influence 
Mg biocorrosion in medical environments. It is hoped that the exploration of Mg biocorrosion 
in this thesis will contribute to a more complete understanding and characterisation of Mg 
corrosion in medical environments, and help to improve patient outcomes by furthering 
investigation of this emerging biomaterial.   
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